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Abstract 
 
Within the ventral midbrain of the developing vertebrate embryo there is 
a transient area of conserved gene patterning called the midbrain arcs, this 
patterning influences the formation and position of nearby nuclei, as well 
as the position of the MLF (medial longitudinal fascicle) axon tract in the 
early axon scaffold. A hypothetical regulatory loop has been identified 
between the genes Nkx1.2 and Emx2 during midbrain arc patterning and 
this project aimed to identify if a highly conserved non-coding sequence 
named Nkx1.2.1 acted as an enhancer for the Nkx1.2 gene, and bound 
directly with the Emx2 protein.  
Electroporation of a reporter construct containing the Nkx1.2.1 
sequence in the chick embryo identified the element was active specifically 
in the ventral midbrain during the time of midbrain arc patterning. The 
Nkx1.2.1 sequence was then analysed for binding affinity with the Emx2 
protein using EMSA. The full Emx2 sequence could not be produced in a 
soluble form, but two artificial sub-forms of the protein were produced. 
The closest binding affinity identified was a value of 0.2 KdµM, compared 
to the control experiment using a non-specific sequence of DNA of 2.6 
KdµM.   
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Chapter 1 – Introduction 
 
1.1 Project Introduction 
The genome activity of an embryo has to be strictly regulated during 
development for accurate gene expression and appropriate spatial and 
temporal cell differentiation to occur.  It is the way the DNA within a cell 
is regulated, through gene regulatory networks (Davidson & Levin 2005) 
(Figure 1.1) that creates the huge diversity of cells within an organism.  
 The predicted number of protein coding genes in the human 
genome has fluctuated (reviewed by Pertea & Salzberg 2010) ever since 
the genetic code was first discovered (Matthaei & Nirenberg 1961). A 
variety of techniques were implemented to estimate the number of genes 
in the human genome; CpG islands have been utilised to quantitatively 
analyse the genes in the human genome, putting the estimate at around 
23,000 (Antequera & Bird 1993). By including the use of expressed 
sequence tags (ESTs) (Adams et al. 1991) The number of protein-coding 
genes was estimated to be approximately 100,000 (Goodfellow 1995). The 
Human Genome Project  (Lander et al. 2001) estimated that the human 
genome contains roughly 30,000 – 40,000 protein coding genes. The 
complexity of the regulation of these genes has been investigated by the 
Encyclopaedia Of DNA Elements (ENCODE) project (Good et al. 2004). 
This project  
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Figure 1.1. Simplified gene regulatory network diagram. The 
hypothetical cascade of transcription and translation which occurs from a 
single gene to form a gene regulation network (GRN). The diagram 
highlights the possible genetic cascade caused by the activation of a gene 
(Gene A). Gene A, C, E, H and I form a genetic cascade, while protein A is 
involved in the activation of both gene B and gene C. The proteins form 
genes B and F form a complex which inhibits the transcription of gene D 
and the product of gene G.  
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identifies and catalogues functionally important DNA elements, and it 
found 80% of the human genome serves some purpose, disproving the 
earlier idea that much of the non-coding DNA was ‘junk’ DNA (Haeussler 
& Joly 2011). The project highlights candidate gene regulatory elements by 
identifying protein binding sites within the genome sequence and 
evolutionary conserved areas of sequence when compared to other 
vertebrate genome sequences. These candidate regulatory sites are often 
not coding sequences, and do not have a standardised structure (such as 
the TATA element within a eukaryotic promoter sequence). This project 
set out to test the possibility of direct gene regulation between two 
homeobox genes that pattern a specific area of the anterior neural tube, the 
ventral midbrain during the development of the embryo, as an original 
contribution to knowledge. 
 
1.2  Gene Regulation in the Embryo 
Gene regulation leads to differential gene expression, and this underlies 
the differentiation of cell types. Understanding gene regulation is key to 
understanding the genetic programme of a developing embryo.  The 
product of the transcription of one gene, be it RNA or protein, can be 
involved in the transcription of multiple other genes, which creates a gene 
expression cascade. Studying gene regulation across spatial and temporal 
axis during embryo development identifies gene regulatory networks 
(GRN); a concept which maps the multiple cascades of gene expression 
caused by gene regulation across the embryo during development. 
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Accurate spatial and temporal control of gene production in a GRN plays 
a key role in the development of the fertilised egg to an independent 
organism. The process is initially aided by maternal mRNA and proteins 
(Weeks & Melton 1987), but the genome within the fertilised egg cell 
contains all the instructions necessary to regulate the development 
process. As shown in Figure 1.1, the transcription of a single gene can 
initiate a cascade which includes multiple different genes, involved in the 
regulation of the cascade as well as further transcription initiation. The 
genes identified in Figure 1.1 can be characterised as transcription factors, 
these genes code for proteins which bind to specific DNA sequences to 
regulate the level of transcription of the gene they have bound to 
(Latchman 1997). As an example, accurate gene regulation in vertebrates 
controls the differentiation path of an ectodermal cell into a 
neuroectodermal cell (Shimamura & Rubenstein 1997), which in turn can 
differentiate into a neuron under complex and controlled gene regulation 
(Camus et al. 2000). This is done by differential gene expression regulated 
by a hierarchy of transcriptional control in GRN (a theoretical example is 
sohwn in Figure 1.1); although each different type of cell contains the 
same genome, the gene expression is tightly regulated at several stages of 
transcription and translation. This differential gene expression creates 
distinct cell types which lie within discrete boundaries creating regional 
specification. Neural cells differentiate relatively early during 
development (Pera et al. 1999).   
Differential gene expression patterns are often conserved through  
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evolution (Veraksa et al. 2000). An example of this is the transcription 
factor Pax6, which is essential for normal eye development in both 
vertebrates and flies (Ashery-Padan & Gruss 2001). 
 
1.2.1   Gastrulation 
 After fertilisation, during blastula stages, the vertebrate embryo is already 
patterned along the mediolateral axis (Pera et al. 1999). The primitive 
streak marking the anterior/posterior axis is then formed through a 
signalling cascade involving a variety of morphogens including Wnt, 
Noggin and Chordin (Wilson & Edlund 2001).  Cells that reside in a 
specific region of the anterior portion of the primitive streak form a node 
which is known as an organiser. It is at this area that gastrulation first 
begins (Weng & Stemple 2003), and this node also determines the dorso-
ventral axis of the embryo initiating the development of axial mesoderm 
(Jones et al. 1995). It is important to note at this point that the processes 
and structures, and the terminology associated with them, are different in 
fish, amphibians and amniotes, although there is homology in the 
dorsoventral patterning of all organisms with bilateral symmetry (De 
Robertis & Sasai 1996), controlled through BMP (bone morphogenic 
protein) signalling and inhibition. 
Later on in development, the central nervous system (CNS) is 
induced from this node region (Storey et al. 1992), although early neural 
induction is initiated before gastrulation.  A variety of names exist in 
different developmental model organisms to describe the orthologous 
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organiser node; Henson’s Node in chick embryos (Selleck & Stern 1991), 
Spemann’s Organiser in Xenopus embryos (Watabe et al. 1995), the shield 
in fish embryos (Iwamatsu 2004) and the node in mouse embryos (Robb & 
Tam 2004). Early research in amphibians using explants of the  node 
showed that the organiser node can induce ectopic neural cells (Spemann 
& Mangold 1923, Waddington 1932).   
In amphibian models, neural induction occurs through the 
influence of the newly induced Spemann’s organiser on dorsal ectoderm; 
initially the organiser induces the ectoderm to become anterior neural 
tissue (the forebrain), neural ectoderm induced after this becomes the 
midbrain and then later the hindbrain and spinal cord (Nieuwkoop 1952). 
A number of BMP inhibitors; Follistatin, Noggin and Chordin, are expressed 
in the Xenopus organiser region during neural induction (Hawley et al. 
1995). Neuroectoderm is the default fate of the ectoderm cells, with BMP 
inducing epidermal fate (De Robertis & Kuroda 2004). The BMP inhibitors 
from the organiser prevent the induction of epidermal fate (Kuroda et al. 
2004) and therefore allow the formation of the neural plate (Wilson & 
Edlund 2001). 
The organiser is orientated at the anterior of the primitive streak, in 
avian, reptilian and mammalian embryos (Schier & Shen 2000). From here 
epiblast cells migrate through the primitive streak (Joubin & Stern 1999) 
(Figure 1.2), similar to the cell migration pattern of neural induction in 
amphibians (Figure 1.2). Cells migrating through the organiser at different 
time points are destined for different cell fates  (Lawson et al. 1991);
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Figure 1.2. A Figure to show the spatial changes in germ layers during the gastrulation process. Panel A shows the 
gastrulation process in the Xenopus embryo, Panel B shows the gastrulation process in the Chick embryo and Panel C 
shows the gastrulation process in the human embryo (adapted from Gilbert 2000). In each Panel the ectoderm is shown in 
blue, the mesoderm in red and the endoderm in yellow. In each species the mesodermal cells migrate, and the germ layers 
are formed 
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the first cells to migrate through become pharyngeal endoderm, which 
migrate further anteriorly and ventrally. Cells which migrate through after 
this become prechordal plate mesoderm and do not migrate as far to the 
anterior as the previous cells. The next wave of cells are destined to 
become axial mesoderm which create the head process and the notochord, 
these cells also migrate anteriorly. A schematic representation of the cell 
migration to form the germ layers is shown in Figure 1.2. As the primitive 
streak regresses the germ layers which differentiate after travelling 
through the organiser create discrete areas of regional specification within 
the body of the embryo. The most anterior part of the neural tube starts to 
swell and begins to form the subunits of the developing brain; the 
forebrain, midbrain and hindbrain, with the neural tube continuing 
caudally.  
 
1.2.2   Prosomeres 
The developing brain is split up into segments called neuromeres which 
are morphologically and molecularly defined regions which exist 
transiently during brain development (Northcutt 2008). The neuromeres 
within the forebrain and midbrain are called prosomeres (Puelles 2009) 
and are governed by Wnt signalling (Puelles & Rubenstein 1993) along 
with BMP, FGF and Shh signalling which creates the two secondary brain 
vesicles; the telencephalon and the diencephalon. The gene patterning 
which creates these neuromeres originates from local signalling centres 
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which determine the boundaries between the neuromeres within the 
developing brain (Kiecker & Lumsden 2005).  
Historically the neuromeres (transient neural structures) within the 
hindbrain (called rhombomeres) have been the most extensively 
researched, because of their metameric (repeating) structure through the 
hindbrain. The rhombomeres are initially patterned by the bi-directional 
signalling of Eph and Ephrin, and the patterning along the anterior-
posterior axis by Fgf and retinoic acid signalling (Marín & Charnay 2000, 
Dupé & Lumsden 2001), which creates the metameric structure of the 
hindbrain (Flanagan & Vanderhaeghen 1998). These morphologically 
identified neuromeres are then determined by the cross regulation of Hox 
genes (Wilkinson & Krumlauf 1990) which leads to each rhombomere 
containing a combinatorial code.  
A major group of genes which encode transcription factors 
involved in early embryonic development are the homeobox genes, these 
homeobox genes can often be identified by the gene name containing an 
‘x’, such as the Hox genes or Nkx1.2 (which is characterised later in this 
chapter). During the development of a Drosophila embryo, multiple 
different genes were identified to be involved in the segmentation process 
(Nüsslein-Volhard & Wieschaus 1980). Many of these genes shared a 
common 183bp homeobox sequence (McGinnis & Krumlauf 1992), this 
homeobox sequence is conserved from insects to vertebrates and is critical 
in the patterning of the developing embryo (Kuroiwa 1986). The 
homeobox gene sequence codes for a homeodomain (HD) within a 
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protein, which recognises and binds directly to specific DNA sequences 
(Gehring et al. 1994) and subsequently regulates target gene expression. 
Through evolution the amino acid sequence of the homeodomain has been 
conserved to a high extent (Gehring et al. 1990). 
The rhombomeres are patterned across the dorso-ventral axis by 
Sonic hedgehog (Shh) (Briscoe et al. 2000) which is expressed along the basal 
plate of the anterior neural tube, and creates a morphogen gradient across 
the dorso-ventral axis. Shh is a highly conserved signalling molecule 
which acts morphogenically within the neural tube but has been 
predominately associated with neural development in the spinal cord, 
where in vitro studies have shown the diverse cell types generated from 
different concentration of the Shh protein (Martí et al. 1995), with distinct 
classes of motor neurons and interneurons being generated at specific 
dorsoventral positions in the ventral neural tube according to the 
concentration of the Shh morphogen (Briscoe & Ericson 1999). 
In conjunction with Shh being integral for hindbrain patterning, Shh 
is also necessary for appropriate region-specific gene expression in the 
thalamus and prethalamus, where it is secreted from the zona limitans 
intrathalamica (ZLI) (Kiecker & Lumsden 2004), the ZLI acts as the 
diencephalic organiser to pattern these areas. The Shh expression, coupled 
with two secreted signalling molecules WNT-1 and FGF8, influences 
neuronal cell fate across the anterior neural tube (Ye et al. 1998), The Fgf8 
and Wnt-1 signalling originates from the isthmic organiser (IsO) (Bally-
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Cuif & Wassef 1994, Crossley et al. 1996) in the midbrain-hindbrain 
boundary (MHB).  
The IsO (Isthmic organiser) controls the development of the midbrain and 
anterior hindbrain during brain development (Wurst & Bally-Cuif 2001a), 
and this organiser centre, with the anterior-posterior patterning controlled 
by FGF (Mason et al. 2011) and the dorso-ventral patterning controlled by 
Shh (Ishibashi & McMahon 2002)(with Wnt1 expression from the roofplate  
(Avilés et al. 2013)), together specifies cell types like the dopaminergic 
neurons in the midbrain (Ye et al. 1998) (Figure 1.3). As well as anterior-
posterior patterning of the neural tube which creates the different brain 
structures; the telencephalon; diencephalon; mesencephalon and the 
rhombencephalon, the neural tube is also subdivided across the dorso-
ventral axis by a structure called the sulcus limitans, which runs along the 
length of the neural tube (reviewed in Haines 2004). The dorsal section 
above the sulcus limitans is called the alar plate or alar lamina, and the 
ventral section is called the basal plate, or basal lamina (His 1893). Several 
genes are expressed in longitudinal stripes across the across the dorso-
ventral axis, with two genes; Shh and Nkx2.2 being expressed throughout 
the neural tube from the forebrain to the caudal spinal cord (Shimamura et 
al. 1995), the extent of Shh patterning within the developing neural tube is 
shown in Figure 1.3. 
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1.3 Midbrain Patterning 
As shown in Figure 1.3, the anterior limit of the midbrain is demarcated 
by the di-mesencephalic boundary (DMB) which is patterned by the 
expression of Pax6 (Mastick et al. 1997). Pax6 acts as a transcriptional  
   
Figure 1.3. Sagittal view through a mouse neural tube at E11 showing 
the signals that pattern anteroposterior and dorsoventral from the mid-
hindbrain border. Secreted factors, which control neuronal identities, 
originate from the neural plate at the mid- hindbrain junction (Fgf8, 
purple) and floor plate (Shh, light blue), as well as from non-neural tissues 
during gastrulation (Fgf4, dark blue) from the anterior mesoderm, and 
members of the BMP family (brown) from the non- neural, dorsal 
ectoderm). Motor neurons of cranial nerve III and dopaminergic neurons 
of the tegmentum respond to a combination of Shh and Fgf8 signals. 
Serotonin neurons of the pons require early Fgf4 signalling, followed by is 
defined by the expression boundary of Oxt2 and Gbx2(Wurst & Bally-Cuif 
2001b). 
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activator (Schwarz et al. 1999) but represses the expression (by inducing a 
repressor) of En1 (Matsunaga et al. 2000), which is induced from the IoS  
(Nakamura 2001), this repressive interaction demarcates the DMB. The 
posterior limit of the midbrain is bordered by the IsO (Martínez 2001), and 
the IoS induces En1 which cross-represses Pax6 to set the DMB. The FGF8 
expression originating from the IoS acts as a morphogen (Mason et al. 
2011) inducing Wnt1, En1 and Pax2, this GRN maintains the expression 
pattern from the IsO.  
1.3.1 Midbrain Arc Patterning 
A transient pattern of reiterating territories created by homeobox genes 
and morphogens spreads out from the ventral midbrain floor-plate and 
extends in a dorso-anterior direction. The expression pattern, called the 
midbrain arcs (Agarwala et al. 2001), lies across the midline of the ventral 
neural tube and precedes the development of specific neuron clusters 
called nuclei in the midbrain (Agarwala & Ragsdale 2002), this is shown in 
the chick ventral midbrain in Figure 1.4. 
The arcs, numbering 1 to 5 from medial to lateral, are molecularly 
distinct from one another with each expressing a unique array of 
homeobox genes (Sanders et al. 2002). This finding was based on research 
published the previous year (Agarwala et al. 2001) showing Shh secreted 
by the floorplate creates a morphogen gradient, which patterns the ventral 
midbrain.  The work by Agarwala in the gene patterning of the midbrain 
arcs found that arc one is marked by the presence of Phox2a and Isl1, Pax6 
marks the gap (interarc) between arcs 2 and 3, Evx1 patterns arc 4 and the  
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Figure 1.4. Gene patterning of the midbrain arcs of the developing chick brain. Panel A is a schematic summary of the 
midbrain arcs. The diagram shows the patterning of the arcs and the arc numbers detailed underneath. The pattern of 
developmental signalling molecules is shown beneath; WNT5A and DELTA1 shown in blue and green, the homeobox genes 
in yellow, orange and red, and the acetylcho-linesterase (ACHE) activity in pink to show the position of the brain nuclei  
(adapted from Sanders et al. 2002). Panels B and C show the results from the in-situ hybridisation experiments using an RNA 
probe and visualised using Alkaline phosphatase (Ahsan et al. 2007).  Panel A shows the arc pattern formed by the Nkx1.2 
gene expression, highlighted by the black arrow. Panel C shows the arc pattern formed by the Emx2 gene expression, 
highlighted by the two black arrows. The location of the midbrain-forebrain boundary is depicted by the black lines in panels 
B and C. 
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interarc between arcs 3 and 4, with the periphery of the Shh gene 
expression area being demarcated by the expression of FoxA2. Research 
the following year (Agarwala & Ragsdale 2002) identified more genes 
involved in arc patterning; Pax3 patterns the lateral edge of the midbrain 
tegmentum and the rostral area of arcs 2-3 is patterned by Emx2 (Fugire 
1.4) and Brn3a expression. Further research (Schubert & Lumsden 2005) 
identified the homeobox gene Nkx1.2 as patterning the rostral area of arcs 
1 and 2, and the caudal region of arcs 2 and 3, as well as the caudal region 
of the interarc 2-3 (Figure 1.4), the research also identified the gene Six3 as 
patterning arcs 2 and 3. 
The gene PHOX2A has been show to play a role in ocular nuclear 
formation in the midbrain (Hasan et al. 2010). As well as this, two of the 
midbrain nuclei; the oculomotor complex (OMC) and the red nucleus 
(RN), were both found to be derived from cells which pattern the most 
medial of the midbrain arcs (Agarwala & Ragsdale 2002) which are 
patterned by FoxA2 (Agarwala et al. 2001). The OMC and RN are both part 
of the motor system but have very different functions; the neurones from 
the RN are involved with general motor function, whereas the OMC 
specifically innervates the muscles of the eye.  The accurate patterning of 
the midbrain arcs leads to multiple nuclei formation, and these have a 
high diversity of function, but there is limited knowledge on the 
interactions and regulation of the genes involved in midbrain arc 
patterning. This project aims to highlight the regulation governing part of 
the midbrain arc patterning by identifying a regulatory element associated 
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with the hypothesised regulatory loop between the genes Nkx1.2 and 
Emx2 (Schubert & Lumsden 2005,Ahsan et al. 2007). 
 
1.3.2 Current Knowledge Concerning Nkx1.2 
The Nkx1.2 gene has been renamed multiple times as genetic sequencing 
has become more accurate and orthologous genes have been identified. 
The homeobox gene Nkx1.2 is involved in patterning the midbrain arcs 
and critical for accurate growth of the medial longitudinal fasciculus 
(MLF) axon tract. A homologue of this gene was first identified in 
Drosophila and named NK1 (Dohrmann et al. 1990), with the Nkx1.2 gene 
first identified in the chick as Chox3, this gene is a protein coding 
homeobox gene conserved through evolution and shares a common 
ancestor with  the Drosophila gene NK1 (Kim & Nirenberg 1989), it was 
first identified in chick embryos in the late 1980’s (Rangini et al. 1989). 
Following this the gene was renamed Sax1 and the expression pattern was 
identified in the neural plate of the developing embryo in chick (Spann et 
al. 1994). Research also published in 1994 identified a mouse homeobox 
gene which they named Nkx1.1, as a relative of the NK Drosophila gene 
(Bober et al. 1994) which was later identified as being the same gene as 
Sax2, a homologue of Sax1. Sax1 was identified as the earliest neural-
specific marker expressed in the posterior regions of the embryo (Storey et 
al. 1998). In 1999 the gene was renamed again as Nkx1.2, relating to the 
Bober research on Nkx1.1 in 1994, in a study in mouse, which identified 
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splice variants of the gene without the homeodomain (Rovescalli et al. 
2000).   
 Nkx1.2 is involved in the GRN associated with neural development 
the embryo. In the caudal neural plate in the spinal cord Nkx1.2 is 
regulated by Fgf signalling in the chick embryo (Delfino-Machín et al. 
2005). The Nkx1.2 gene is expressed early in development in the, 
tegmentum and pretectum of the mouse (Schubert et al. 1995b). By stage 
E11 there is dorsal expression in the area of the pretectum, and ventral 
expression, continuing from the midbrain arc patterning. There is also 
expression within the ventral anterior mesencephalon of the embryonic 
mouse brain. Nkx1.2 is expressed in the ventral midbrain as shown in the 
embryonic midbrain of the developing Zebrafish embryo (Bae et al. 2004), 
this midbrain expression pattern is similar to that of the chick (Schubert & 
Lumsden 2005) and the mouse (Schubert et al. 1995b). The experiments by 
Schubert and Lumsden (2005) showed that the Nkx1.2 gene is expressed 
early on in development of the chick embryo, at stage HH15, when it can 
be observed with in-situ hybridisation in the area of the ventral midbrain-
forebrain boundary. By stage HH20 the Nkx1.2 expression appears 
dorsally across the midbrain from the ventral mesencephalon to the dorsal 
pretectum. Ectopic expression of Nkx1.2, carried out in the same paper, 
created an enlargement of the axon tract the mlf, part of the early axon 
scaffold – the first defined neural structure in the brain. The mlf is an axon 
tract which runs from the diencephalon to the spinal cord, and is initially 
formed from neurons created in the midbrain-forebrain boundary (MFB). 
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The mlf is one of the earliest tracts in the brain (McConnell & Sechrist 
1980) Although Nkx1.2 is expressed in the ventral midbrain during 
development, its role in controlling the GRN in this area is poorly 
understood. 
 
1.3.3 Current Knowledge Concerning Emx2 
Two gene conserved through vertebrate evolution are Emx1 and Emx2. 
They were identified through sequence homology with the Drosophila  
‘empty spiracles’ (ems) gene (Simeone, et al. 1992). Ems plays a key role in 
patterning of the head region (Cohen & Jürgens 1990) and formation of the 
posterior spiracle (Dalton et al. 1989) of the Drosophila embryo, and, like 
the vertebrate homologues, encodes a homeodomain containing 
transcription factor. Emx2 has a known binding site, HBS 1, situated 
within a Wnt1 enhancer  (Ilera et al. 1995a) and transgenic analysis 
indicates that Emx2 negatively regulates Wnt1 expression with mutations 
to the HBS1 site causing up-regulation of Wnt1 expression (Yoshida et al. 
1997). 
Emx2 has been shown to be key in the development of the 
urogenital system; Emx2 is expressed in the epithelium of the pronephros 
and mesonephros (Pellegrini et al. 1997); the areas of the embryo which 
will later develop into the kidneys. It is the incomplete formation of these 
areas during urogenital development in knock out (KO) experiments in 
mice that leads to homozygous mutants not developing kidneys, ureters, 
gonads or genital tracts (Miyamoto et al. 1997).  
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Emx2 is expressed in the roof of the telencephalon of the developing 
mouse brain (Simeone, Acampora, et al. 1992), this expression extends into 
the dorsal telencephalon and ventral diencephalon, under the control of 
Wnt and BMP (Theil et al. 2002). Emx2  is expressed in the ventral 
midbrain during the patterning of the midbrain arcs (Agarwala & 
Ragsdale 2002), with distinct boundaries of Emx2 in arcs 2 and 3 (Figure 
1.4), with Emx2 expression extending anteriorly into the ventral forebrain  
(Schubert & Lumsden 2005). 
Gain and loss of function experiments also form the foundations for 
the current, limited understanding of the function and regulation of Emx2 
in the developing brain. Emx2 KO experiments focusing on mouse brain 
development presented both the cerebral hemispheres and the 
hippocampus being reduced in size compared to wild type (WT) controls. 
The neuroepithelum also forms abnormally which results in the dentate 
gyrus missing from the KO mice (Pellegrini et al. 1996). 
Emx2 was found to influence the position of the neocortex; when 
ectopically expressed along the telencephalic ventral midline (following 
the fgf8 gene expression pattern (Shanmugalingam et al. 2000)), FGF8 
levels were decreased by excess Emx2, and increased in mice lacking 
Emx2 (Fukuchi-Shimogori & Grove 2003). In the ventral midbrain 
specifically, Emx2 KO mice did not develop the Red nucleus (RN) 
(Agarwala & Ragsdale 2002), one of the two nuclei to be derived from cells 
which pattern the most medial of the midbrain arcs. This finding indicates 
that Emx2 is necessary for the development of the RN.  
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KO experiments in vitro using mutant Emx2-/- neural stem cells 
(NSC) showed an increased proliferation of cells in long-term neurosphere 
cultures, with the symmetrical division of stem cells increasing in the 
absence of Emx2, and cell division decreasing when Emx2 expression is 
increased (Galli et al. 2002). The homeobox gene Sox2 exerts an opposing 
role with the major function of Sox2 being to maintain pluripotency of 
neural progenitor cells and stem cells in the vertebrate CNS (Graham et al. 
2003, Avilion et al. 2003). Sox2 is expressed in all neural stem cells (NSC) 
in the developing brain and spinal cord, and keeps neural cells 
undifferentiated. The inhibition of Sox2 leads to cell differentiation into 
neurons (Bylund et al. 2003). Emx2 negatively regulates sox2 in the 
telencephalon (Mariani et al. 2012) indicating that both Emx2 and Sox2 are 
part of a GRN which governs pluripotency and differentiation of neural 
stem cells during development. 
The Emx2 protein has three isoforms produced through alternate 
splicing of the exons, of which two are protein coding. One variant 
(known as isoform 2) lacks one of the three exons in the coding region, 
which results in a frameshift, making the protein shorter and lacking in 
the C-terminal homeodomain. The homeodomain is a highly conserved 
homeobox sequence (Scott et al. 1989) which creates a fold in the tertiary 
structure which is associated with binding of DNA (Billeter et al. 1993). 
Isoform 1 of the Emx2 protein contains this homeodomain and is therefore 
the most commonly studied protein isoform, it is also the protein used in 
this project. 
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Figure 1.5. the expression patterns of the homeobox genes Nkx1.2 and 
Emx2 in the tegmentum of early chick embryo brains identified by high 
magnification images of in situ hybridisation stained embryos.  Panels 
A and B contain HH25 embryos, Panels C and D show HH20 embryos. 
Panels A and B focus at the midbrain-forebrain border of whole mounted 
embryos, Panels C and D are coronal sections through the tegmentum. 
Red staining in all Panels indicates expression of Isl1, marking the 
oculomotor (nIII). Nkx1.2 is expressed in the rostral ventral 
mesencephalon (black arrow) and ventral pretectum (black arrowhead. 
Emx2 is expressed in two stripes in ventral mesencephalon (arrows) and 
pretectum (filled arrowheads) .The black lines across Panels A and B 
indicates the MFB. The expression of Nkx1.2 and Emx2 is restricted to the 
mantle layer. The black arrows indicate the position of the expression 
relative to the nIII, the black star shows the margin of the signal in both 
Panels C and D. The expression of Nkx1.2 lies distal to the nIII, compared 
to the expression pattern of Emx2 which sits in a more dorsal position 
relative to the nIII. Nkx1.2 expression also extending more medially into 
the ventricular zone than Emx2 expression, indicating that Emx2 
expression precedes Nkx1.2 expression during neurone differentiation 
(adapted from Schubert & Lumsden 2005, Ahsan et al. 2007) 
        Nkx1.2            Emx2 
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1.3.4 Comparing and Contrasting Nkx1.2 and Emx2 Expression 
Both Nkx1.2 and Emx2 exhibit expression patterns in the ventral midbrain 
during development (Schubert & Lumsden 2005), the arc pattern 
previously described in this chapter is created through precise gene 
regulation which governs the accurate neural development within the  
midbrain. The genes have an overlapping expression pattern across the 
dorso-ventral axis of the midbrain arcs, with both genes patterning arcs 2 
and 3. Nkx1.2 expression lies more laterally than the Emx2 expression, 
with Emx2 lying dorsal to the oculomotor nucleus and Nkx1.2 expression 
patterning the area lateral to the oculomotor nucleus, as shown in Figure 
1.5. This means that the dorso-ventral pattering is similar, but the genes 
occupy different medio-lateral positions, although directly next to each 
other. This patterning might indicate possible cross-regulation of the two 
genes. 
A variety of gain and loss of function experiments has identified 
that a direct regulatory loop may govern the expression of both genes. The 
over expression of Nkx1.2, carried out by ectopically electroporating the 
Nkx1.2 sequence into the neural tube of a chick embryo, caused a down 
regulation of the Emx2 gene in vivo (Schubert & Lumsden 2005). The 
ectopic expression of Emx2 through electroporation upregulates the 
expression of Nkx1.2 (M. Ahsan and F. R. Schubert, unpublished data). No 
regulatory elements of intermediaries have been identified which would 
govern this hypothetical regulatory loop, schematically represented in 
Figure 1.6. 
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Emx2 NKX1.2 
Expression of the homeobox genes which pattern the midbrain arcs, 
specifically the genes Emx2 and Nkx1.2,  has been predominantly studied 
using mouse and chick embryos as model organisms, as the genetic 
sequence is conserved through amniotes. 
 
 
 
 
Figure 1.6. Proposed regulatory loop involving the Emx2 and Nkx1.2 
genes. Emx2 up-regulates Nkx1.2 expression, which in turn down 
regulates the expression of Emx2 
 
 
 
1.4 Elements which Control Gene Expression 
The molecular patterning which underlies the fate decisions in the embryo 
highlights the critical role of differential gene expression for accurate 
development. Certain genes which play key roles in embryo development 
are termed “master developmental control genes”; they encode 
transcription factors, which indicates that the regulation of transcription is 
one of the main control mechanism for gene expression in development.  
The transcriptional regulation of each gene within an organism’s 
genome is controlled by a variety of regulatory elements including 
promoters, enhancers, repressors, silencers and insulators (Riethoven 
2010). These elements control the patterning of genes to create, for 
example, the midbrain arc patterns studied here in the following sections. 
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 A Highly Conserved Non-Coding Sequence (HCNCS) is an element 
of DNA sequence which is a candidate regulatory element of DNA 
selectively conserved through evolution, indicating it may be necessary 
for appropriate spatial and temporal transcription to occur. Elements 
which are characterised as regulating genetic expression are often called 
cis regulatory elements; from the Latin meaning “along with” referring to 
the element’s position on the same chromosome of DNA as the gene it is 
regulating.  
 
1.4.1 Promoters 
Promoters are critical regions for gene regulation as they are the points at 
which the transcriptional machinery (TM) is recruited. The promoter is 
situated upstream of the transcriptional start site (TSS) (Gagniuc & 
Ionescu-Tirgoviste 2012). A Promoter can consist of a core promoter and 
proximal regulatory domains which work in conjunction with one another 
(Hahn 2004). A promoter is characterised by the presence of one or more 
of a number of elements; TATA box (Juo et al. 1996), GC-box (Ioshikhes & 
Zhang 2000), CCAAT-box (Mantovani 1999), BRE (Lagrange et al. 1998) 
and INR (Xi et al. 2007). These elements are associated with binding RNA 
polymerase to transcribe the downstream gene. The position of the 
elements and their DNA sequence is shown in Figure 1.7 on the next page. 
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Figure 1.7. The core promoter motifs that can contribute to basal 
transcription (adapted from Smale & Kadonaga 2003). A particular core 
promoter many contain some, all, or none of these elements. The TATA 
box can function in the absence of BRE, INR, and DPE sequences whereas 
the DPE motif requires the presence of an INR. Transcription initiates at 
the INR as indicated by the black arrow, the distance in bp from the 
transcriptional start site to the position of the element is indicated 
numerically above each element. The BRE is located immediately 
upstream of a subset of TATA box motifs, with the distal promoters 
CCAAT box and GC box positioned approximately 110 bp upstream 
(Lemon & Tjian 2000). The INR consensus is shown for both mammals and  
Drosophila. 
 
 
 
 
1.4.2 Enhancers 
Enhancers are bound by activator proteins which are associated with the 
transcriptional machinery containing RNA polymerase II and other 
transcription factors which initiate transcription of the gene. The activator 
protein associates to the transcriptional pre-initiation complex (PIC) 
through a mediator protein (Kuras et al. 2003). 
An enhancer is a distal transcription element (Bulger & Groudine 
2011) which can be situated multiple kilo-bases away from the target gene. 
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To influence transcription the enhancer element is brought into closer 
proximity to the target gene by bending the DNA between the two 
elements, bringing the enhancer into a closer proximity of the target gene 
(Giese et al. 1995). The change in orientation of the DNA strand to bring 
the two elements together is shown in Figure 1.8 on the next page. 
To characterise an enhancer is challenging; they are not 
standardised and contain a variety of elements including transcription 
factor binding sites, and CpG islands. Their location is also not 
standardised, they can be located within the introns of the gene they act 
upon, or they can be up to 1MB away along the chromosome (Pennacchio 
et al. 2013), or on a different chromosome from the gene they regulate, this 
is called trans-regulation (reviewed by Williams et al. 2010). 
 
1.4.3 Repressors 
A repressor is a transcription factor that binds to a silencer element of 
DNA. It is activated in the same way as an enhancer; it is bound by a 
transcription factor (TF) protein, but instead of recruiting the 
transcriptional machinery thereafter, it recruits proteins that block the 
binding sites for the transcription proteins, therefore inhibiting the 
expression of the target gene (G. A. Maston et al. 2006). 
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Figure 1.8. The bending, or looping, of DNA to orientate the enhancer 
close to the target gene for transcription as part of the PIC. The activator 
protein (green) is bound to the upstream enhancer sequence, the activator 
protein associates with a mediator protein (orange) which bridges the gap 
between the activator protein and RNA polymerase (grey) by binding to 
both of them, The DNA can loop around on itself to enable the interaction 
between an activator protein and other proteins that mediate the activity 
of RNA polymerase and therefore the expression of the target gene. (taken 
from O’Connor & Adams 2010) 
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1.4.4 Silencers 
A silencer is a negative regulatory genetic element involved in 
transcriptional repression by repressing promoter activity (Brand et al. 
1985). Silencers are sequence specific and, similar to enhancers, function 
independently of orientation or distance from the promoter of the gene 
being acted on (Maston et al. 2006). 
 
1.5 Thesis overview 
This project aimed to identify a candidate regulatory element involved in 
the control of the hypothetical regulatory loop between Emx2 and Nkx1.2. 
Multiple sequence alignments (MSA) (Ahituv et al. 2005) were carried out 
on the Nkx1.2 gene locus of multiple vertebrate species, and highly 
conserved non-coding sequences (HCNCS) were identified adjacent to the 
gene of interest (Frazer et al. 2004). These HCNCS have been positively 
selected against evolutionary divergence of the DNA sequence and 
therefore have a high probability of being functional to the genome 
(Woolfe et al. 2005). The details of this bioinformatic analysis are 
explained in chapter 3 of this thesis. 
The candidate regulatory element was assessed for functional 
significance through electroporation experiments in chick embryos 
(Haeussler & Joly 2011) this is  detailed in Chapter 4 this thesis. 
Finally the interaction of the candidate regulatory element with the 
Emx2 protein was assessed using electro-mobility shift assays (EMSA) to 
see if direct binding occurred, which would indicate if the candidate 
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regulatory element mediated the regulatory loop involving Nkx1.2 and 
Emx2. The results of these experiments can be found in Chapter 5. 
 
 
1.6 Project aims 
No previous regulatory sequences for the Nkx1.2 gene have been 
characterised, despite its critical role in mlf patterning. This research aims 
to explore the regulatory characteristics exerted on the Nkx1.2 gene by the 
Emx2 protein through an intermediary regulatory sequence that is 
evolutionarily conserved in the non-coding sequence of multiple 
vertebrate species. 
 
1.6.1 Specific Aims 
 To identify HCNCS associated with Nkx1.2 
 To Characterise the transcriptional activity conferred by the 
HCNCS 
 To test whether there is a direct interaction between Emx2 
and the HCNCS through EMSA studies 
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Chapter 2 – Project Materials and Methods 
2.1 Chapter Introduction 
The sections in this chapter are set out in the order that most closely 
reflects when they were used during the thesis. The opening Sections 
identify suppliers, solutions and buffers. 
 
2.2 Suppliers 
Chemicals, reagents and laboratory consumables were purchased from 
Bioline, Bio-Rad, Fisher Scientific, GE Healthcare, Life Technologies, New 
England Biolabs, Promega, Qiagen, Roche and Sigma. Restriction 
enzymes, Taq and PCR polymerase were purchased from (NEB) and 
stored at -20°C.  
Oligonucleotides were synthesised by Invitrogen and stored in 
distilled water (DW) as 50 μM stocks at -20°C.  
 markers were purchased from Bioline and protein molecular 
weight size-markers from Life Technologies. Plasmid and PCR 
purification kits were from Qiagen. A BIORAD Gel Dock Imager was used 
for autoradiography.  
 
2.3 Stock Solutions 
 
Acetic Acid (10% (v/v))   Fresh 1l solution per 4x45 cm denaturing gel 
Ammonium acetate (10.0 M)   Stored at 4°C as 100 ml solution  
APS (10% (w/v))    Stored at 4°C for one week as 1 ml solution  
Ampicillin (50.0 mg/ml)   Stored at -20°C in 1 ml aliquots  
Bromophenol blue (0.4% (w/v) Stored at RT as 100 ml solution  
BSA (100×) from NEB   Stored at -20°C in 200 μl aliquots 
CaCl2 (1.0 M)     Stored at 4°C as 500 ml solution  
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DTT (1.0 M)     Stored at -20°C in 1 ml aliquots  
EDTA (0.5 M, pH 8.0)   Stored at RT as 500 ml solution  
EtBr (5.0 mg/ml)    Stored at RT as 100 ml solution foil wrapped  
EtOH (70%, 100% (v/v))  Stored at -20°C as 100 ml solutions 
Formamide (99.5% v/v)  Stored at RT as 1 l solution 
Glucose (1.0 M)    Stored at 4°C as 100 ml solution  
Glycerol (50% (v/v))    Stored at 4°C as 500 ml solution  
Glycine (3.5 M, pH 8.3)  Stored at RT as 500 ml solution  
HCl (11.6 M stock, 2.5 M dilution) Stored at RT as 20 ml solution in glass vial  
IPTG (0.8 M)    Stored at -20°C in 1 ml aliquots  
Isopropanol (100% (v/v) )  Stored at -20°C as 100 ml solution  
KCl (1.0 M)    Stored at RT as 500 ml solution  
Clonse™ (LR and BP)   Stored at -70°C as 40µl aliquot 
MgCl2 (1.0 M)     Stored at RT as 500 ml solution  
NaCl (5.0 M)     Stored at RT as 1 l solution  
NaOH (10.0 M stock, 2.0 M dilution)  Stored at RT as 20 ml solution,plastic sterilin 
PBS  (10x)    Stored at RT as 4 l solution 
PMSF (100 mM stock in ethanol)  Stored at 4°C as 100 ml solution  
SDS (10% (w/v))    Stored at RT as 100 ml solution; heat to use  
TEMED (~98% w/v)    Stored at RT as 50 ml solution  
Tris-HCl (1.0 M, pH as required) Stored at RT as 1 l solution  
Urea diluent (50% (w/v))   Stored at RT as 1 l solution; warmed to use  
 
 
2.4 Reagents 
Alkaline Phosphatase (AP) buffer  Stored at RT as 500 ml solution 
Tris-HCL (100mM, pH 9.5), NaCl (150mM), MgCl2 (25mM) 
Buffer A (AKTA prime)   Stored at RT as 500 ml solution 
Tris HCl (50 mM, pH 7.5), MgCl (30 mM), Imidazol (40 mM), Degassed and filtered (0.2 µm) 
Buffer B (AKTA prime)   Stored at RT as 500 ml solution 
Tris HCl (50 mM, pH 7.5), MgCl (30 mM), Imidazol (500 mM), Degassed and filtered (0.2 µm) 
10% BBR (Blocking reagent)    Stored at -20oC as 10 ml Aliquots 
10g BBR [Roche] per 100ml 5X MAB  
Coomassie stain brilliant blue R250  Stored at RT as 1 l filtered solution  
Coomassie blue (0.25% (w/v)), methanol (45% (v/v)), acetic acid (10% (v/v))  
Coomassie destain     Stored at RT as 1 l solution  
Methanol (45% (v/v)), acetic acid (10% (v/v))  
DAB stain solution    Stored at RT,  10 ml aliquot, foil wrapper 
10mg DAB Tablet [Fisher] dissolved in 15ml 0.1M Tris-HCl pH 7.5 and filtered (0.22μm)  
Distilled water (dH2O, Fisher)    Stored at RT as 1 l solution 
Detergent Mix      Stored at RT as 500 ml solution 
Igepal (1%), SDS (1%), Deoxycholate (0.5%), Tris-HCl (50mM, pH8.0), EDTA (1mM), NaCl 
(150mM 
Foetal Calf Serum (FCS) (Biosera, France) Stored at -20oC as 10 ml aliquots 
LB (Luria-Bertani) agar plates                 Stored at 4°C, wrapped  
Yeast tryptone (10 g/l), yeast extract (5 g/l), NaCl (10 g/l), pH 7.0, bacto-agar (15 g/l)  
LB (Luria-Bertani) growth media   Stored at RT as 500 ml solution  
Yeast tryptone (10 g/l), yeast extract (5 g/l), NaCl (10 g/l), pH 7.0  
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5X MAB      Stored at RT as 1 l solution 
Maleic acid (0.5M), NaCl (0.75M), For pH7.5 solution was adjusted with 5M NaCl  
1X MABT     Stored at RT as 1 l solution  
1X MAB, Tween-20 (0.1%),  Levamisole (2mM)  
1M MgCl2      Stored at RT as 100 ml solution 
40.7g MgCl2 per 200ml dH2O (Autoclaved)  
0.5 M MgSO4      Stored at RT as 100 ml solution 
24.7g MgSO4 per 200ml dH2O (Autoclaved)  
5M NaCl      Stored at RT as 500 ml solution 
58.4g NaCl in 200ml dH2O (Autoclaved)  
NTMT       Stored at 4oC as 50 ml solution 
NaCl (100 mM), Tris-HCl (100 mM, pH9.5), MgCl2 (50 mM), Tween-20 (1%) 
PBS (Phosphate Buffered Solution)   Stored at RT as 1 l solution 
 10X PBS [Fisher] (10%) , dH2O (90%) 
PBT       Stored at RT as 1 l solution 
1 X PBS, Tween-20 (0.1%) 
Pre-hybridisation mix     Stored at -20oC as 50 ml solution 
Formamide (50%), SSC (5X, pH4.5), BBR (2%), yeast RNA (250 μg/ml), Heparin (100 μg/ml) 
4% PFA/PBS      Stored at -20oC as 10 ml aliquots 
Paraformaldehyde (8 g), H2O (200 ml), dissolved  
Add a drop of 5M NaOH and heated to 60oC.  
Once dissolved, 1 PBS Tablet (Sigma) was added per 200 ml.  
Polyethyleneimine (PEI) (25 kDa branched PEI – Sigma-Aldrich, UK).   
Stored at -20°C as 1 ml solution 
Prepare a 100 mg/ml stock solution in water before diluting to 1 mg/ml.  
 Neutralise the solution with HCl, filter sterilise 
SDS gel-destaining solution (1×)   Stored at RT as 1 l solution  
Methanol (45% (v/v)), acetic acid (10% (v/v))  
SDS Loading Buffer    Stored at RT as 1 l solution 
Tris (100 mM, pH 6.8), SDS (4% w/v), Bromophenol blue (0.2% w/v), Glycerol (20% v/v) 
SDS running buffer (5×)                                        Stored at RT as 1 l solution 
Tris-base (125 mM), glycine (1.25 M, pH 8.3), SDS (0.5% (w/v)., Used at 1x 
SDS gel-staining solution (1×)    Stored at RT as 1 l solution  
Coomassie brilliant blue R-250 (0.25%(w/v)), methanol (45% (v/v)), acetic acid (10% (v/v)). 
Filtered 
SOC growth media     Stored at RT as 500 ml solution  
Tryptone (20g/l), yeast extract (5g/l), NaCl (0.5g/l), KCl (2.5mM), MgCl2 (10mM), pH 7, 
glucose (20mM)  
20X SSC (Saline Sodium Citrate)   Stored at 4oC as 50 ml solution 
NaCl (3 M), Sodium Citrate (0.3 M), For pH4.5 solution was adjusted with citric acid  
TAE buffer (50×) for agarose gels   Stored at RT as 1 l solution  
Tris-acetate (2 M), EDTA (50 mM). used at 1x 
2M Tris-HCl      Stored at RT as 1 l solution 
Tris Base (121 g), dH2O (500ml), HCl (5 M) was added for the required pH.  
Triton X-100      Stored at RT as 50 ml solution 
Triton X-100 (5ml), 1X PBS (45ml) 
Solution X      Stored at RT as 1 l solution 
Formamide (50%), SSC (2X, pH 4.5), SDS (1%) 
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2.4.1 OPPF Reagents 
OPPF DNA Loading Buffer   Stored at RT as 1 l solution 
 0.25%w/v Bromophenol Blue in 30%v/v Glycerol 
Buffer NPI-10-Tween     Stored at 4°C as 1 l solution 
50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 1% v/v Tween 20, adjust pH to 8.0 using 
NaOH and filter before use. 
Buffer NPI-20-Tween (Wash buffer)   Stored at 4°C as 1 l solution 
50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, 0.05% v/v Tween 20, adjust pH to 8.0 using 
NaOH and filter before use. 
Buffer NPI-250-Tween, 50 ml: (elution buffer) Stored at 4°C as 1 l solution 
50 mM NaH2PO4 , 300 mM NaCl,  250 mM Imidazole , 0.05% Tween , adjust pH to 8.0 using 
NaOH and filter before use.  
DNAse I Stock Solutions (40,000 units/ml)  Stored at -20°C as 25µl aliquots  
To a 200,000 unit bottle of DNAse I (Sigma D-4527) add 5ml of UHQ Sterile Water. Add one 
aliquot to the 25ml of Buffer NPI-10-Tween buffer to be used for lysis. 
Lysozyme 
Add 25mg of freshly-weighed Lysozyme (Sigma L-6876 or equivalent) to the 25ml of Buffer NPI-
10-Tween buffer to be used for lysis 
AMPure XP bottle (Agencourt/Beckman Product Numbers A63881 and A63882) 
SPRIPlate 96R magnet (Beckman Product Number 000219) 
OmniMaxII competent E. coli cells (Invitogen) 
Gas-permeable adhesive seals (ABgene AB-0718) 
MTP (Greiner V-Bottom Microplate -651 261) 
Solid cover seal (ABGene AB-0558) 
Deep-well blocks (BD Falcon 353966 or ABgene AB-0932) 
Elution Buffer (NPI-250) 
Wash Buffer (NPI-20) 
Instant Blue (ISB01L Expedon) 
T4 ligase buffer for protein expression vector   Stored at -20°C as 100 ml  
       solution 
1X Buffer Components (x10 stock), 50mM Tris-HCl, 10mM MgCl2, 1mM ATP, 10mM DTT,  
pH 7.5 
 
2.5 Methods 
2.5.1 Electrophoresis 
A 1% agarose gel was made by heating 0.5g agarose (Bioline) with 50ml 
2X TAE buffer until dissolved. When the solution had cooled 0.5μl 
ethidium bromide was added and the gel poured. Gels were run at 40V 
for approximately 30 minutes to separate the DNA. HyperLadder1 
(Bioline) was used as a size marker.  
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2.5.2 Production of Chick Genomic DNA  
The genomic DNA was extracted from chick embryos using the Qiagen 
DNEasy kit. Synthesis of genomic chick DNA sequence which acts as a 
template for Nkx1.2.1 in sequence PCR reaction 
 
 
Oligo no. Name  length  sequence (5’-3’) 
1  Nkx1.2.1_F 22  TCCAAATGCTGCCTTATTGCTA 
2  Nkx1.2.1_R 22  GCATGGCAACTGACCTACAGAC  
3  Nkx1.2_5_F 24  CCAATGGGAAATGCAGTCCCGGCC 
4  Nkx1.2_5_R 22  GCATGGCAACTGACCTACAGAC 
Table 2.1.  Primers sequences used in this project. The origin of the 
templates for each of the fragments are listed as follows; GAL4; UAS; E1B 
kindly given by the RIKEN institute, Japan. TK derived from the Sox2 
enhancer. Emx2 sequence is from Esther Bell. Nkx1.2 5’ and Nkx1.2.1 were 
sequenced from the chick genomic sequence, the production of which can 
be found in chapter 2. 
 
 
 
2.5.3 Polymerase Chain Reaction (PCR) 
PCR utilised thermo-stable DNA polymerases to rapidly produce multiple 
copies of a DNA molecule. It involves cycles of denaturing the double 
stranded DNA to break the H-bond at 90-95oC, annealed primers to the 
target sequence at 40-65oC and elongation of the primers at 72oC. 
For PCR (first reaction) with flanking primers the following reagents were 
mixed in a 0.2ml PCR reaction tube: 21μl dH2O, 25μl 2X Pwo polymerase 
mix (Roche), 1μl (50mM) MgCl2 (Bioline), 1μl (100μm) F-primer, 1μl 
(100μm) R-primer, 1μl cDNA. The programme used is: 
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Step  Temp (°C)  Time (sec)  Purpose 
1  95   120   preheat lid 
2  95   30   denaturation 
3       30 cycles 58   30   annealing 
4  72   300   extension 
5  72   600 (10 mins)  final extension 
6  4   hold   prevent further cycling 
Table 2.2. PCR (first reaction) steps and temperature profile; runs took 
about 2 hr.  
 
For PCR (second reaction) with gateway nested primers the following 
reagents were mixed in a 0.2ml PCR reaction tube: 21μl dH2O, 25μl Pwo 
(Roche), 1μl (50mM) MgCl2 (Bioline), 1μl (100μm) F-primer, 1μl (100μm) 
R-primer, 1μl 1st PCR reaction.  
The programme used is stated below: 
 
Step  Temp (°C)  Time (sec)  Purpose 
1  95   120   preheat lid 
2  95   30   denaturation 
3        5 cycles 40   30   annealing 
4  72   300   extension 
5  95   30   denaturation 
6        25 cycles 58   30   annealing 
7  72   300   extension 
8  72   600 (10 mins)  final extension 
9  4   hold   prevent further cycling 
Table 2.3. PCR (second reaction) steps and temperature profile; runs 
took ~2 hr.  
 
For some primers the annealing temperature was changed for optimum 
binding of the primers (52oC-62oC).  
 
2.5.4 Gateway™ cloning 
The Gateway™ Cloning Technology from Life Technologies is derived 
from the Lambda Bacteriophage and works using a number of enzymes to 
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form entry vectors and expression vectors (which are used for 
electroporation in this project) through site specific recombination (Freuler 
et al. 2008). The clonase system uses the BP clonase enzyme to make entry 
vectors from donor vectors and the specific DNA (Figure 2.1). It can also 
create expression vectors containing three distinct genetic sequences by 
using specific recombinant enzymes to cut and ligate the elements. 
 
2.5.4.1  BP CLONASE™ 
The BP CLONASE™ enzyme mix catalyses the in vitro recombination of 
PCR products containing the aatB sites with a donor vector containing the 
aatP sites (Figure 2.1). This creates a vector containing the genetic sequence 
of interest, flanked by CLONASE™ restriction binding sites. In E. coli 
there is a short sequence of DNA called attb ( B for bacteria), which has an 
orthologous sequence in the lambda bacteriophage called attP (P for 
phage), during the BP CLONASE™ experiment the lambda DNA attP 
recombines with the attb of the bacterial sequence.  The BP CLONASE™ 
enzyme mix also contains Int (integrase protein) and IHF(intergration host 
factor protein), these proteins are the catalyst in the recombination of the 
attP and attb sequences. 
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Figure 2.1. Recombination reaction occurring during the BP 
CLONASE™ experiment. The site-specific recombination between the att 
sites (red and yellow shapes) from the PCR gene (green box) product and 
the donor vector to form the entry clone. (diagram adapted from the life 
technologies website www.lifetechnologies.com) 
 
 
2.5.4.2  LR CLONASE™ 
The LR CLONSE ™ enzyme mix catalyses the in vitro recombination of the 
entry clones created using the BP CLONASE™ recombination assay, to 
create an expression clone containing multiple entry clone sequences in a 
specific order according to the sequence of the recombination sites 
highlighted in Figure 2.2 as coloured shapes. The process of precisely 
aligning multiple genetic sequences is carried out using Multisite 
Gateway™ Pro Technology and uses multiple variants of the same att 
sequence sites as utilised in the BP CLONASE™ reaction to create the 
Entry clone. 
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Figure 2.2. Recombination reaction occurring during the LR 
CLONASE™ experiment. The site-specific recombination between the att 
sites (pink, red, yellow and green shapes) around the three different 
elements needed to be included into the expression vector (5’ fragment in 
blue, the gene of interest in green and the 3’ fragment in orange), and their 
specific recombination which forms an expression vector from three entry 
clones and a donor vector. (Diagram adapted from the Life Technologies 
website www.lifetechnologies.com) 
 
 
 
2.5.5 Transformation into Competent Cells 
The BP or LR reaction was added to ~70μl of competent cells (Silver 
efficiency, Bioline) and incubated on ice for 15 minutes. The cells were 
heat shocked at 42oC for 30 seconds to allow the vector to enter the E. coli 
cells then placed back onto ice. 200μl LB medium was added and 
incubated for 1 hour at 37oC with shaking. All of the reaction was spread 
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evenly onto kanamycin (BP reaction) or carbenicillin (LR reaction) LB agar 
petri dishes and incubated overnight at 37oC.  
 
 2.5.6 Construction of Entry Vectors 
The expression constructs were made using gateway cloning technology, 
which uses recombinases that were more efficient than using restriction 
enzymes as it was easier to clone multiple fragments.  
All of the second PCR reaction was run on a gel and the DNA was 
removed from the gel using UV light to visualise the bands and a clean, 
sharp scalpel to remove the bands. The DNA was isolated from the gel 
using QIAquick Gel Extraction (Qiagen). 2μl of the purified DNA was run 
on a gel to check the DNA was correctly removed from the gel.  
The entry vector was then made using Gateway BP clonase II 
enzyme mix (Invitrogen). The following reagents were mixed together in a 
1.5ml reaction tube: 3μl purified DNA, 0.5μl donor vector p221 
(Invitrogen) and 1μl BP clonase II. The reaction was vortexed and 
centrifuged briefly then incubated for 1 hour at 25oC. 0.5μl Proteinase K 
was added to terminate the reaction and vortexed briefly. The reaction 
was incubated for 10 minutes at 37oC.  
 
2.5.7 Construction of Expression Vectors 
The expression vector was made using Gateway LR Clonase II ™ enzyme 
mix (Invitrogen). The following reagents are mixed together in a 1.5ml 
reaction tube: 1μl purified middle entry vector, 1μl 5’ entry chick β-actin, 
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1μl 3’ entry IRES-GFP PolyA, 1μl pDEST Tol2TR and 2μl LR clonase II. 
The reaction was vortexed, centrifuged briefly and incubated for 1 hour at 
25oC. 0.5μl Proteinase K was added and vortexed briefly. The reaction was 
incubated for 10 minutes at 37oC.  
 
2.5.8 Ethanol Precipitation of DNA 
A 1 ml aliquot of fridge-cold EtOH (100% (v/v)) was added to the DNA 
solution, mixed and the DNA allowed to precipitate on ice for 10 min. The 
tube was spun at full-speed for 10 min at 4°C. The supernatant was 
removed, without disturbing the DNA pellet. The DNA was washed with 
1 ml of cold 70% (v/v) EtOH, spun at full speed for 5 min and the 
supernatant removed. The pellet was air-dried for 15 min, before 
resuspending in 100 μl of TE buffer. The concentration and purity of the 
miniprep sample was checked by spectrophotometry and agarose gel 
electrophoresis. 
 
2.5.9 E. coli transformation 
A 50 uL aliquot of chemically competent E. coli was thawed on ice and 1uL 
of plasmid DNA was added (at a concentration of 10ng/uL). The cell 
suspension mixture was then incubated on ice for 30 minutes. The cells 
were heat-shocked by suspending the mixture in a water-bath at 42oC for 
45 seconds, and then placed back on ice for a further 2 minutes. 900uL of 
Lysogeny broth (LB) medium was added to the mix and the Eppendorf 
tube containing the mixture was put on the shaker and left for 1 hour, 
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running at 200rpm. The tube was spun in a microfuge at full speed for 2 
minutes and 900uL of LB discarded. The cell pellet was resuspended with 
100uL of fresh LB and streaked on LB agar plates containing 100ug/ml of 
the appropriate antibiotic. The plates were inverted and incubated at 37oC 
overnight. The resulting colonies were counted. 
 
2.5.10 Plasmid Purification 
To set up liquid cultures individual colonies were taken from each plate 
and added to universal tubes containing 2ml of LB with kanamycin or 
carbenicillin (100mg/ml). The tubes were left overnight at 37oC with 
shaking. Approximately 1.5ml of liquid culture was put into a 1.5ml 
reaction tube and centrifuged for 30 seconds to pellet the bacterial cells. 
The supernatant was discarded, removing as much liquid as possible. The 
plasmid was purified using Nucleospin plasmid QuickPure protocol 
(Macherey-Nagel).  
To replicate larger quantities of the plasmids, liquid cultures were 
set up in conical flask containing 50ml LB medium, 50μl AMP (100mg/ml) 
and an individual colony from the plate. This was incubated at 37°C 
overnight with shaking. For large quantities of plasmid, these were 
purified using HiPure Plasmid Midi prep kit (Invitrogen).  
 
2.5.11 Vector Analysis 
To identify if accurate ligation of the entry clones into the destination 
vector to create the expression vector had occurred, restriction digest 
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analysis of the expression vector was carried out; a solution was prepared 
with the reagents noted in Table 2.4 below, and incubated at 37oC for 1 
hour. A restriction digest map of the expression vectors was created and 
the lengths of the DNA fragments from the restriction digest were 
compared to the restriction maps.  
 
 
Reagent        Amount 
10x Buffer        2 µL 
Vector DNA        50 ng 
enzyme        1 µL 
Nuclease free water       to 20 µL 
Table 2.4. Reagents used in restriction enzyme experiment.  
 
2.5.11 Plasmid sequencing 
Sequencing of all DNA plasmids was carried out by SourceBioscience™ 
and visualised using the Finch TV chromatogram viewer.  
 
2.5.12 Electroporation vectors 
2.5.12.1   Entry vector clones 
Entry clones were created by synthesising the sequence of interest through 
PCR, then ligating the sequence fragment into a donor vector using the BP 
CLONASE™ system. These are then stored in libraries at -80oC. A concise 
Table of all the entry clones and their recombinase sites, aligning to either 
the 5’ middle or 3’ position of the LR CLONASE™ expression vector, can 
be found in Table 2.4. 
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5’ Entry Clone   Middle Clone   3’ Entry Clone 
 Nkx1.2    TK minimal promoter  eGFP + Poly A 
 Nkx1.1    E1B minimal promoter  Poly A 
 Emx2    ELF minimal promoter 
Nkx1.2.1   Nkx1.2 endogenous promoter 
Nkx1.1.1   eGFP 
Nkx1.1 VII 
Emx2 C 
Emx2 D 
Emx2 C+D 
SCL +23 
Nkx1.2 5’ 
Nkx1.2.2 
Nkx1.2 IV 
Table 2.5. A Table showing the library of entry vector clones 
synthesised for this project. The left hand column shows the 5’ entry 
clone constructs, the central column shows the middle entry clone 
constructs, and the right hand column shows the 3’ entry clone constructs. 
All the constructs were made using the BP and LR CLONASE™ reaction 
kits. 
 
 
 
 
2.4.12.2   Expression vector clones 
 
5’ Entry Clone      Middle Entry Clone  3’ Entry Clone 
Nkx1.2   TK   eGFP 
Nkx1.1   TK   eGFP 
Emx2   TK   eGFP 
UAS   E1B   eGFP 
UAS   TK   eGFP 
CAG   GAL4   Poly A 
CAG   TK   eGFP 
Nkx1.2.1  TK   eGFP 
Nkx1.2_5’  TK   eGFP 
Nkx1.1.1  TK   eGFP 
Nkx1.2 VII  TK   eGFP 
Emx2 C   TK   eGFP 
Emx2 D  TK   eGFP 
Emx2 C+D  TK   eGFP 
SCL   TK   eGFP 
SCL +23  TK   eGFP 
Table 2.6. A Table showing the library of expression vectors created 
through the CLONASE recombinase assays.   
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2.5.13 Chick Egg Preparations for Electroporation 
Fertilised chicken eggs were incubated until HH10/HH11 (images of 
staged embryos in ovo are shown in Figure 2.3). The eggs were sprayed 
with ethanol to prevent contamination and sellotape was placed over the 
top of eggs. Using a sterile needle (Fisher), a hole was placed at one end of 
the egg and 2-2.5ml of albumin was removed. Another hole was placed, 
slightly off centre at the top of the egg, through the sellotape. A window 
was cut into the shell (Figure 2.3) using curved scissors to expose the live 
embryo. 2-3 drops of PBS + ampicillin (100mg/ml) were added to prevent 
the embryos drying out.  
Figure 2.3. A comparison of chick 
embryo brain development in H&H 
stages 10-12 and the process of in-ovo 
electroporation on a chick embryo. The 
three embryo images at the top if the 
Figure (taken from (Hamilton & 
Hamburger 1951) Hamilton & 
Hamburger 1951, more detailed stages 
than those shown here can be found in 
Appendix 1) highlight the subtle 
changes to the anterior neural tube 
which occur between H&H stages 10-12 
(H&H stages stated in the top left of 
each embryo image). H&H stage 11 is 
the stage at which electroporation of the 
embryo brain is carried out. In the lower 
panel of the Figure the green area of the 
chick neural tube highlights the area 
which has been injected with the DNA 
vector. The blue minus and red plus 
symbols indicate the charge of the 
electrodes and their orientation around 
the embryo during electroporation. 
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2.5.14 Electroporation 
1μl of fast green (Sigma) was added to 5μl of expression construct (at a 
concentration of ~1µg/ml) in a 1.5ml reaction tube and a small quantity 
was transferred to a fine glass needle and placed into a micromanipulator. 
The vitelline membrane was removed from above the embryo with fine 
forceps. The injection needle was placed inside the neural tube and the 
construct was injected into the embryo. The platinum cathode (set up on 
micromanipulator) was placed to the left of the neural tube and the 
tungsten cathode (hand-held) was placed on the opposite side of the 
neural tube, a schematic representation of a transverse section through the 
neural tube is shown in Figure 2.4 on the next page. 3 pulses of 15V with 
20ms time and 50ms space between pulses was applied and the electrodes 
were then removed. A further 1-2 drops of PBS were applied to the 
embryo; the lid of the egg was replaced and sealed with sellotape. The 
embryos were then re-incubated until the required stage. During 
electroporation the negatively charged DNA was drawn towards the 
positive electrode, meaning one side of the embryo has no ectopic DNA 
and so it can be used as a control (Itasaki et al. 1999). 
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Figure 2.4. Transverse section across the midbrain brain of a chick 
embryo during electroporation. The electrodes are depicted by the black 
lines, they pierce through the vitelline membrane (yellow) but do not 
damage the yolk sac membrane (green) and orientate with the narrowest 
point between the two electrodes across the ventral side of the embryo, 
which sits closest to the yolk (towards the bottom of the Figure). The 
dorsal side of the embryo is orientated towards the top of the page in this 
Figure. The Exogenous DNA is shown as the dashed black lines, contained 
in the neural tube. 
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2.5.15 Chick Embryos 
Fertilised chicken eggs were obtained from Henry Stewart and Co 
(Peterborough, UK) and incubated at 38oC for the required stage (4.5 hours 
per stage) (relevant stages are shown in Figure 2.3). The embryo was 
harvested by cracking the egg open into a glass dish. The embryo was 
removed from the yolk by cutting into the yolk sac and putting the 
embryo into PBS using a spatula to wash. The vitelline membrane was 
removed and for embryos at and beyond stage HH24 the amnion was 
removed over the top of the rostral region. Embryos were then put into 
fixative. For embryos pre-electroporation the embryos were staged by 
counting somites. For older stages embryos were staged according to the 
morphological features described by Hamburger and Hamilton (1951).  
 
2.5.16 Whole-Mount Preparation of Embryos 
All embryos were fixed with 4% PFA/PBS overnight then put into 80% 
glycerol for long term storage. The neural tube was prepared by removing 
the eyes and mesenchyme. Much of the spinal cord, notochord and heart 
were removed. The brain was opened by cutting along the dorsal midline 
and placed onto a microscope slide. The brain tissue was covered with a 
glass cover slip with silicone feet and sealed using nail varnish. 
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2.5.17 Microscopy 
A Zeiss Stereo Lumar V12 fluorescent stereomicroscope was used to 
obtain low magnification images of the embryos. For more detailed 
images, Zeiss LSM 710 confocal microscope was used.  
 
2.5.18 Confocal microscopy 
Visualisation of the expression pattern of the fusion proteins created from 
the expression vectors was carried out using two fluorescent proteins: 
eGFP and DsRed. The images were captured using the Zeiss confocal 
microscope LSM 710 using the excitation laser lines 488 and 543 
respectively. 
 
2.5.19 SDS Polyacrylamide Electrophoresis 
SDS Polyacrylamide gels were set up for the use in western blots. Firstly, 
the glass plates, gasket and comb were cleaned using dH2O and then 
ethanol. They were assembled together and held in place using the 
clamps. The resolving gel was made up, poured between the plates and a 
small amount of isopropanol (Sigma) was poured on top to allow the gel 
to set smoothly. When the resolving gel had set, the isopropanol was 
rinsed off using dH2O. The stacking gel mixture was poured on top of the 
resolving gel and the comb was secured in place. Once the gel had set the 
comb, clamps and gasket were carefully removed and the gel was set up 
in the gel tank.  
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To prepare the 20 μl samples, 3x SDS PAGE loading buffer was 
added to the protein samples and they were heated at 95°C for 5 minutes. 
The samples were loaded carefully onto the gel, leaving a gap between the 
ladder and the first sample. Each gel was loaded with 5 μl pre-stained 
protein ladder (New England Biolabs). The gel was run at 250 V for 1 hour 
45 minutes. Once the gel had run, it was set up for a western blot.  
 
2.5.20 Western Blotting 
The protein samples were first run on a SDS Polyacrylamide gel. The gel 
was removed from the tank, the gaskets were removed and the glass 
plates separated to access the gel. Four pieces of Whatman 3MM 
chromatography paper and one piece of nitrocellulose membrane 
(Amersham Life Sciences) about the same size as the gel were cut and pre-
soaked in the Western Transfer buffer. The western blot was set up as 
shown in Figure 2.5. The membrane was secured in place and placed into 
the tank filled with transfer buffer. The proteins were transferred onto the 
nitrocellulose membrane by electroblotting at 400 mA for 2 hours 15 
minutes.  
The membrane was then removed and blocked in 100 ml 3% milk 
powder in TBST overnight at 4oC. The primary antibody, at a 
concentration of 1:500 in 3% milk powder in TBST, was added to the 
membrane and incubated on a shaker at room temperature for 3 hours. To 
remove unbound antibody, the membrane was washed with 100 ml 3% 
milk powder in TBST, three times for 30 minutes. The secondary antibody 
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was added at a concentration of 1:500 and the membrane was incubated 
on a shaker at room temperature for 2 hours. The membrane was washed 
3x 30 minutes with 100 ml of 3% milk powder in TBST, 1x 20 minutes with 
100 ml TBST and 1x 20 minutes with 100 ml PBS. The membrane was then 
left to rest for 30 seconds and placed into the Western Blot Lab 3000 
Fujifilm (Fuji). The membrane was exposed for 10 minutes and 
photographed for analysis. The alkaline phophatase on the secondary 
antibody cleaves the luminol in order to cause a light reaction. This 
allowed the detection of the AP-conjugated antibody bound to the protein 
on the membrane. 
 
 
 
 
 
 
Figure 2.5. Diagram showing the set up of a western blot. Two pre-
soaked pieces of 3MM paper and one pre-soaked piece of membrane were 
placed onto of the fibre pad. The SDS Polyacrylamide gel was placed on 
top of the membrane. Two more pre-soaked pieces of 3MM paper were 
placed over the gel and a second fibre pad was place on top. The stack was 
secured and placed into the tank.  
 
2.5.21  HEK Cell expression 
HEK 293 (ATCC no. CRL-1573 – LGC Standards, UK) Medium scale 
expression was carried out using T175 tissue culture flasks (Greiner Bio-
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One, UK). All cell manipulations were carried out in a Class 2 laminar 
flow hood.  
The HEK 293 cells were seeded at 7.5 x 105 cells/ml in 5 ml so that the 
cells were ~80 % confluent after 24 hours.  The solution was made up to 45 
ml with DMEM containing 2% FCS, 1 x non-essential amino acids and 1 
mM glutamine. The cells were then incubated  at 37°C in a 5% CO2/95 % 
air atmosphere for 24 hours. 
87.5 µl of plasmid DNA was mixed with 2.6 ml of DMEM 
supplemented with 1 x non-essential amino acids and 1 mM glutamine. In 
a separate vessel, 154 µl 1 mg/ml PEI was mixed with 2.6 ml of DMEM 
containing 1 x non-essential amino acids and 1 mM glutamine.  Added to 
this was the DNA cocktail this was mixed thoroughly then incubated at 
room temperature for 10 minutes.The supernatant from the T175 flask of 
confluent HEK 293T cells was removed and the transfection cocktail was 
added to the cells. The flask was topped up with 40 ml of DMEM 
containing 2% FCS, 1 x non-essential amino acids and 1 mM glutamine. 
The flask was incubated at 37°C in a 5% CO2/95 % air atmosphere for 3 
days at which point the phenol red pH indicator in the DMEM should 
have started to change colour to orange. 
 
 
2.5.21.1  Harvesting secreted protein 
The supernatant (which contains the protein) was collected, centrifuged at 
6,000g for 15 minutes to remove any detached cells, and filtered through a 
0.22 µm bottle top filter before storing at 4°C. 
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OPPF Methods 
2 X KOD Hot Start Buffer      25 µL 
dNTP mix (2mM)      10 µL 
KOD Hot Start (1 U/µl)     1 µL 
Sterile Water (µL)      6 µL 
Total Reaction Volume      42 µL 
Table 2.7 OPPF HTP PCR master mix 
 
 
Number of (25µl) Reactions     100 
10 X Phusion Flash       1250 µl 
Sterile Water       935 µl 
pOPIN forward primer at 100µM    15 µl 
Total Volume       2200 µl 
Table 2.8 OPPF HTP PCR master mix for construct screening 
 
 
2.5.22 Setting up HTP PCR Reactions 
High throughput (HTP) PCR reactions were set up to synthesise the 
varying lengths of Emx2 sequence. The PCR reactions were set up on ice as 
follows. First 42µl of the Master Mix was dispensed into each well of the 
PCR plate, 3µl of diluted (10µM) forward and reverse primer was added 
to the appropriate wells of the PCR plate, followed by 2µls of template 
plasmid (10-20ng/ul) into each PCR well. The plates were sealed with a 
foil seal and loaded into the Veriti PCR machine (ABI) the PCR settings 
and stages are shown in Table 2.9. 
 
2.5.23 Analysis of PCR products 
The PCR sequences were analysed to identify if they were accurately 
synthesised. When the thermal cycling was complete 2.0 µl of 5x DNA 
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Loading buffer was added to each well of a fresh PCR plate. 5µl aliquots 
of each PCR product was then added to the dye and loaded onto a 1.25% 
TBE Agarose gel, a column at a time. The gel was run at 100V for 30 
minutes. The gel was imaged using BIORAD gel dock imager. 
 
Step  Temp (°C)  Time (sec) Purpose 
1  94   120  Pre-heat lid 
2  98   10  Denaturing 
3        x30 60   30  Annealing 
4  68   30  Extension 
5  68   120  Final extension 
6  4   Hold  Prevent further cycling 
Table 2.9. HTP PCR steps and temperature profile, run took about 2 
hours 
 
2.5.24 Purification of PCR products 
The PCR fragments are bound to magnetic beads to purify the PCR 
products before ligation into the pOPIN vectors. This is done by gently 
shaking the AMPure XP bottle to re-suspend any magnetic particles then 
pipetting 90µl AMPure into each reaction in the PCR plate from section 
2.4.4. The AMPure XP and PCR reaction solution was mixed thoroughly 
by pipetting. The samples were incubated for 3-5 minutes at room 
temperature to bind the PCR products of 100bp and larger to the magnetic 
beads. The reaction plate was placed onto a SPRIPlate 96R magnet for 5 
minutes to separate the beads from the solution. This step separates the 
bead-bound PCR products, 100bp and larger, from un-bound PCR 
reagents and primers. With the reaction plate still situated on a magnet, 
the cleared solution was aspirated from the reaction plate and discarded 
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without disturbing the magnetic beads. 200 µL of 70% ethanol was added 
to each well of the reaction plate and incubated for 30 seconds at room 
temperature. The ethanol was then aspirated  and discarded, this ethanol 
step was repeated twice more, and the plate was air-dried for 10-20 
minutes on a bench top to allow complete evaporation of any residual 
ethanol. 30 µL of elution buffer (EB 10mM Tris pH 8.0) was added to each 
well of the reaction plate and mixed by pipetting the mixture up and 
down. With the reaction plate still situated on the magnet, 30µl of the 
supernatant was taken from each well to a fresh PCR Plate. In this fresh 
PCR plate 5 µL of purified PCR product was mixed with 2µL of DNA 
loading buffer and run on a 1.25% TBE Agarose gel. 
 
2.5.25 In-Fusion reactions and HTP transformation 
The Purified PCR fragments were then ligated into the pOPIN vectors. To 
add the fragment into the pOPIN vector 1µl (100ng) of the appropriate 
linearised pOPIN was transferred to each well of a fresh PCR plate.  Then 
10-250ng of purified insert was then added to the appropriate wells of the 
PCR plate.  10 µl of water was transferred to each well and 10µl of the 
total solution was transferred to a dry-down In-Fusion™ plate within 
which the contents were mixed briefly by pipetting up and down. The 
reactions were then sealed with a foil seal. The reactions contained in the 
plate were incubated at 42°C for 30 minutes in the Veriti thermocycler.  
When complete the In-Fusion reactions were transferred to ice and diluted 
by the addition of 40µl of TE.  This solution was then transformed into 
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OmniMaxII cells by transferring 5ul of the diluted In-Fusion reaction into 
each aliquot of competent cells. The cells were then incubated on ice for 30 
minutes followed by a heat-shock of the cells for 30 seconds at 42°C in a 
water bath. The cells were then returned to the ice for 2 minutes. 300µl of 
Power Broth(PB)/SOC (with no antibiotic) was added to each tube of cells 
which were then transferred to a 37°C incubator for 1 hour. After 
incubation, 30µl of the cells was transferred onto LB Agar plates 
supplemented with Antibiotic. The plates were shaken vigorously by 
hand, and allowed 10-15 minutes for the plates to dry off before inverting 
the plates and incubating overnight at 37°C. 
 
2.5.26 Colony Picking and HTP culture 
Individual colonies were picked and added into each well containing 
300µl of Power Broth (PB)/SOC with appropriate antibiotic. The plate was 
sealed with a gas-permeable adhesive seal and shaken at 200-225 rpm at 
37°C over-night in a shaker. 
 
2.5.27 HTP harvesting and glycerol stock preparation 
Permanent glycerol stocks were made by transferring 100µl from each 
well containing cells from section 7.4.5 to an MTP which contained 
100µl/well of filtered LB/30% v/v glycerol, this was sealed and stored at      
-80°C. To harvest the cells the gas-permeable seal on each 96-well culture 
plate was replaced with a solid seal and the cells were harvested by 
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centrifugation at 5000g for 15 minutes. Following the centrifugation step 
the supernatant media was discarded. 
 
2.5.28  HTP mini plasmid preparation Using Wizard SV96 purification 
plates  
The plasmid mini-preps were performed on the Bio-Robot 8000, according 
to the manufacturer’s instructions.   
 
2.5.29 PCR screening for construct verification  
The validity of the vector constructs was ascertained through PCR 
screening with the reverse primer initially used in section 7.4.1. The 
reactions were set up on ice in the skirted PCR plates. 22μl of the “OPPF 
HTP PCR master mix for construct screening” was dispensed into each 
well of the PCR plate followed by 1.5µls of diluted (10µM) reverse primer 
which was added to the appropriate wells of the PCR plate. Finally 1.5µls 
of construct plasmid was added to the appropriate wells of the PCR plate 
which was then sealed with a foil seal and loaded into the Veriti thermal 
cycler. The PCR settings are shown in Table 2.10. A 6.5µl aliquot of PCR 
product was analysed on a 1.5% Agarose gel (Appendix 2), and the 
colonies were scored (see Appendix 3). 
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Step  Temp (°C) Time (sec)  Purpose 
1  94  120   Pre-heat lid 
2  94  30   Denaturing 
3 x30 60  30   Annealing 
4  68  120   Extension 
5  68  240   Final extension 
6  4  Hold   Prevent further cycling 
Table 2.10. Verification PCR steps and temperature profile, run took 
about 2 hours 
 
 
2.5.30 E coli expression strain transformations  
The pOPIn vectors containing the Emx2 fragments were expressed in E. 
coli cells. 3µl of each mini-prepped expression plasmid was added to the 
competent cell aliquots which were incubated on ice for 30 minutes. This 
was followed by Heat-shocking of the cells for 30 seconds at 42°C before 
the cells were returned to ice for 2 minutes. 300µl of Power Broth (no 
antibiotic selection) was added to each cell tube. The tubes were then 
transferred to a 37°C static incubator and incubated for 1 hour. 30µl of the 
cells per well were transferred from the transformation reactions onto LB 
Agar plates supplemented with Antibiotic which were tipped by hand to 
spread the cells, the plates were then left for 10-15 minutes for the plates to 
dry off before inverting the plate and incubating overnight at 37°C. 
 
2.5.31  Small scale expression screen  
2.5.31.1 Standard IPTG induced expression screen 
To prepare the growth media for IPTG expression 0.7ml of Power Broth 
was supplemented with 1µl/ml of the appropriate antibiotic (100mg/ml) 
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per well of a deep-well block plate. Individual colonies were picked and 
transferred into each well. The deep well plates were sealed with gas-
permeable adhesive seals and shaken at 240 rpm at 37°C overnight.  The 
overnight cultures were then diluted transferring 150µl (Lemo21) or 250µl 
(Rosetta2 placI) of overnight culture into 500 µl of fresh power broth (with 
appropriate antibiotic). The diluted cultures were shaken at 240 rpm at 
37°C for 3-5 hours. After shaking the cultures were cooled by shaking at 
240 rpm at 20°C for 20 minutes. Once cooled the cells were induced with 
IPTG, which was added to a final concentration of 1mM per well. The 
cultures were grown overnight (~18 hours) by shaking at 200-225 rpm  at 
20°C. 
 
2.5.31.2 Expression screen with auto-induction media 
To prepare the growth media for auto-induced expression, 0.7ml of Power 
Broth was added to a deep-well block plate and supplemented with 
1µl/ml of the appropriate antibiotic (100mg/ml) per well. Individual 
colonies were picked and transferred into each well. The deep well plates 
were sealed with gas-permeable adhesive seals and shaken at 200-225 rpm 
or 600 rpm at 37°C overnight. The overnight cultures were then diluted 
transferring 150µl (Lemo21) or 250µl (Rosetta2 placI) of overnight culture 
into 500 µl of fresh power broth (with appropriate antibiotic). The diluted 
cultures were shaken at 200-225 rpm at 37°C for 4-6 hours. The 
temperature was then reduced to 25°C and shaking continued at 200-225 
rpm for a further 20-24 hours. 
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2.5.32 HTP Expression Screen Plate Re-formatting and Harvesting 
The cells needed to be isolated from the growth media so that their 
content could be analysed. To do this 1.0 ml of culture was transferred 
from each well into a fresh 96-well deep-well plate. The cells were 
harvested by centrifugation at 6000g for 10 minutes, thereafter the media 
was decanted and discarded from the cell pellets by inverting the plates. 
The plates containing the pellets were then sealed and stored at -80°C.  
 
2.5.33 The Ni2+-NTA Miniature Expression Screen Protocol 
This manual protocol was adapted from that used on the QIAGEN 
BioRobot 8000 with QIAGEN Magnetic Ni-NTA. 
The frozen cell pellets were re-suspended completely in 210µl of 
Lysis Buffer (NPI-10-Tween) supplemented with 1mg/ml Lysozyme and 
400 units/ml of DNAse Type I.  The solution was left for 30 minutes for the 
Lysozyme and DNAse to take action before the lysate was cleared by 
centrifugation of the deep-well block plates at 6000g for 30 minutes at 4°C. 
20µl of the Ni-NTA (nickel-nitrilotriacetic acid) magnetic bead suspension 
was added into each well of a fresh flat-bottomed MTP and the 
supernatant of the spun solution was transferred into the plate containing 
the magnetic bead solution without disturbing the ‘Insoluble’ pellet. The 
plate was mixed at room temperature using a microtiter plates (MTP) 
shaker. After shaking the plate was placed on the 96-Well Magnet for 1 
min and the supernatant was removed from the beads with a pipette. 200 
μl of Wash Buffer was added to each well, the plate then removed from 
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the magnet and shaken on the microplate shaker for 5 minutes. The plate 
was placed back on the 96-Well Magnet for 1 minute, and the buffer 
removed. Finally, 50 μl of Elution Buffer was added to each well, mixed 
on the MTP shaker for 1 minute, placed on the 96-Well Magnet for 1 
minute, and the supernatant transferred to a fresh MTP for analysis on 
SDS-PAGE. 
 
2.5.34 SDS PAGE analysis of Ni2+-NTA purified proteins 
The results of the expression screen were analysed on an SDS 
PAGE gel. 10µl of each fraction was mixed with 10µl of SDS-PAGE 
loading in a fresh 96-well PCR plate. The plate was re-sealed and boiled 
for 3 min. The gel tanks were set up in accordance with the instructions 
from Invitrogen. 10µl/ was loaded into each well of the gels. 5µl of Low 
M.W. marker was placed in well 1 of each gel and 5µl in well 26 of each 
gel. The Voltage was set to 200V and the gel run until the blue dye reached 
the bottom. 
To stain the gel, it was removed from the plastic casing and placed 
in a plastic box.  The gel was covered with Instant Blue and left for 30-60 
min. The gel was De-stained by removing the stain and covering the gel 
with water until de-stained (this de-stain step was repeated as necessary). 
The gels were photographed (Appendix 4) and scores given for the 
expression (the Table of scoring can be seen in Appendix 3). 
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Chapter 3 – Bioinformatic Analysis of the Non-
Coding Sequence Surrounding the Nkx1.2 Gene 
 
3.1  Chapter Introduction 
A genetic interaction between Nkx1.2 and Emx2 is already identified 
through previous work (Section 1.3.4), but the intricacies of the interaction 
are yet to be characterised. It is not clear whether the two genes directly 
interact, or if other unidentified genes are also involved in the genetic 
regulation. To begin to answer this question bioinformatic analysis of the 
area surrounding the Nkx1.2 gene was used to identify highly conserved 
non-coding elements (HCNCS). Sustained evolutionary conservation over 
millions of years when compared to the pressure of genetic rearrangement 
indicates which of the possible sequences is functionally relevant to the 
genome (Wasserman et al. 2000, Cooper et al. 2003, Poulin et al. 2005). The 
aim of the bioinformatic analysis is to identify candidate regulatory 
elements that can then be tested experimentally, firstly for their 
transcription regulation and secondly for binding with the Emx2 protein. 
Because no enhancers or repressors have been characterised for the 
Nkx1.2 gene and the relationship between the Nkx1.2 gene and the Emx2 
gene has not been investigated, this research aims to fill these gaps in 
knowledge. 
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 Despite the detailed understanding of the transcriptional process, 
for many genes little is known about the regulation of their expression 
(Haeussler & Joly 2011). But identifying regulatory elements is key to a 
more thorough understanding of how the expression of a given gene is 
controlled. 
The majority of an organism’s DNA is non-coding (Lander et al. 
2001); it does not code for genes which are transcribed and translated into 
proteins. It has been shown that this large amount of non-coding DNA is 
not ‘junk DNA’ but serves to regulate the genetic activity of the coding 
regions (Good et al. 2004, Woolfe et al. 2005). 
Candidate regulatory elements can be identified through the use of 
bioinformatic analysis looking for highly conserved non-coding elements 
(HCNCS) in multiple sequence alignments (MSA) of different species’ 
genomes (Chapman et al. 2004). From there the HCNCS is tested in vivo to 
establish if the sequence does have regulatory properties. Bioinformatic 
analysis is a cost-effective way of identifying candidate regulatory 
elements which display a high level of evolutionary conservation, similar 
to that of coding sequences, which would indicate they are of use within 
the genome of the organisms. Through the use of a variety of 
bioinformatic analysis software including multiple species alignment 
(MSA), non-coding DNA elements can be identified for further in vitro and 
in-vivo functional analysis to discover if the sequence is an enhancer or 
repressor element.  
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Bioinformatic analysis of evolutionary-conserved sequences is one 
way to identify candidate regulatory elements, but not all regulatory 
sequences are conserved at sequence level. Analysis of the higher order 
structure of chromatin identifies epigenetic modifications, indicating if the 
chromatin is active or repressed (Hebbes et al. 1988, Jenuwein & Allis 
2001). This research used chromatin immunoprecipitation to investigate 
the interaction between protein and DNA in the cell. Acetylation of 
histone H3 on lysines 9 and 14 and methylation on lysines 4, 36, and 79, 
indicate active chromatine, while methylation of histone H3 on lysines 9 
and 27 are linked with repressive chromatin (Litt et al. 2001). This work 
was carried out in chick erythrocytes. Work carried out in human 
embryonic stem cells (ES) found that acetylation of lysine 16 on histone H4 
is also a marker of active enhancers (Taylor et al. 2013).  Chromatin 
modifications can occur at regulatory sequences with high levels of 
histone acetylation indicating the presence of gene promoters and 
enhancers (Roh et al. 2006).   
 
3.1.1 Evolutionary Conservation of Genomic Sequences 
The coding regions of orthologous genes are known to have highly 
conserved sequence even though millions of years separate the species 
from their common ancestor. The DNA surrounding genes is no longer 
termed ‘junk’ DNA as has been found to hold the key to understanding 
the operating system of the genome of vertebrates.  
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98.5% of the human genome has been identified as non-protein 
coding (Lander et al. 2001), with conserved non-coding regulatory 
elements conserved through mammals accounting for just ~5% of the 
human genome (Lindblad-Toh et al. 2011), but >80% of the genome is 
transcribed, bound by a protein or associates with chromatin, implying 
regulatory function (Birney et al. 2007). The small percentage of conserved 
non-coding elements in the genome are  conserved through evolution and 
can therefore be identified through multiple sequence alignment (MSA) 
from different species  (Elnitski et al. 2003).  Identifying regulatory 
elements within the genome is not as easy identifying as gene coding 
sequences, because they have diverse sequence elements and their  
location with respect to the gene is not usually standardised (Alonso et al. 
2009). Identifying regulatory sequences that show evolutionary 
conservation is a straight-forward way of identifying candidate regulatory 
elements. The idea of comparative genomics to study functional non-
coding sequences is not new; researchers studying Drosophila in the 1980’s 
identified a cis-regulating element involved in the regulation of the chorion 
genes (de Cicco & Spradling 1984). This was studied more closely through 
sequenced  analysis of a the Chorion gene loci of two distantly (D. virilis 
and D. grimshawi) and one closely (D. subobscura) related species 
(Martínez-Cruzado et al. 1988). The research found highly conserved 
sequences of non coding DNA existed upstream of the s15 and s19 Chorion 
genes in all three Drosophila species, the researchers hypothesised that 
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these sequences were ‘essential amplification control elements’ involved in 
the process of amplifying genomic DNA. 
 
3.1.2 Multiple Sequence Alignment (MSA) 
Comparing DNA sequences across diverse species can highlight 
functional elements with significant sequence similarity; to identify 
evolutionary conserved regulatory elements surrounding the Hox gene 
cluster, the cluster sequence from a wide variety of vertebrates was 
aligned using multiple sequence alignment (MSA) to identify putative 
regulatory elements (Santini et al. 2003). To select species for MSA their 
known evolutionary relationships (years since divergence) needs to be 
identified. 
All life on earth is connected through evolutionary history and 
phylogenetics is the study of the evolutionary relationship between the 
different organisms (Nei & Kumar 2000). The expression pattern of the 
midbrain arcs in the developing embryo is conserved between mouse and 
chick (Agarwala & Ragsdale 2002), it can be hypothesised that conserved 
regulatory elements for the genes involved in the midbrain arcs would be 
evolutionarily conserved too.  Therefore a diverse group of species 
needed to be analysed in this research, comparing multiple species to 
acquire an accurate picture of the relationship between a HCNCS of 
interest and the target gene. The phylogenetic tree in Figure 3.1 spans 
approximately 450 million years of evolutionary divergence to include  
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Figure 3.1. A phylogenetic tree of the 29 vertebrate species analysed in this 
research. This data was compiled from the tree of life website 
(http://tolweb.org/tree) and using the Timetree webpage (http://www.timetree.org) 
to identify the point on time of evolutionary divergence between species.  
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fish, amphibians, reptiles, birds, marsupials, ungulates, carnivores, 
primates and rodents. All model organisms identified in the phylogenetic 
tree in Figure 3.1 have published genome sequences, whether partial or 
full. This is another factor to take into account when analysing data using 
MSA; if the genomic species is incomplete, the gene coding sequence may 
be published, but the associated HCNCS may be missing.  
 
3.1.3 Identifying Regulatory Elements 
By using computational methods to identify possible regulatory elements 
the length and position of a regulatory element can be located with great 
accuracy. In vertebrates, bioinformatic data comparison highlighted 
conservation between human and rodents, primarily because the mouse 
genomic sequence was one of the first, after human, to be intensely 
analysed (Waterston et al. 2002). As the genomes of other model 
organisms were sequenced it meant that pair-wise genome comparison 
was superseded by MSA, and this is a more powerful tool to analyse 
genomic data (Elnitski et al. 2003). Comparing more than two species 
statistically increases the resolution with which a conserved element can 
be identified (Cooper et al. 2003) and, by including birds, fish and reptiles 
the evolutionary distance between the species is increased, in theory, to a 
point where DNA rearrangement has diversified all but the specific 
sequences of functional relevance.  
MSA studies have shown that the position of HCNCS is not totally 
random but that they are often found within 1MB of the target gene 
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(Pennacchio et al. 2013) and found to cluster near genes encoding 
transcription factors that are involved in the developmental processes 
(Bejerano et al. 2004). Both Emx2 and Nkx1.2 are transcription factors 
which are involved in embryonic development (Schubert & Lumsden 
2005). By using MSA software, HCNCS can be identified for further 
analysis to establish if they constitute an enhancer or repressor element 
associated with the gene regulatory loop between Emx2 and Nkx1.2. 
A comprehensive map of the synteny of genes which lie upstream 
and downstream of the Nkx1.2 gene would highlight the evolutionary 
conservation of the sequence. Figure 3.2 illustrates the use of an 
evolutionary map of the upstream and downstream genes of Nkx1.2. If a 
HCNCS existed between genes A and B, and through evolution gene A 
underwent translocation but the HCNCS stayed in position relative to 
gene B, then it is more likely that that HCNCS is involved with gene B. 
The genes were therefore mapped to identify if the areas upstream and 
downstream of the genes Nkx1.2 and Emx2 underwent rearrangement, and 
from there it could be hypothesised whether any HCNCS could be 
associated with Nkx1.2 or Emx2 specifically. 
At the start of 2003 was the announcement that the human genome 
was fully sequenced. Subsequently a pilot study was established to 
analyse 1% of this human genome to identify and analyse functional 
genetic elements (Good et al. 2004) working directly or indirectly or with 
what DNA elements may be involved in the transcriptional start sites  
 
69 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. The genomic rearrangement of different species, which 
occurs through evolutionary diversity of millions of years. The red 
HCNCS is orientated around gene B and not genes A or C so it can be 
predicted to be associated with gene B. 
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(Birney et al. 2007). This included their relationship to specific regulatory 
sequences and features of chromatin accessibility and histone 
modification, as well as a better understanding of chromatin structure and 
its relationship with DNA replication and transcriptional regulation. After  
this the full ENCODE (encyclopedia of DNA elements) project was 
launched (Myers et al. 2011). The ENCODE project aims to research the 
non-coding DNA of the human genome (representing about 98% of DNA), 
which acts to regulate the activity of the genes. Among other things, the 
ENCODE website compares chromatin conformation of a specific DNA 
sequence of the genome in multiple human cell lines, from data gained 
through ChIP-seq high-throughput sequencing. The ENCODE data can be 
used as an alternative approach to predicting the genomic position of 
tissue specific enhancers; the ENCODE data highlights the chromatin 
conformation of a genomic sequence in a specific cell line, this chromatin 
‘signature’ shows which sections of DNA are in an active conformation 
and able to be bound by TFs (reviewed by Berger 2007). 
The aim of the research detailed in this chapter was to analyse the 
bioinformatic data surrounding the Nkx1.2 gene looking for a candidate 
regulatory element sequence involved in the hypothetical regulatory loop 
between Emx2 and Nkx1.2. A genetic map was created to identify the 
synteny within which the gene of interest was situated, to identify genetic 
rearrangements. The upstream and downstream region of the gene of 
interest was then mapped to identify regions of particular sequence 
conservation between a wide range of vertebrates, particularly sequences 
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conserved despite genetic rearrangement. Finally, the regions of 
conservation were processed through the data collected from the 
Encyclopaedia of DNA elements (ENCODE) project to identify inter-
species conservation of transcription factor binding sites and chromatin 
modifications in multiple cell lines.  
 
3.2 Materials and Methods for Bioinformatic Analysis 
The main computational software packages used in this project are shown 
in Table 3.1 below:  
 
Program          website    Summary 
Bioedit   mbio.ncsu.edu/bioedit/bioedit.html          A biological sequence alignment editor 
BLAST  blast.ncbi.nlm.nih.gov/Blast.cgi              Online software used to carry out  
                  BLAST searches to identify  
                          orthologous sequences in a variety of  
                  different genomes. 
ECR  browser ecrbrowser.dcode.org              Online tool for visualizing and  
                  accessing  data from comparisons of  
                  multiple vertebrate genomes. 
Ensembl ensembl.org                Online genome database for   
                  eukaryotic species 
VISTA  genome.lbl.gov/vista/index.shtml             Programs and databases for   
                  comparative analysis of genomic 
                  sequences.  
ENCODE genome.ucsc.edu/ENCODE             Used to identify the regulatory  
                  elements of the human genome. 
MEGA  megasoftware.net              A tool for inferring phylogenetic trees 
                  from syntenic sequences of multiple  
                 species.  
rVista  rvista.dcode.org               Website which combines database  
                searches with comparative sequence  
                analysis to identify regulatory element 
Table 3.1. The bioinformatic software used in this project, with a 
summary of its uses 
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3.2.1 Phylogenetic Footprinting 
To identify areas of high conservation directly surrounding the Nkx1.2 
gene, an MSA of the surrounding non-coding DNA sequence needed to be 
carried out. To do this the Nkx1.2 gene locus in the mouse gene was 
identified using the Ensembl website (the mouse sequence was used as a 
base for comparison because it has the most numerous alignments of other 
genomes to compare against it when using the Vista website). The position 
of the Nkx1.2 gene is Chromosome 7: 132,594,878-132,599,637. The position 
of Nkx1.2 in the mouse genome  was identified through the Ensembl 
website (Flicek et al. 2014) and input into Vista-Point software (Frazer et 
al. 2004) with up to 1MB either side of the gene of interest in accordance 
with the findings previously stated  (Bejerano et al. 2004, Pennacchio et al. 
2013). The resulting areas of conservation are displayed as peaks along the 
genome sequence, highlighted in different colours to show coding-
sequences (blue) or HCNCSs (red, yellow, green to highlight different 
individually conserved elements).   Conservation peaks produced using 
the Vista-point software were checked against those produced using the 
ECR browser to identify any differences between the conserved sequence 
peaks (the ECR browser produces a similar readout of conserved sequence 
‘peaks’ as the Vista-point software). 
 
3.2.2 Inferring phylogeny  
To identify orthologous sequences BLAST (basic local alignment search 
tool) searches were used. BLAST uses an heuristic algorithm (maximum 
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efficiency prioritised over maximum accuracy) to compare nucleotide 
sequences in DNA (Altschul et al. 1990). BLAST can identify library 
sequences comparable to the query sequence above a certain threshold, 
which can be altered; from exact matches to distal homologies. In this 
study BLAST searches were used to identify the HCNCS in as many 
different species as were in the Ensembl genome browser database 
(release 56), based upon the mouse sequence.  
For specific DNA sequence conservation analysis a smaller cohort 
of species was analysed, species which spanned the vertebrate 
phylogenetic tree and had a fully sequenced genome. Orthologous 
HCNCS sequences were retrieved from the Ensembl by BLAST with the 
mouse (Mus musculus) HCNCS against the genome of ten other species, 
using the search parameters “allow local mismatches”: human, Homo 
sapiens; marmoset, Callithrix jacchus; opossum, Monodelphis domesticus; 
chicken, Gallus gallus; zebra finch, Taeniopygia guttata; anole lizard, Anolis 
carolinensis; Xenopus, Xenopus tropicalis; coelacanth, Latimeria chalumnae; 
fugu, Takifugu rubripes; zebrafish, Danio rerio. The sequences were aligned 
with ClustalW command line interface (Larkin et al. 2007) implemented in 
BioEdit software (Thompson et al. 1994). 
The aligned sequences were then input into MEGA (Molecular 
evolutionary genetic analysis) software in FASTA format to map a 
phylogenetic tree of the HCNCS across the multiple species to identify the 
pattern of the evolutionary divergence of the element, using maximum 
likelihood estimation method (Tamura et al. 2011). MEGA6 is a software 
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programme for comparative analysis of DNA sequences (Hall 2013) and 
produces a hypothetical evolutionary molecular pattern of species 
divergence over time (Tamura & Nei 1993).  
 
 3.2.3 Method for Plotting Gene Synteny Map 
A gene cluster map surrounding the Nkx1.2 gene was created by plotting 
the upstream and downstream genes as annotated by the Ensembl 
website, and comparing a large variety of different species, including fish, 
amphibian, reptile, bird and mammalian gene synteny. A schematic 
representation of the genes in order of sequence was created, excluding 
the spaces between the genes. The sequences were centred around the 
Nkx1.2 gene and the position of the HCNCS highlighted. 
 
3.2.4 ENCODE data analysis methodology 
By inputting the chromosomal position of the HCNCS into the ENCODE 
website, the chromatin activity in multiple different cell lines can be 
visualised on the area of the HCNCS in the genome browser of the website 
(Myers et al. 2011).  
Chromatin formation across multiple relevant cell lines can be 
analysed for the use of the data collected through the ENCODE project in 
the area of the Nkx1.2sequence, to highlight if the HCNCS is in an open 
conformation of DNA. The ENCODE project as yet does not list neural 
stem cells as a stem cell line for analysis, so for this project the cell lines of 
interest were the human embryonic stem cell line H1-HESC, as a 
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substitute for neural cells, and the human umbilical vein endothelial cell 
line HUVEC as a negative control. Histone H3K4m2 (di methyl K4) and 
histone H3K27m3 (tri methyl K27) were the histone modifications 
visualised, because histone H3K4m2 marks promoters and enhancers (Li 
et al. 2007), and most CpG islands are marked by H3K4m2 in primary cells 
(Birney et al. 2007), this histone conformation may also be associated with 
poised promoters (Bernstein et al. 2006). H3K27m3 marks promoters that 
are silenced (Schwartz & Pirrotta 2007) and because of this, this histone 
modification was used as a negative control. 
 
3.2.5 Plotting TFBS using rVISTA 
The cause of the conservation of the non-coding sequence could be related 
to the site containing transcription factor binding sites (TFBS) which 
would be preferentially conserved during evolutionary divergence of the 
genome sequence, if functional. The online software rVISTA was used to 
identify potential TFBS (Loots et al. 2002). The Vista-Point software output 
from section 3.3.1 was analysed through the rVista software and a 
graphical representation of the position and conservation of the TFBS on 
the HCNCS was produced. This software enables two different sequences 
to be compared to identify conserved TFBS. The software highlights 
potential TFBS, but whether the sites are used during actual gene 
regulation can only be tested in vivo. 
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3.3 Results 
 Bioinformatic analysis was used to identify a putative regulatory element 
associated with the Nkx1.2 gene. Multiple sequence alignment (MSA) 
analysis was utilised to align orthologous gene sequences, and nucleotide 
bases, to identify conserved regions, phylogenetic software was used to 
infer evolutionary divergence of the conserved sequence, and conserved 
transcription factor binding sites (TFBS) were identified through computer 
analysis. The ENCODE data was used to infer activity of the element 
during development. 
 
3.3.1 Characterisation of the Nkx1.2 Locus 
Sequence conservation is one way to identify candidate regulatory 
elements, so multiple sequence alignments (MSAs) were used to identify 
areas of high sequence conservation including, but not limited to, the 
coding elements of the genome. The results of the MSA show coding and 
non-coding regions of high evolutionary conservation (Figure 3.3). The 
MSA in Figure 3.3 shows multiple HCNCS in proximity to the Nkx1.2 
gene. three HCNCS (red, yellow and green) were identified in the 9 kbp 
region surrounding the Nkx1.2 gene, all of which showed a higher than 
75% conservation of sequence between mouse and human, but only one 
sequence showed a >50% conservation of sequence in all 7 species 
compared to mouse; the element coloured red in Figure 3.3.  This element 
(in the chick genome measures 384bp in length) was named Nkx1.2.1 and 
was advanced for further analysis. The HCNCS identified in yellow is 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.  The level of base-pair sequence conservation of Nkx1.2 orthologues; comparing the mouse sequence against the 
human, opossum, chicken, lizard, Xenopus, gar and fugu sequences using Vista online programme. The red peaks identify 
HCNCS 1, yellow peaks identify HCNCS 2, blue peaks represent coding sequences associated with the Nkx1.2 gene and green 
peaks represent HCNCS 3. The scale can be found at the base of the Figure in k, represent 1000 bp. The transcriptional start site 
(TSS) is identified on the mouse-human comparison sequence with a black arrow. 
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353bp in the human genome and was named Nkx1.2.2 and the HCNCS 
identified in green is 145bp in the chick genome and was named Nkx1.2.3. 
The Nkx1.2.1 element identified in red in Figure 3.3 showed the highest 
level of conservation outside of the coding sequence of the Nkx1.2 gene, as 
a result the Nkx1.2.1 element was further analysed across a broader range 
of vertebrate species. The sequence of the mouse Nkx1.2.1 sequence was 
used to BLAST search for orthologous sequences in a wider range of 
species than those tested in Figure 3.3. The sequences that were identified 
were first checked that they were orientated near the Nkx1.2 gene and then 
aligned (Figure 3.4). A high level of conservation between 10 of the 11 
species can be seen in areas across the ~450bp region. The exception is the 
opossum DNA sequence which shows relatively poor alignment 
homology, this could be attributed to sequence divergence, or because of 
genetic rearrangement, which could have resulted in the opossum 
Nkx1.2.1 sequence being in a reverse orientation relative to the Nkx1.2 
gene. 
3.3.2 Identification of a Candidate Regulatory Region 
The MEGA software was utilised to map a phylogenetic tree of the ~450bp 
Nkx1.2.1 sequence (Figure 3.5). A phylogenetic tree is an estimate of the 
evolutionary relationship between species or sequences (Nei & Kumar 
2000). In this method a simplistic phylogenetic tree was created to assess if 
the ~450 bp sequence of the Nkx1.2.1 element mapped a similar pattern of 
evolutionary divergence to the true phylogenetic tree of the organisms. 
Generally this was true; with the allowance of some mismatches the 
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Figure 3.4. MSA of the HCNCS 1 aligned using ClustalW software form the 
Bioedit program. The Figure shows varying levels of conservation with the 
centre of the element being the most highly conserved (between 110-300bp 
through the sequence). The opossum and Xenopus sequences show the least 
conservation of sequence from 250bp to the end of the element, with both 
exhibiting possible DNA rearrangement/ insertion, creating gaps (--) in the 
conservation pattern.The length of sequence is shown on the top of each row, 
ranging from 0-441 bp. The ATGC base pairs are colour coded to identify 
homologous sequences through the different species, which are listed down the 
left hand side of each row of sequences. 
80 
 
Nkx1.2.1 element mapped a phylogenetic tree similar to that in the Figure 
3.1. The marsupials (opossum and tasmanian devil) were accurately 
mapped as diverging before the separation of rodents and primates 
(rodents: squirrel, mouse and rat. primates: human, chimp, gorilla, 
organgutan, macaque, marmoset, mouse lemur and bush baby). The 
mouse lemur and bush baby, although evolutionary close species (and 
mapped together in Figure 3.5) should be associated with a division from 
the primate branch of the tree, as opposed to the carnivora and ungulata 
branches (these branches also showed a more recent divergence from one 
another than is accurate). The position of the mouse, chicken and human 
in the tree is accurate compared to the whole species phylogenetic tree in 
Figure 3.1. 
 The Nkx1.2.1 sequence was retained throughout vertebrate 
evolution, although it underwent some local genetic rearrangement 
(Figure 3.4) following a similar pattern to the coding sequence of the 
genome (from which phylogenetic trees of species are created).  
To identify if the spatial evolutionary conservation of the Nkx1.2.1 
sequence was retained because of a functional association with either the 
Lhpp or Nkx1.2 gene (Lhpp and Nkx.1.2 sit either side of the conserved 
element), the synteny of the Nkx1.2.1 locus was mapped (Figure 3.6).  The 
information for Figure 3.6 was gathered from the Ensembl website and 
laid out according to the phylogenetic tree of evolutionary divergence 
stated in the Chapter introduction in Figure 3.1. 
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Figure 3.5 
  Figure 3.5. A phylogenetic tree created using MEGA6™ software. This tree was 
created using the 400bp HCNCS. Molecular Phylogenetic analysis by Maximum 
Likelihood method  The evolutionary history was inferred by using the 
Maximum Likelihood method based on the Tamura-Nei model (Tamura & Nei 
1993). The tree with the highest log likelihood (-2453.5254) is shown. Initial tree(s) 
for the heuristic search were obtained automatically by applying Neighbor-Join 
and BioNJ algorithms to a matrix of pairwise distances estimated using the 
Maximum Composite Likelihood (MCL) approach, and then selecting the 
topology with superior log likelihood value. The analysis involved 29 nucleotide 
sequences. Codon positions included were 1st+2nd+3rd+Noncoding. All positions 
containing gaps and missing data were eliminated. There were a total of 265 
positions in the final dataset. Evolutionary analyses were conducted in MEGA6 
(Tamura et al. 2013). 
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All the species aligned in Figure 3.6 contained a sequence homologous to 
the mouse Nkx1.2.1 sequence identified through BLAST search. Of the 54 
genome sequences available for analysis, 19 genomes contained the 
sequence orientated close to the Nkx1.2 gene. The other 35 genomes either 
did not contain a homologue of the Nkx1.2.1 sequence due to partial or 
incomplete sequencing of the genome, or the respective genomes did not 
contain the Nkx1.2.1 sequence due to genetic divergence, with the 
sequence being deleted or significantly altered. 
The genomes of the bush baby, ferret, Xenopus, colacanth, spotted 
gar and fugu were all in scaffold format, which hindered the plotting of 
the upstream and downstream gene map, as shown by the double-line 
dash on the right hand side of the frog (Xenopus), pufferfish and 
coelacanth sequences which indicates the termination of a scaffold. There 
is a high level of synteny within amniotes, with the gene order reading;  
Ctbp2 – Zranb1 – Fam175B – Mettl10 – Fam53B – Lhpp – Nkx1.2 – Oat – 
Chst15 – Cpxm2 – Gpr26 – Bub3. Rearrangements around Nkx1.2 have 
occurred in the marsupial and amphibian genomes identified in this 
research to contain the Nkx1.2.1 sequence. The opossum genome shows 
the rearrangement of the Nkx1.2 gene with the Nkx1.2.1 sequence flanked 
only by the genes Lhpp and Oat, and the frog sequence rearrangement of 
the locus downstream from the Nkx1.2 gene. The most extensive re-
arrangement around the Nkx1.2 gene is seen within the teleost fish species  
(pufferfish and zebrafish) which were analysed. 
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FAM53B HPDL PLAU EXOC7 FAM18B
1 
OAT ZRANB1 LHPP MTR FABP RYR2A 
FAM53B CTBP2 MMP21 UROS OAT ZRANB1 LHPP CHST15 CPXM2 GPR26 BUB3 
Turkey 
Meleagris gallopavo 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Chicken 
Gallus gallus 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Zebra Finch 
Taeniopygia guttata 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP Anole Lizard 
Anolis carolinensis 
Spotted Gar 
Lepisosteus oculatus 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
PWWP2B NKX 1.2 IKZF5 METTL10 FAM175B ZRANB1 CTBP2 NKX6.2 INPP5A LHPP Frog 
Xenopus tropicalis 
Mouse 
Mus musculus 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Human 
Homo sapien 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Chimp 
Pan troglodytes 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Orangutan 
Pongo Abelii 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Marmoset 
Callithrix jacchus 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Bush Baby 
Otolemur garnettii 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Ferret 
Mustela putorius furo 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Dog 
Canis lupus familiaris 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Cow 
Bos taurus 
METTL10 FAM53B BUB3 GPR26 CPXM2 CHST15 OAT FAM175B ZRANB1 CTBP2 NKX 1.2 LHPP 
Opossum 
Monodelphis domestica 
TMEM2 CCDC6 ANK3 RHOBTB1 CDK1 OAT NKX 1.2 ACTG2 LHPP ANKRD22 STAMBPL1 LIPM 
Zebrafish             1 
Danio rerio 
FAM53B HPDL ADKB PLAU EXOC7 OAT NKX 1.2 ZRANB1 LHPP MTR FABP RYR2A 
Coelacanth 
Latimeria chalumnae 
FAM53B METTL10 FAM175B HPDL ZRANB1 OAT NKX 1.2 CHST15 LHPP CPXM2 
Puffer fish            1 
Takifugu rubripes 
METTL10 FAM53B HMX2 GPR26 FAM175B ZRANB1 CTBP2 NKX 1.2 IKZF5 EDRF1 
Zebrafish             2 
Danio rerio 
Puffer fish            2 
Takifugu rubripes 
Figure 3.6. Syntenic analysis of the genes surrounding the Nkx1.2. the 
patterns of synteny were compiled by ordering the genes which appeared 
up and down-stream of the Nkx1.2 gene, information which was gathered 
using the Ensembl website. The diversity of species is laid out along the 
phylogenetic tree of species divergence, with the two teleost fish species 
having two Nkx1.2 gene loci due to the whole-genome duplication (WGD). 
The orthologous genes are highlighted in the same colour, genes not 
orthologously represents more than once are in a blank box. Nkx1.2 genes 
not annotated on the genome sequence but found through blast search are 
identified in blank ovals with a green outline. The position of the Nkx1.2.1 
sequence as identified in Figure 3.3 is highlighted by the red triangle.  
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Because of the whole genome duplication (WGD) which occurred in 
teleost fish after divergence from other vertebrates (Meyer & Van de Peer 
2005), the syntenic pattern of genes, including Fam53B, Lhpp and Oat, 
occurs in two different positions on the genome of the pufferfish and the 
zebrafish, however only one sequence contains the Nkx1.2 gene and the 
Nkx1.2.1 element. 
Synteny analysis identified the Nkx1.2.1 sequence as being 
associated with the Nkx1.2 gene specifically, as the Nkx1.2.1 did not 
orientate around Lhpp or other adjacent genes. An indication of the 
activity of a HCNCS can be ascertained by analysing the conservation of 
transcription factor binding sites (TFBS).  
 
3.3.3 Further Evidence Suggesting Nkx1.2.1 as an Enhancer 
To assess the conservation of TFBS the Vista online software was 
used to create pairwise comparisons of the Nkx1.2.1 sequence of different 
species. The human, mouse and chick Nkx1.2.1 sequence were used 
because they are three model organisms that have complete published 
genomes and are regularly used in bioinformatic studies of developmental 
processes (Alonso et al. 2009). Figure 3.7 shows the resulting maps of the 
TFBS within the Nkx1.2.1 sequence of both species used in each pairwise 
analysis.  
 The 11 transcription factors (TF) which were analysed were chosen 
either because the protein contained the Homeobox domain – Nkx6.1; 
Nkx2.5B, Nkx2.5_Q5; HoxA3; Pax5; Pax6_Q2; Sox9_B1; Sox5; Sox_q6 (as  
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Figure 3.7. Conserved transcription factor binding sites within the 
Nkx1.2 element shown using Vista software. Panel A shows the 
human/mouse conservation of key TFBS in HCNCS 1. Panel B shows the 
human/ chick conservation of key TFBS in HCNCS 1. Panel C shows the 
Mouse/ chick conservation of key TFBS in HCNCS 1. The HCNCS 
upstream of Nkx1.2 identified as a red peak in Figure 3.1 was found in 
chick, mouse and human using the ECR browser software and compared 
for pairwise conserved TFBS using the rVista website program. The 
alignments show varying levels of conservation across the sequence 
(shown in red at the base of each panel). Putative conserved TFBS 
positions are shown as coloured boxes and identified down the left of the 
Panels. 
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5’     EMX2 
TGTTTGAAGTTGGTTTGCTTTCCAGCTCAAGCATTAAAATTCAGCCTGAGTGCTGTCTTTAAATTG 
ACAAACTTCAACCAAACGAAAGGTCGAGTTCGTAATGGGAAGTCGGACTCACGACAGAAATTTAAC 
3’ 
 
TCTTTGATGCGGGTGGGTTTCAACCCTGACCTGTCCTGACGGCAGTGATGGCTGTAACAAGCTGCG 
GAAACTACGACCCACCCAAAGTTGGGACTGGACAGGACTGCCGTCACTACCGACATTGTTCGACGC 
 
       GATA 1      GATA 2    
GATCAATATTCATAGCGGGTGTCCTGGGCTGATAACACTATCCAAGACAATGTTCGCTATCAGCGT 
CTAGTTATAAGTATCGCCCACAGGACCCGACTATTGTGATAGGTTCTGTTACAAGCGATAGTAGAA 
 
           CEBPB 
AGACAGCTGAGATATTGCGCCATTAGTGATGTTGTTTTAAATAACCTGATCCATTTCTGGGTCTAT 
TCTGTCGACTCTATAACGCGGTAATCACTACAACAAAATTTATTGGACTAGGTAAAGACCCAGATA 
 
   GATA 1/2 
TTAGTGAATTTCACAGTTTAGATATTATCTTTAAGGAGAAGCCAAAGGCTGTTCCAGACGCGGCGA 
AATCACTTAAAGTGTCAAATCTATAATAGAAATTCCTCTTCGGTTTCCGACAAGGTCTGCGCCGCT 
 
         
TGCAAATCAATGCTGCCAAGGCTCCTCTGCTTTCCTTAAAACAAAGTGGACTGTGGTTCCAGCGCA 
ACGTTTAGTTACGACGGTTCCGAGGAGACGAAAGGAATTTTGTTTCACCTGACACCAAGGTCGCGT 
 
       EMX2 
GCTTGTGATGTGTTCTGTGAGCCACGGTGTGCTATCGATAATATTAGCAATAAGGCAGCATTTGGA 
CGAACACTACACAAGACACTCGGTGCCACACGATACGTATTATAATCGTTATTCCGTCGTAAACCT 
 
              3’ 
CTATACCGAGGGAG 
GATATGGCTCCCTC 
    5’ 
 
Figure 3.8. Nkx1.2.1 DNA sequence from the chick genome showing the 
TFBS. The sequence shows the position of conserved TFBS,  EMX2 
binding sequence  is ATTA (Catena et al. 2004), GATA1 binding site is 
GCTGATAACA (Ko & Engel 1993), GATA2 binding site is 
CGCTATCAGC (Ko & Engel 1993), CEBPB binding site is 
ATATTGCGCCATTA (Yamamoto 1996), GATA1 /2 consensus binding 
sequence is GATATTATCTTTAA (Ko & Engel 1993).  
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homeobox genes are TFs which bind directly to DNA (Choo & Russell 
2011), with Emx2 also containing a homeodomain and hence may 
recognise the sequence), or because they are known to be involved in 
neural patterning; Gata1 and Smad_Q6 (Engel et al. 1992; de Sousa Lopes 
et al. 2003). 
 The three pairwise comparison Panels in Figure 3.7 show that the 
most TFBS conservation appears between the human and mouse sequence 
of the Nkx1.2.1 sequence (Figure 3.7A). Panel B of the Figure is the 
comparison of the Nkx1.2.1 sequence between Human and chicken and 
shows that two TFBS are conserved in the sequence, between the species. 
Panel C of the Figure shows that 4 TFBS are conserved between the mouse 
and the chicken in the Nkx1.2.1 sequence.  Nkx6.1 and GATA1 TFBS are 
both contained in the Nkx1.2.1 sequence of all three of the diverse species. 
The MSA analysis and the conservation of TFBS in the HCNCS 1 sequence 
indicate that the Nkx1.2.1 sequence is an element of DNA which has been 
positively selected against genetic rearrangement in vertebrate species. To 
specifically identify the TFBS which exist within the NKX1.2.1 element the 
nucleotide sequence of the element was analysed for known binding sites 
of the Emx2 protein. Emx2 has been shown to bind specifically to an 
ATTA sequence in mouse forebrain neural precursor cells as well as 
mouse ES cells (Catena et al. 2004). In total the ATTA sequence which has 
been shown to bind EMX2 exists in 4 separate positions within the 
Nkx1.2.1 sequence, as well as the two highlighted regions. The ATTA 
sequence also appears within the CEBPB binding sequence and the GATA  
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Figure 3.9  ENCODE data from the human Nkx1.2 gene locus. The Figure shows (from the top of the image to the 
bottom); the position of the area of interest on the chromosome is highlighted by a red line on the chromosome.  Peaks 
of vertebrate sequence conservation are highlighted by the line named ‘100 vert. Cons’. The Histone modifications of the 
H1-hESC and HUVEC cell lines are at the base of the Figure under the heading Histone modifications by ChIP-seq from 
ENCODE/Broad institute’. The peak of vertebrate conservation containing the Nkx1.2.1 element is indicated by a red 
arrow, the activity of the Nkx1.2.1 element in the cells lines is highlighted by a red box. . The positioning of the Nkx1.2 
exons along the genetic sequence is highlighted by a blue box. 
The 
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1/2 binding sequence. This Figure shows that potential TFBS exists across 
the majority of the length of the sequence indicating that this element may 
be functional and involved in the regulation of gene expression. 
The Nkx1.2.1 sequence was analysed using the ENCODE online 
data to test which cells within an organism the Nkx1.2.1 sequence is active 
in. In the absence of neural cell data the Nkx1.2.1 sequence was shown to 
occur in an active chromatin conformation in ES cells, at the same time as 
the Nkx1.2 gene. 
As stated before, the ENCODE project data does not include neural 
cell lines, so the H1-HESC line, which is human embryonic stem cell line, 
was analysed instead, with the Nkx1.2 gene and associated elements 
expected to be active in this chromatin conformation (since the homologue 
of Nkx1.2 ; Nkx1.1 has been shown to be active in ES cells which are 
beginning to differentiation, known as embryoid bodies (Yamada et al. 
1994)).  The human umbilical vein endothelial cell line HUVEC acted as a 
negative control because the Nkx1.2 gene is not expressed in endothelial 
cell in-vivo (Bae et al. 2004) but is active, or poised, in ES cells, this is 
shown in Figure 3.9 on the previous page. 
Figure 3.9 covers ~17 Kb of the human genome sequence on 
chromosome 10. The H3K4m2 histone modification was used to visualise 
if the Nkx1.2 gene and the Nkx1.2.1 sequence were in an open chromatin 
conformation in embryonic stem cells. 
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Figure 3.10. ChIP-Seq data for the mouse Nkx1.2 gene locus.  The Figure shows (from the top of the image to the bottom); 
the position of the area of interest on the chromosome is highlighted by a red line on the chromosome.  Peaks of mammal 
sequence conservation are highlighted by the line named ‘Mammal Cons’. The Histone modifications of the Cerebellum, 
Cortext and Brain cell lines are at the base of the Figure,. . The peak of mammal sequence conservation containing the 
Nkx1.2.1 element is indicated by a red arrow, the activity of the Nkx1.2.1 element in the cells lines is highlighted by a red 
box. The positioning of the mouse Nkx1.2 exons along the genetic sequence are highlighted by a blue box 
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The H3K27m3 histone modification, marking promoters that are silenced, 
was analysed in the same area in the H1HESC cell genome, to highlight 
the chromatin conformation of the Nkx1.2 gene and associated elements in 
a cell line where the gene is not expressed, as it is in endothelial cells.  
Unlike the ENCODE human project, the ENCODE mouse project 
list cell lines from multiple organs and brain regions, including cell lines 
from the cerebellum, cortex and the whole brain. The analysis of the 
Nkx1.2 gene locus using the Mouse Encode data is shown in Figure 3.10. 
The ChIP-seq data obtained from the cells of the cerebellum and cells from 
the cortex were from mice aged 8 weeks to adult stages. The ChIP-seq data 
obtained from the cells of the whole brain were from mice at pre-natal 
stage E14.5. There was no H3K27m3 marker in the cortex cell tissue to act 
as a negative control. The locus in the cerebellum is predominantly 
enriched in the H3K27m3 chromatin conformation, indicating that the 
Nkx1.2 gene and the Nkx1.2.1 element are repressed or silenced in the 
post-natal cerebellum. The cortex shows minimal activity, and the whole 
brain is most enriched in the H3K27m3 line, showing prominent 
repression at stage E14.5. This could be attributed to the function of Nkx1.2 
as a developmental gene, shown to be involved during patterning of the 
midbrain. 
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3.4 Discussion 
Bioinformatic analysis was carried out to identify a candidate regulatory 
sequence specifically associated with the Nkx1.2 gene so that its biological 
activity could be assayed.  
 
3.4.1 Several HCNCS are Associated With Nkx1.2 
When analysing the conservation of the sequence in the Nkx1.2 gene locus 
a number of HCNCS were orientated around the Nkx1.2 gene. The most 
conserved of these, Nkx1.2.1, was located 2,625 bp upstream of the Nkx1.2 
transcriptional start site. Its high degree of conservation between species 
ranging from human to fish made this sequence a prime candidate for a 
cis-regulatory region. Several bioinformatics approaches were used to test 
whether there was a possible function for the Nkx1.2-I element. The use of 
bioinformatic analysis as the first stage of identification of a regulatory 
element has been shown to be effective when characterising enhancers. 
Research to identify a evolutionary conserved enhancer associated with 
the Dachshund gene (Poulin et al. 2005) used genome sequence analysis 
with the online mVista software, carried out MSA of the conserved 
element and identified conserved transcription-factor binding sites within 
the element sequence, before creating reporter constructs of the sequence 
for expression in mouse embryos, this bioinformatic research proved 
successful in characterising the conserved enhancer Dc2. 
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3.4.2 The Nkx1.2.1 Element contains an evolutionarily conserved 
genomic sequence  
In an MSA of the Nkx1.2.1 element the results showed a high level of 
conservation across all but one species tested, allowing for some sequence 
mismatches. This analysis was carried out using 11 genomes, and 
sequence conservation was identified to exist across ~450 million years of 
evolutionary divergence between the species (Naruse et al. 2004). The 
opossum DNA sequence shows relatively poor alignment homology, this 
could be due to a reversal of the orientation of the element, to test this, the 
reversed sequence should be re-aligned with the other sequences and 
another BLAST search carried out to identify if this hypothesis is correct. If 
the alignment has higher homology when the opossum sequence is in a 
reverse orientation, it would suggest the sequence underwent genetic 
rearrangement but was retained, possibly because it is a functional 
element. 
This MSA identified areas of highly conserved sequence within the 
Nkx1.2.1 element, a study looking at a conserved sequence between 
elephant shark, zebrafish and mouse (MacDonald et al. 2010) carried out a 
similar MSA of the conserved sequence regulating Dxl gene expression in 
the forebrain, to identify key areas which exhibited 100% conformation 
within the ~1000bp of the conserved sequence.  These small ~100% 
conserved sequences were then tested for their activity in vivo. By carrying 
out deletion analysis of the conserved element it could be refined from the 
~450bp sequence to the smaller sub-sequence ~190bp, the research was 
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able to identify the minimal sequence of the element. The initial MSA 
carried out to identify the enhancer included the distantly related jawed 
vertebrate; the elephant shark. The evolutionary distance between mouse 
and elephant shark tested the theory that the DNA sequences not utilised 
for regulation or coding had undergone such evolutionary rearrangement 
between mouse and elephant shark that the regulatory elements became 
easier to identify. The theory was accurate and a forebrain specific 
enhancer was characterised. 
  A phylogenetic tree was created by using phylogenetic software, 
and differences in sequence indicate divergence of an evolutionary 
ancestor; which can be mapped as branches on the tree. The phylogenetic 
tree was based on multiple different species’ Nkx1.2.1 sequence. This 
showed that the sequence of DNA, although not a coding sequence or 
included in the transcriptome of any of the species, is highly conserved 
through evolutionary divergence. The phylogenetic tree of the conserved 
sequence follows evolutionary divergence and is broadly comparable to 
the full-genome based phylogenetic tree, indicating that the element 
evolved due to positive selection of the sequence against evolutionary 
divergence of the genome (Tagle et al. 1988). 
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3.4.3 Gene Synteny Surrounding The Nkx1.2 Gene is Highly 
Conserved in Tetrapods, but has Undergone Rearrangement Between 
Ray-Finned and Lobed-Finned Fish Lineages  
The synteny of the gene map surrounding the Nkx1.2 gene could indicate 
if the Nkx1.2.1 sequence was associated specifically with the Nkx1.2 gene 
or acts as a distal element involved in a gene situated a number of genes 
away. When the genes which lie directly upstream and downstream of 
Nkx1.2 were mapped for each species, the rearrangement of the genes 
through the evolutionary tree becomes apparent by colour coding the 
orthologues in the different species. 
When analysing the synteny map the evolutionary divergence of 
the genes within which Nkx1.2 is situated can be more fully understood. 
Initial rearrangement occurred when the tetrapods diverged from 
modern day fish (Dehal & Boore 2005), roughly 400 million years ago; 
Lhpp has been translocated through rearrangement into another position 
away from Nkx1.2 in fish. The same is true of Oat whose presence is 
directly upstream of Nkx1.2 in all model vertebrates apart from fish. The 
360 million years of evolutionary divergence between Xenopus and 
amniotes could account for the lack of gene sequence conservation 
upstream of the Nkx1.2 gene or alternatively it could be a discrepancy in 
the current published Xenopus sequence. The Oat – Chst15 – Cpxm2 gene 
sequence predominantly found upstream of the Nkx1.2 is instead 
replaced with three genes not seen in the Nkx1.2 gene neighbourhood in 
any other species, and the scaffold then ends. 
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Because of the third WGD which occurred in teleost fish (Amores 
1998), there are two copies of the genes Oat and Lhpp in Zebrafish and 
Pufferfish, but the Nkx1.2 gene along with the Nkx1.2.1 sequence exists 
within only one of these two duplicates. This is important because in all 
the other organisms it could be assumed that the Nkx1.2.1 sequence may 
be associated with the LHPP gene, and because the two persistently 
orientate adjacent to each other, however by including the teleost 
genomes it highlights the existence of LHPP independently of the 
Nkx1.2.1 sequence. In the pufferfish genome, known for its lack of genetic 
redundancy (Brenner et al. 1993), the genes Ctbp2, Zranb1, Fam53b and 
Gpr26 exist as two versions of the same genes in different chromosomal 
positions in the pufferfish genome. What is interesting is that the gene 
series Lhpp – (Nkx1.2.1) – Nkx1.2 – Oat determined in other organisms 
analysed does not exist; instead the Nkx1.2.1 sequence is orientated next 
to the Nkx1.2 gene without either Lhpp or Oat flanking the series. This 
could be due to the mutational bias of the pufferfish genome towards 
elimination of redundant DNA (Venkatesh et al. 2000). Through genetic 
redundancy one copy of both the Nkx1.2 gene and the Lhpp gene have 
been deleted (unlike genes like Fam53B no homologues for Nkx1.2 or Lhpp 
exist within the current published puffer fish genome), but the Nkx1.2.1 
sequence is only present directly next to Nkx1.2. The gene synteny of the 
lob-finned fish, which did not undergo the third WGD, is very similar to 
that of amniotes, with three genes upstream and downstream of the 
Nkx1.2 gene being identical in sequence.  
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Not all the genomes utilised in the Bioedit alignment were fully 
annotated or sequenced; the genomes of the coelacanth, spotted gar and 
fugu were organised on scaffolds, which precede chromosomes during the 
assembly of the genome sequence. The chick and zebra finch genomes, 
although fully sequenced, contain strings of N sequences in the genome 
sequence where the accurate sequence has yet to be determined.   
          The analysis of the synteny within a diverse range of vertebrates 
identified that, due to genetic rearrangement, the conserved element 
Nkx1.2.1 is likely to be associated specifically with the Nkx1.2 gene, as the 
element is orientated to the Nkx1.2 gene, regardless of upstream or 
downstream genetic rearrangement. 
 
3.4.4 The Presence of Conserved TFBS and Enhancer-Specific 
Epigenetic Signatures All Point to Nkx1.2.1 Being a Regulatory Element 
A cis-regulatory element influences the transcription of genes; to do this it 
binds TF proteins. An indication of the function of a DNA sequence can be 
obtained by screening the sequence for TFBS. There are conserved TFBS 
within the Nkx1.2.1 sequence that are retained between the human, mouse 
and chicken element. These are only predicted sites, with further in vitro 
analysis of the binding ability of the element, or in vivo analysis using 
ChIP, needed to test specific binding. Conformation of the validity of the 
TFBS may be an answer to the origin of its conservation; the element may 
be a binding site associated with regulation of the Nkx1.2 gene. The genes 
Gata1 and Nkx6.1, which both have TFBS conserved between mouse, 
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human and chick in the Nkx1.2.1 sequence, are both expressed during 
development. Nkx6.1 controls the fate of two ventral midbrain nuclei; the 
red nucleus and the oculomotor in mouse brain development (Prakash et 
al. 2009), and is therefore expressed in a similar spatial and temporal area 
to that of Nkx1.2 and Emx2. Gata1 is an erythroid transcription factor 
which is not expressed in the brain (Hannon et al. 1991). The answer as to 
why it has a TFBS within the Nkx1.2.1 sequence may lie in the DNA 
binding specificity of the GATA family.  Gata1, -2 and -3 have a consensus 
sequence overlap; WGATAR (in which W indicates A/T and R indicates 
A/G) (Ko & Engel 1993), so although the conserved TFBS analysis 
identified Gata-1 as having a conserved binding site in all three diverse 
organisms, it may be that the sequence is actually a TFBS used by Gata-2 
during embryonic brain development. Gata-2 expression is found in the 
ventral midbrain during development and is present during the 
patterning of the midbrain arcs (Agarwala et al. 2001). Although GATA-1 
was identified as having a TFBS within the Nkx1.2.1 sequence, this is 
unlikely to occur in the ventral midbrain, as Gata-1 is not expressed in the 
developing CNS (Hannon et al. 1991). This binding site could indicate the 
Nkx1.2.1 element also regulates the expression of Nkx1.2 during the 
process of differentiating mesoderm. Nkx1.2 has been shown to regulate 
mesoderm formation during gastrulation (Tamashiro et al. 2012), Gata-1 is 
involved in the commitment of mesoderm into blood (Kelley et al. 1994), 
so it is conceivable that their expression would overlap. Further research 
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into the possible regulation of Nkx1.2 by GATA-1 through the Nkx1.2.1 
element would need to be carried out to clarify this hypothesis.  
Although useful information was obtained from the conserved 
TFBS software, this analysis was limited by the availability of 
experimentally confirmed TFBS. With further updates to the Vista online 
program, more TFBS can be identified within regulatory elements active 
during patterning of the ventral midbrain. From this data, possible 
connections within the GRN involving the Nkx1.2 gene may become 
clearer. Alternatively individual TFBS of proteins of interest can be 
manually searched for within the conserved sequence in Bioedit, but this 
approach is restricted by the limited knowledge of TFBS consensus 
sequences. When testing the sequence conservation with the full array of 
TFBS contained in the software, a total of 32 TF were found to bind at 33 
TFBS on the sequence conserved between mouse and chicken (Appendix 
5). There is limited information regarding the DNA sequence which the 
Emx2 protein binds to in vivo. Experiments looking at Emx2 as a negative 
regulator of the Sox2 gene have identified the homeodomain binding 
sequence ATTA/TAAT (Catena et al. 2004) in the Sox2 regulatory elements 
as directly binding with the Emx2 protein and suppressing Sox2 
expression in the brain development of mouse embryos (Mariani et al. 
2012). The Nkx1.2.1 sequence contains 3 ATTA/TAAT sites in the 
conserved ~450bp sequence. 
 The data gained from the ENCODE website about the histone 
conformation of the Nkx1.2 gene and Nkx1.2.1 sequence shows that the 
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area of DNA is in an active conformation in ES cells, meaning TF could 
access the DNA, and the genes are capable of being transcribed in this 
conformation. By comparing this to the negative control of the same area 
in the endothelial cell line, it is clear that the Nkx1.2 gene and Nkx1.2.1 
sequence are in an open conformation in stem cells but not in endothelial 
cells, which is logical, as the Nkx1.2 gene is expressed in neural precursor 
cells (Schubert & Lumsden 2005), and not in endothelial cells. The analysis 
identified that enhancer-associated histone modifications are present on 
the location of the Nkx1.2.1 sequence, and this is a strong indicator that the 
HCNCS is a regulatory element and acts as an enhancer. Relating to the 
data produced by the ENCODE project, research has shown an overlap of 
active and repressive modifications in certain chromatin (Bernstein et al. 
2006). These bivalent domains in stem cells mean the area is poised 
between an active and repressed state, and should be taken into account 
when characterising genetic activity.   
 The mouse ENCODE data enabled specific brain regions to be 
analysed through ChIP-seq. The data were limited to mice aged between 
stage E14.5 to 8 weeks post-natal. All of the data from these time points 
showed that Nkx1.2 and the Nkx1.2.1 region was silenced. This could be 
due to the time at which the data were collected. The later stages of Nkx1.2 
expression appear in mouse by stage E11 (Schubert et al. 1995a). Nkx1.2 
may not be expressed in the early stages of the cerebellum or the cortex, 
and may only be expressed in a small percentage of cells within the brain, 
this is indicated with the results from the H3K4M3 brain cell lines 
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showing marginal activity surrounding the area of the Nkx1.2  gene and 
the Nkx1.2.1  element.   
By analysing the chromatin conformation of the Nkx1.2 gene and 
Nkx1.2.1 sequence in neural cells which develop during the patterning of 
the midbrain, definitive conclusions can be drawn as to whether the 
Nkx1.2 gene and associated regulatory elements are active in developing 
neural tissue, and this would be more specific than the stem cell line or 
organ cell line analysis. 
 
3.5 Chapter Conclusions 
The bioinformatic analysis carried out in this chapter has identified an 
element which is highly conserved in a variety of vertebrate species. This 
suggesting it was positively selected for during evolution, against genetic 
rearrangement pressures. This sequence has been shown to be specifically 
orientated around the Nkx1.2 gene and it has been shown to contain 
conserved TFBS in the sequence, both these traits can be associated with a 
cis-regulatory element and have been previously used to successfully 
identify a candidate enhancer (Poulin et al. 2005, G. a Maston et al. 2006). 
Finally, the sequence has shown to be in a similarly active chromatin 
conformation to the Nkx1.2 gene in stem cell lines, suggesting it is active 
during development, and, more interestingly, the Nkx1.2.1 sequence is 
enriched in the presence of enhancer-associated histone modification, 
which further indicates the HCNCS role as a conserved enhancer.  
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Chapter 4 - The Expression Analysis of Reporter 
Constructs Containing the Nkx1.2.1 Element 
 
4.1 Introduction to Transgenic Expression 
One possible way to test the Nkx1.2.1 sequence (identified in chapter 3) as 
a candidate enhancer is to transgenically express the element in a reporter 
construct during development of an organism to ascertain whether the 
sequence showed enhancer activity in cells that express endogenous 
Nkx1.2. To test whether the Nkx1.2.1 element drove reporter gene 
expression in the same cells as the Nkx1.2 mRNA is detected, 
electroporation experiments were carried out with the Nkx1.2.1 sequence 
which was cloned into an expression vector containing a minimal 
promoter and the GFP reporter sequence to enable the visualisation of the 
expression pattern. This identifies if the Nkx1.2.1 element drives 
transcription and in which area within the midbrain the expression occurs.  
For this information to be accurately collected, the minimal 
promoter associated with the Nkx1.2.1 sequence in the expression vector 
must not activate transcription of the vector independently, but should 
only initiate transcription of the vector once the appropriate transcription 
factors, associated with the candidate enhancer, are present.  
Reporter constructs use a minimal promoter to drive the expression 
of a reporter gene, this is a well established functional test system for 
enhancer activity. Heterologous expression of a candidate regulatory 
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element can be brought about by introducing exogenous DNA into an 
organism with the use of a minimal promoter in conjunction with the 
candidate regulatory element’s DNA, and together these initiate 
transcription (Müller et al. 1997, Uchikawa et al. 2004, Streit et al. 2013). 
This minimal promoter is necessary but not sufficient to drive expression 
of a vector independently. On its own an enhancer is not sufficient to 
drive gene expression independently (Echols 1986), but when associated 
with a minimal promoter in an expression vector, the transcription 
machinery (TM) associates with the enhancer in a specific cell and initiates 
expression of the reporter construct.  
Transgenic analysis of the activity of a candidate-regulatory 
sequence has been carried out on a number of different model organisms 
previously, with different protocols employed to identify the activity. 
As an example; the Hox genes were first identified in Drosophila 
(Scott & Carroll 1987) and their key role in segment patterning during 
development has meant they have been well studied (Soshnikova et al. 
2013). Because their function has been well documented, their 
transcriptional control by regulatory elements such as enhancers has also 
been established (Whiting et al. 1991, Gould et al. 1997, Soshnikova 2014). 
Research carried out at the end of the 1990’s (Itasaki et al. 1999) tested a 
Hox gene enhancer, which was exogenically expressed in chick embryos 
and which drove restricted expression of the reporter GFP construct, along 
the endogenous pattern of the Hox gene, marking the cells within which 
the enhancer was involved in regulating the Hox gene expression.  
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The chick is a useful model system used to study the 
developmental processes (Table 4.1); its genome has been sequenced 
(Hillier et al. 2004); its phylogenetic position as a non-mammalian amniote 
is key for cross-species sequence comparison to identify conserved 
genomic regions (Streit et al. 2013); the development of the chick embryo 
has been well described (Hamilton & Hamburger 1951); fertilised eggs can 
be acquired all year round at relatively low cost and the embryo is in 
sterile conditions within the egg (reviewed in Rashidi & Sottile 2009). The 
embryo is also easily accessible for experimental manipulation through 
windowing of the egg (Selleck & Stern 1991).  
Genetic manipulation of the chick embryo can be carried out in-ovo 
through the use of electroporation of DNA into the embryonic cells. 
Electroporation is the process by which DNA is injected into the tissue of 
the developing embryo and an electric current is then run across the tissue 
(Nakamura & Funahashi 2001) so the exogenous DNA can enter the cells. 
The cells then heterologously express the exogenous DNA, which, because 
it is not designed to integrate into the host cell genome (Pahl et al. 1991), is 
only transiently expressed (Muramatsu et al. 1997) and expression 
diminishes during cell division of the embryo (Nakamura & Funahashi 
2001).  
The experiment to test a Hox gene enhancer used the above 
mentioned protocol as a way to precisely identify the spatial and temporal 
activity of the putative enhancer in-vivo. Although this early experiment 
used chick embryos to transgenically express a reporter under the control 
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of the candidate enhancer sequence, identification of enhancer regions can 
be carried out in a variety of different model organisms.  
To identify the tissue specific enhancers activating the SCL gene, 
transgenic mice were created by performing pronuclear injections of the 
SCL-LacZ reporter constructs into fertilized mouse oocytes before 
implantation into the oviduct of the female mouse (Sinclair et al. 1999). 
The gene SCL was first identified (and subsequently named) because of its 
involvement in stem cell leukaemia. This form of leukaemia is caused by a 
chromosomal translocation, which disrupts the endogenous SCL 
expression and activates the SCL gene (Begley et al. 1989). Wild-type SCL 
is expressed in the embryonic hematopoietic and vascular systems 
(Kallianpur et al. 1994) and codes for a basic helix-loop-helix transcription 
factor protein (Visvader et al. 1991). The reporter constructs used to 
identify tissue specific enhancers contained the putative enhancer 
sequence with the endogenous SCL promoter cloned upstream of the 
bacterial LacZ gene. The results from the research show that three discrete 
enhancer sequences positioned 5’ to the SCL gene direct transcription of 
the gene in diverse regions of the SCL expression pattern.  
The mouse has historically been the dominant model organism 
because of its genetic and physiological similarities to humans (Green. 
1966). Diseases including cancer, atherosclerosis, hypertension, diabetes, 
osteoporosis and glaucoma naturally occur in mice and can therefore used 
for biomedical research (Paigen 1995). Human conditions such as cystic 
fibrosis and Alzheimer’s disease, although not naturally occurring in mice, 
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can be induced in the mouse model through manipulation of the mouse 
genome and/ or their environment (Rossant & McKerlie 2001). In 2002 the 
mouse genome was fully sequenced (Waterston et al. 2002). It was the first 
genome to be sequenced after the human genome project and through 
comparison between the two mammalian genomes large-scale synteny 
across the two genome sequences was identified. 
Although mouse has historically been predominately used in 
genetic analysis during development because of its similarities with 
human, the main limitation of using mouse as a model organism, and the 
reason other model organisms such as zebrafish and chick have seen an 
increase in use in genetic research, is the cost per embryo, although mice 
are capable of reproducing at a relatively early age and can produce 
young multiple times per year, the cost is still high. A comparison of 
definitive genetic model organisms is shown in Table 4.1. 
Species Zebrafish X. Laevis X. tropicalis Chick Mouse 
Brood size 100-200 300-1000 1000-3000 1 5-8 
Cost per embryo Low Low Low Low High 
Gestation/ incubation time 12-36 hours 30-40 hours 30-40 hours 21 days 19-21 days 
Generation time 3-4 months 1-2 years 4 months 4-5 months 6-8 weeks 
Access to embryo Good Good Good Good Poor 
Micro-manipulation of embryo Fair Good Good Good Poor 
Genome sequence Known Known Known Known Known 
Knockdowns (RNAi, morpholinos) Good Good Good Limited Limited 
Transgenics Good Good Good Limited Good 
Table 4.1.  A comparison of common model organisms 
(Adapted from Wheeler & Brändli 2009) 
 
The zebrafish, as noted in Table 4.1 above as having the shortest 
incubation period, is a useful model organism to study genetic regulation 
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during development, and was utilised to identify an enhancer upstream of 
the Gbx2 gene. 
 To identify the regulatory elements involved in the expression of 
the Gbx2 gene at the midbrain-hindbrain boundary (MHB), zebrafish 
embryos were injected with transgenic DNA containing putative enhancer 
sequences (Islam et al. 2006). The Gbx2 gene is active very early in 
development (Bouillet et al. 1995), and also plays a role in the patterning 
of the MHB (Katahira et al. 2000).  Transient expression of reporter 
constructs was preformed and stable transgenic lines were created, using 
GFP as the reporter, with both approaches utilised to show the upstream 
enhancer drives transcription of the Gbx2 gene specifically in the isthmic 
region. Zebrafish are the most evolutionary diverse vertebrate model 
organism from humans among those frequently used for genetic analysis 
(Postlethwait 2000). Zebrafish produce up to 200 eggs every 7 days and 
this high level of fecundity in conjunction with a short egg incubation 
period means that results from transgenic experiments can be gained 
relatively quickly (Lopes & Tavares 2013). Another advantage of using 
zebrafish when studying embryo development is that the embryos are 
translucent so reporter constructs can be easily visualised easily. Indeed a 
mutant strain of zebrafish exists called casper has transparent skin in the 
adult fish (White et al. 2008). Zebrafish have been utilised in large scale 
forward genetic screens (Patton & Zon 2001) as well as knockdown (KD) 
experiments using morpholino oligonucleotides (MO). As the zebrafish 
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genome has been fully sequenced (Howe et al. 2013), genetic assays and 
bioinformatic analysis is available as well. 
Members of the amphibian genus Xenopus offer experimental 
advantages over other vertebrate species when studying developmental 
processes as they produce a large number of robust eggs and embryos 
which, unlike mouse embryos for instance, are accessible at all stages of 
development  
Although the first enhancers were characterised using  reporter 
constructs in cultured cell lines (Banerji et al. 1981), one of the earliest 
enhancers to be identified in-vivo were those associated with the ribosomal 
RNA genes in frogs (Xenopus laevis) (Busby & Reeder 1983). The enhancers 
bind RNA Polymerase I to start transcription of the ribosomal gene 
(Pikaard et al. 1989). In this same research paper it was also discovered 
that a X. laevis RNA polymerase I protein binds to the human enhancer 
sequence, indicating the evolutionary conservation of the binding. The 
research was carried out using X. laevis kidney cells cultures in vitro. But 
X. laevis as a model organism can be used for genetic analysis in vivo too. 
The Xenopus genus contains two species regularly used in genetic 
expression experiments during development. The advantages of using 
Xenopus laevis are its high resistance to disease (Gurdon & Hopwood 
2000), the large numbers of eggs which are large and tough enough to 
withstand microsurgery (Kay & Peng 1992), and the ability to induce 
breeding through-out the year through the use of commercial hormone 
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preparations. These favourably compare to the limited breeding seasons of 
other amphibians (Gurdon & Hopwood 2000). 
Xenopus tropicalis (Western clawed frog) diverged from Xenopus 
laevis approximately 50 million years ago (Hellsten et al. 2007) and, unlike 
X. laevis, has a diploid genome similar to that of chick, mouse, humans, 
and adult Zebrafish (Zebrafish embryos can exist for several days in a 
haploid state (Kroeger et al. 2014)). This makes X. tropicalis suiTable as a 
genetic model system and the X. tropicalis genome has been sequenced 
(Hellsten et al. 2010). X. tropicalis produces a larger number of eggs than X. 
laevis and they take a shorter time to reach maturity (4 months for X. 
tropicalis compared to 1-2 years for X. laevis) (Harland & Grainger 2011). 
However X. tropicalis is less resistant to disease than X. laevis, which makes 
them less resilient when bred in laboratory conditions.  
 
4.1.1` Chick as a Model Organism for this Project 
As noted in the previous section the chick embryo is an appropriate model 
organism for this research because the embryo is easily accessible and can 
withstand embryonic manipulation such as electroporation (Selleck & 
Stern 1991). There are multiple methods for culturing chick embryos for 
transgenic and fate mapping analysis. The standard in ovo protocol was 
first used to transplant quail cells into chicken embryos, because the quail 
cells had a different nuclear appearance it was possible to distinguish 
between the two different species’ cells (Le Douarin 1973) and follow the 
implanted cells fate during development.  Retroviral vectors can be used 
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to introduce foreign genes into the avian germline to create transgenic 
chickens (Mozdziak & Petitte 2004). The transgenic expression can be 
visualised through dissection of the embryo or whole mounting (WM) the 
embryo to identify report construct expression patterns. To visualise 
reporter expression in the ventral midbrain of the chick embryo the area 
was dissected from the main neural tube and flat mounted as shown in 
Figure 4.1. 
 
Figure 4.1. The area of the ventral midbrain dissected from the HH20 
chick embryo and flat mounted for visualisation of fluorescence under a 
confocal microscope. The ventral midbrain arc orientation within the 
dissected area is shown on the right, containing the midbrain arc 
patterning in colours relevant to the different numbered arcs (Figure 1.4 
adapted from Sanders et al. 2002) 
 
 
New (1955) first published a method to culture the whole chick embryo on 
albumin within a watch-glass, with the embryo held in place within a 
glass ring. This protocol enabled the embryo to be visualised more easily 
and allowed more detailed observation and operations to be carried out. 
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One weakness of this method is that there is limited development of the 
extraembryonic vasculature, and a more recent technique for culturing 
chick embryos in vitro replaced the glass ring with a circle of autoclaved 
filter paper to retain the tension on the embryo (Chapman et al. 2001). This 
method, called EC (early chick) is more time and cost efficient, and the 
development of the extraembryonic vasculature is more extensive than 
New’s method.  
Both in vitro methods increase the accessibility to the embryo and 
the ease of micro manipulation such as electroporation because the 
embryonic structures are more easily visible when the embryo is not 
suspended upon the yolk. One main limitation to the in vitro culture 
techniques is that the period of development is limited to a maximum 
level of H&H stage 15-17 and embryos which survive to these later stages 
show growth retardation in the forebrain as neurogenensis progresses. 
There are limitations to using chick as a model organism for 
transgenic expression however. Because of the nature of electroporation 
exposing eukaryotic cells to brief electrical currents which induces the 
uptake of exogenous material, the proportion of cells which uptake the 
DNA cannot be guaranteed. This leads to mosaic expression of the 
reporter construct within the tissue that was electroporated (Chalfie & 
Kain 2005). The degree of DNA uptake varies depending on the tissue 
being electroporated, with research into the transfection of GFP reporter 
constructs in the neural tube showing electroporation in neural tissue to 
be very efficient, with >95% of cells being GFP-positive (Megason & 
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McMahon 2002). As mentioned before, the process of electroporating chick 
embryos using a reporter construct produces transient expression, because 
the expression vector is not integrated into the host genome the time 
period of expression is limited, with a restricted amount of time before the 
plasmid concentration is reduced due to cell division, and the reporter 
protein is degraded.  The timescale over which GFP as a reporter is 
expressed in the neural tube after electroporation has been researched 
(Nakamura & Funahashi 2001). As stated in this paper GFP expression 
peaks 20 hours after electroporation, so electroporation experiments 
designed to observe the expression of a putative Nkx1.2 enhancer should 
be carried out so that the peak of the GFP expression  coincides with 
patterning of the midbrain arcs which includes the endogenous Nkx1.2 
expression.  
 
4.1.2 The Use of Heterologous Promoters in Reporter Constructs 
For the activity of the Nkx1.2.1 sequence to be characterised, a minimal 
promoter needs to be incorporated into the reporter construct. The 
minimal promoter should not be able to initiate expression without the 
association of an enhancer, if it does it is termed as “leaky”. In this project 
two heterologous promoters were tested for their suitability for further 
use as genetic analysis as downstream elements for the Nkx1.2.1 sequence 
in an expression vector; the thymidine kinase promoter and the E1b 
promoter. Both of these are virally-derived promoters. 
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Thymidine Kinase (TK) is a gene which shows conservation of 
sequence from virus to vertebrates (Harrison et al. 1991). It is a 
phosphorotransferase (kinase) enzyme, catalysing the conversion of 
Deoxythymidine to Deoxythymidine monophosphate, and this is further 
phosphorylated to deoxythymidine triphosphate (dTTP) which forms part 
of the DNA (Wintersberger 1997). Because it is involved in the salvage 
pathway for TTP formation leading to DNA synthesis (Rabinowitz & 
Wilhite 1969) it is therefore critical in the cell cycle. The enzyme’s activity 
is cell cycle-regulated (Bello 1974), with an increase during S-phase 
because of the need for TTP in DNA replication, and declining following S 
phase when the cell is quiescent (Sherley & Kelly 1988).  
The minimal promoter for the TK gene was identified by Arcot et 
al. (1989) and has been used to assay the activity of candidate enhancers 
previously. For instance candidate enhancers for the Eya1 gene activated 
the TK-promoter which drove expression of eGFP (Ishihara et al. 2008), 
these experiments identified enhancers from sequences of highly 
conserved non-coding elements (similar to this research, Chapter 3). They 
characterised the in vivo pattern of each enhancer activity during chick 
embryo development using TK as a minimal promoter to drive expression 
of the reporter construct only when the putative enhancers were activated.  
The other minimal promoter tested in this research is the E1b 
promoter. The E1b gene of the adenovirus produces two isoforms of the 
protein; 55kDa protein and a 19kDa protein. Both of these work to delay 
cell lysis during viral replication (White et al. 1992, Tollefson et al. 1996). 
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After death of the host cell is induced the E1b proteins control the export 
of viral transcripts by inhibiting p53 acetylation (Querido et al. 1997). The 
isolated E1b promoter is necessary but not sufficient to drive transcription 
independently (Mautner et al. 1999), E1b has been utilised as a minimal 
promoter in cancer virotherapy. The upregulation of marker genes 
associated with certain tumours was exploited to analyse the possible use 
of adenoviruses as a future oncolytic therapy (Ko et al. 2005). The 
regulatory elements associated with the marker genes were spliced into 
adenoviral vectors containing the endogenous promoter E1b. The 
regulatory elements activated the E1b promoter to produce tissue specific 
expression of the viral vector. 
E1b has also been successfully utilised as a minimal promoter in 
research studying the roles of Pax6.1 and Pax6.2 in zebrafish eye 
development (Nornes et al. 1998). Human HeLa cells were transfected 
with luciferase reporter constructs containing six Pax6 binding domain 
sites upstream of the E1b minimal promoter. The Pax6.2 induced the 
minimal promoter at a higher rate than Pax6.1, suggesting Pax6.2 is a more 
efficient transactivator than Pax6.1. 
 
4.1.3 The Use of CAG Ubiquitous Promoter to Drive a Positive Control 
Vector 
The CAG ubiquitous promoter is often used in expression vectors as it 
drives expression from the vector in all mouse cells except erythrocytes 
and hair (Okabe et al. 1997). The CAG promoter contains three sequences 
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(Miyazaki et al. 1989); the cytomegalovirus (CMV) early enhancer element; 
the promoter, first exon and first intron of the chick beta-actin gene; the 
splice acceptor of the rabbit beta-globin gene. The promoter has been 
utilised to drive fluorescence in chick electroporation experiments where a 
vector driven by CAG acts as a positive control, fluorescently labelling 
with GFP cells which have been successful electroporated (Momose et al. 
1999). 
4.1.4 The GAL4/UAS System Controls Expression 
A positive control is required to test the activity of the minimal promoters 
in vivo, for this the GAL4/UAS system was utilised. GAL4 is a 
transcriptional activator protein from yeast, which, when bound to an 
upstream activation sequence (UAS), activates gene transcription. 
Although GAL4 is a yeast protein it has been shown to initiate 
transcription in vertebrates such as human (in vitro tests on cell lines, 
Webster et al. 1988) and chicken (Soustelle et al. 2007), and this shows the 
conservation of the principal mechanism of activation. 
The gene expression system GAL4/UAS  (Brand & Perrimon 1993) 
can be utilised to identify “leaky” minimal promoters which drive 
expression independently. This system can be most easily used in an 
embryo that is accessible during development, can withstand micro-
manipulation and does not need lab based breeding infrastructure to 
access fertilised eggs.  
The GAL4/UAS system is a biochemical method used to study gene 
expression, and was first utilised to study the eye structure of Drosophila. 
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The system was inserted into the Drosophila genome to target specific gene 
expression of the even-skipped gene in the invertebrate equivalent of the 
eye (Brand & Perrimon 1993). The GAL4 gene was inserted into one fly 
line, and the UAS sequence (upstream of a target gene) into a specific area 
of the flies genome in a separate line, and only when the two lines were 
crossed was the target gene downstream of the UAS sequence 
transcriptionally activated. This meant that the downstream gene could be 
selectively targeted for expression in the tissue specific area where the 
UAS sequence was introduced.  
The GAL4/UAS system was utilised in zebrafish (Scheer & 
Campos-Ortega 1999) to identify the function of a specific gene product. 
Two stable transgenic lines were created; in one, the ‘activator’ line with 
the GAL4 gene under the control of an endogenous promoter, with the 
second ‘effector’ zebrafish line containing the gene of interest fused to the 
UAS sequence, driven by the minimal promoter E1b. Crossing the two 
lines shows that the effector genes are transcribed dependent on the 
spatial pattern of the activators. By expressing the minimal promoters in a 
vector downstream of the UAS sequence and upstream of a GFP sequence, 
and electroporating the construct into chick embryos, the system can be 
modified to test the basal level of transcription of the two minimal 
promoters TK and E1b. It can be identified if the minimal promoters are 
necessary but not sufficient to drive transcription on their own. The 
expression of GFP, when electroporated without the GAL4 vector, means 
that the minimal promoter has driven the transcription of the GFP 
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independently. The minimal promoter expression construct UAS- GFP, co-
electroporated with a vector expressing the GAL4 protein will initiate 
gene transcription of the GAL4 by the ubiquitous promoter CAG upstream 
of the GAL4 element. The GAL4 protein will bind to the UAS element 
which would drive expression of the GFP. So embryos electroporated only 
with the UAS or GAL4 constructs should show no GFP expression, and 
embryos co-electroporated with both the UAS and the GAL4 constructs 
should show GFP in every cell that takes up both expression constructs. 
 
4.1.5 Fluorescent Protein Reporters used in this Project 
Green fluorescent protein (GFP) from the jellyfish Aequorea victoria was 
used as a reporter gene (Tsien 1998). The GFP protein was used as a 
marker for exogenic gene expression (Chalfie et al. 1994).  Enhanced GFP 
‘eGFP’ is a synthetic variant of GFP (Cormack et al. 1996) with increased 
fluorescent intensity. Transgenic mice were produced with eGFP under 
the control of the ubiquitous promoter CAG to create a ‘green mouse’ 
expressing GFP in all cells except the erythrocytes and hair cells (Okabe et 
al. 1997). 
 DsRed was originally isolated from the coral of 
the Discosoma genus (Matz et al. 1999) and was used in this project to 
visualise the positive control vector, driven by the ubiquitously expression 
chick beta-actin promoter (CAG) to identify the region of the embryo 
which was successfully electroporated. The difference in excitation 
wavelengths between the eGFP and the DsRed meant that there was 
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minimal signal crosstalk between the two signals (Jakobs et al. 2000) 
therefore reducing the risk that signal ‘bleed’ between channels. Optimum 
excitation of eGFP is 488nm, with an emission peak at 509nm (Cormack et 
al. 1996), while DsRed has an excitation peak at 554nm and an emission 
peak at 586nm (Strack et al. 2008). 
 
4.2 Materials and Methods 
4.2.1 DNA Constructs 
The gateway cloning system was used (chapter 2) to construct plasmid 
UAS-E1b-GFP, UAS-TK-GFP,  CAG-GAL4 –PolyA, Nkx1.2_5’-eGFP-pA 
and Nkx1.2.1-TK-eGFP. The oligonucleotide sequences used to create the 
gateway fragments for vector ligation are listed in Table 4.2.  
Oligo no. Name  length  sequence (5’-3’) 
1  E1b_F  19  GC’AAGGGTCGACTCTAGAG 
2  E1b_R  19  G’CTGCAGGAATTCGTGTGG 
3  TK_F  19  TG’CTGCTTCATCCCCGTGG 
4  TK_R  18  G’GCTTTACCAACAGTACC  
Table 4.2.  Oligonucleotide sequences used in PCR reactions. 
The protocols for construction and verification of the entry vectors and 
expression vectors can be found in the Material and Methods chapter 2 of 
this thesis, along with the methods of electroporation used to introduce 
exogenic DNA to the developing chick embryo. The protocol for the 
preparation of the embryos for microscopy is also listed in Chapter 2. 
Restriction enzyme      cut site (5’ – 3’) 
EcoR I        G//AATTC 
Pst I        CTGCA//G 
Nco I        C//CATGG 
Pvu II        CAG//CTG 
Table 4.3. Restriction enzymes used in this project. 
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4.3 Results 
4.3.1 Testing the Activity of the Minimal Promoters TK and E1b 
As stated in the Introductory Chapter 1 of this thesis, the Emx2 and Nkx1.2 
genes are involved in arc patterning in the ventral midbrain during H&H 
stage 15-20. To introduce exogenic DNA into the cells within the ventral 
midbrain to enable expression during arc patterning the reporter 
constructs are injected into the neural tube and the ventral neural tube is 
electroporated to target the cells in the ventral side of the developing 
neural tube within the midbrain.  
To test the suitability for these experiments of the two most widely 
used minimal promoters, the promoters were expressed in conjunction 
with the UAS-GAL4 system to identify if either E1b or TK were “leaky”. 
The Nkx1.2.1 sequence was analysed in two parts, with one sequence 
containing only the highly conserved ~400bp sequence within the reporter 
construct. The other sequence contained the ~400bp sequence plus the 
~1600bp sequence which exists between the Nkx1.2.1 sequence and the 
start of the Nkx1.2 gene, which contained the endogenous Nkx1.2 
promoter, this is illustrated in Figure 4.2. The longer length sequence was 
used to test if the element’s distance from the TSS was significant; is the 
tertiary structure of the DNA played a role in the activity of the element.  
The results from experiments carried out to test the activity of two 
minimal promoters, TK and E1b, when electroporated into the chick 
embryo neural tube under the control of the GAL4/UAS system, are 
shown on the next 6 pages. The GAL4 system was included in one 
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expression vector, with a separate expression vector including the UAS 
sequence upstream of the minimal promoter and a reporter construct 
(GFP). Only when the two expression vectors were co-electroporated 
should the GFP be visualised. If the minimal promoter is initiating 
transcription independently, then the GFP expression will be visible when 
the UAS containing-vector if electroporated in the absence of the GAL4 
vector. The primers were designed (Table 4.2) with nested primers 
including a gateway sequence to facilitate the Gateway™ Cloning 
Technology (Chapter 2, Section 2.5.4), the non-coding sequences were 
amplified using PCR (Chapter 2, Section 2.5.3) with chick genomic DNA 
as the template. A detailed description of entry vector and expression 
vector check accurate recombination, the results from the restriction digest 
of the construction can be found in Chapter 2.5.6. The vectors were 
digested to three expression vectors UAS-TK-eGFP, UAS-E1b-eGFP and 
CAG-GAL4- PolyA are shown in Figure 4.3. The Figure also shows the 
restriction digest of the expression vectors with the digested fragments of 
the size expected from the restriction digest maps shown in Figures 4.5, 4.6 
and 4.7. This shows that the vectors were accurately ligated from the entry 
clones into the expression vectors.  Lane 1 of the agarose gel shown in 
Figure 4.3 shows the restriction digest of the UAS-TK-eGFP vector using 
PstI restriction enzyme, this enzyme cuts at 4 sites on the expression 
vector, creating four fragments, because two of the fragments were <400bp 
in length they were not well visualised on the gel, but the two larger 
fragments were readily visualised and of the appropriate size.   
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Figure 4.2. Length of the Nkx1.2 5’ and the Nkx1.2.1 sequences. Panel A 
shows the Nkx1.2.1 element on the left of the Figure as a blue box with a 
red triangle above, the Nkx1.2 gene is shown in green. The scale of the 
elements is depicted below Panel A, with the Nkx1.2.1 element ~400 bp in 
length and the sequence length between the Nkx1.2.1 element and the 
Nkx1.2 gene ~1600 bp in length, the Nkx1.2 gene is ~2500 bp in length 
(based on chick genome). Panel B shows the length of the Nkx1.2 5’ 
sequence which includes the Nkx1.2.1 element and the non-coding 
sequence up to the Nkx1.2 gene, highlighted by the yellow-dashed outline. 
Panel C shows the length of the Nkx1.2.1 sequence which includes only the 
HCNCS, highlighted by the yellow-dashed outline. 
  
122 
 
Lane 2 of the agarose gel shown in Figure 4.3 shows the restriction digest 
of the UAS-E1b-eGFP vector using PstI restriction enzyme, this enzyme 
cuts at 3 sites on the expression vector, creating three fragments, because 
one of the fragments was <400bp in length it was not well visualised on 
the gel, but the two larger fragments were readily visualised and of the 
appropriate size. Lane 3 of the agarose gel shown in Figure 4.3 shows the 
restriction digest of the CAG- GAL4-PolyA vector using EcoRI restriction 
enzyme, this enzyme cuts at 3 sites on the expression vector, creating three 
fragments, the largest fragment of 5139bp is easily visible at the top right 
of the image, further down lane three is a faint double band showing the 
correct sized fragments of 490bp and 577bp in size.  
 
    
Lane     Vector    Restriction enzyme    Digested fragment size (bp) 
M   Hyper ladder 1 
1     UAS-TK-eGFP      PstI  64, 302, 1012, 3836             
2     UAS-E1b-eGFP     PstI  302, 799, 3701 
3     CAG- GAL4-PolyA EcoRI  490, 577, 5139 
 
Table 4.4. restriction enzyme digest fragment 
size of the three expression vectors. The 
expression vectors were tested to see if the 
ligation of the entry vectors into the expression 
vector was successful by checking the size of the 
digested fragments after specific restriction 
digest of the expression vector. 
 
Figure 4.3. 1.5% agarose gel, run for 45 minutes 
at 80 volts. The contents of the gel lanes are 
shown in Table 4.2 above.  
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Figure 4.4. Restriction digest map of the UAS-TK-eGFP expression 
construct created using Vector NTI software. The Figure shows the 
vector in circular form, in total the vector is 5214bp in size with the UAS 
element identified as a black and white arrow on the lower right of the 
vector, the TK promoter position is identified by the green line to the right 
of the vector and the eGFP element is identified as the orange arrow at the 
top left of the vector. The position of the restriction digest sites are 
identified by blue lines across the vector, with the name of the restriction 
digest site attached. Restriction digest names shown in red indicate a 
restriction digest site that only appears once on the vector and so would 
linearise the vector only. 
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Figure 4.5 Restriction digest map of the UAS-E1b-eGFP expression 
construct created using Vector NTI software. The Figure shows the 
vector in circular form, in total the vector is 4802bp in size with the UAS 
element identified as a black and white arrow on the lower right of the 
vector, the TK promoter position is identified by the green arrow to the 
right of the vector and the eGFP element is identified as the orange arrow 
at the top left of the vector. The position of the restriction digest sites are 
identified by blue lines across the vector, with the name of the restriction 
digest site attached. Restriction digest names shown in red indicate a 
restriction digest site that only appears once on the vector and so would 
linearise the vector only.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 Restriction digest map of the CAG-GAL4-PolyA expression construct created using Vector NTI software. The Figure 
shows the vector in circular form, in total the vector is 6206bp in size with the CMV enhancer element identified as a black and 
white arrow on the lower right of the vector, the CAG chick beta actin promoter position is identified by the green arrow to the 
right of the vector and the GAL4 elements is identified as the orange arrow at the top left of the vector.  
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Spectrophotometry of the expression constructs was carried out to 
ascertain the concentration of DNA in the samples. 
Figure 4.7 A, B and C shows the spectrophotometry traces of the 
DNA samples, showing a smooth peak at 260nm with no other peaks 
which would imply contamination of the samples, the high level of purity 
of the sample is shown by the 260/280 ratio, with all samples scoring 
higher than 1.9. The concentration of the samples varied from 643.7ng/uL 
to 2439.3ng/uL. The level of transgenic expression depends of the 
concentration of DNA solution injected (Momose et al. 1999), so all 
solutions were standardised to 1000ng/µL (with DNA concentrations 
below that being processed through ethanol precipitation (Chapter 2.5.7)). 
 The vectors were sequenced by Source Bioscience™ and this, with 
the spectrophotometry traces, coupled with the results gained from the 
agarose gel shown in Figure 4.3, identify that all three vectors contain the 
accurate sequences and are of an appropriate concentration to carry out 
the electroporation experiments.  
Both reporters were visualised in electroporated embryos using the 
confocal microscope, the GFP protein has an excitation peak at a 
wavelength of 488 nm (Inouye & Tsuji 1994), and DsRed has an excitation 
peak of 543 nm (Baird et al. 2000).  
The transgenic expression analysis was carried out in chick 
embryos because of the ease of access to the developing embryo and the 
relatively lost cost per embryo, as explained in the introduction to this 
Chapter. 
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Figure 4.7 Spectrophotometry traces showing the purity and 
concentration of the expression vectors. Panel A shows the Nanodrop 
readout for the UAS-TK-eGFP expression vector showing the DNA peak 
at 260 nm with a high concentration of sample after Maxi prep 
purification. Panel B shows the Nanodrop readout for the UAS-E1b-eGFP 
expression vector showing the DNA peak at 260 nm with a high 
concentration of sample after Maxi prep purification. Panel C shows the 
Nanodrop readout for the CAG-GAL4-PolyA expression vector showing 
the DNA peak at 260 nm with a high concentration of sample after Maxi 
prep purification. 
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Figure 4.8. Chick embryos at H&H stage 11 were electroporated with 
CAG-DsRed positive control plasmid and either TK or E1b minimal 
promoters driving GFP expression. Embryos were allowed to develop to 
stage 22 and were fixed in 4% PFA for 24 hours before visualisation using 
LSCM.  The E1b promoter independently activated transcription of GFP 
(panels D and F) whilst the TK did not (panels A and C). GAL4 in the 
absence of UAS was a negative control for the experiment. The vector 
containing the ubiquitous promoter CAG driving DsRed expression was 
utilised to mark all cells which were successful targeted with 
electroporation, these are shown in red in Panels B, E and H. 
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The images of the fluorescence from these experiments can be seen in 
Figure 4.8. Panels A, B and C of Figure 4.8 show the results from the co-
electroporation of the UAS-TK-eGFP and CAG-DsRed vectors. Panel A 
shows that no cells expressed the eGFP protein from the vector containing 
the TK minimal promoter. Panel B shows that the electroporation 
experiment was successful in introducing fluorescence expressing vectors 
into the embryo, by the expression of the DsRed under the control of the 
ubiquitous CAG promoter. Panel C is an overlay of Panels A and B 
showing only DsRed was expressed from the co-electroporation 
experiment. A similar pattern of results as seen in Figure 4.8 Panels A, B 
and C was observed in seven embryos of 12 which displayed the positive 
control. 
Panels D, E and F show the results from the co-electroporation of 
the UAS-E1b-eGFP and CAG- DsRed vectors. Panel D shows that cells 
expressed eGFP protein from the vector containing the E1b minimal 
promoter independently, without the activation of the UAS element by the 
presence of the GAL4 protein. Panel E shows that the electroporation 
experiment was successful in introducing fluorescent expressing vectors 
into the embryo, by the expression of the DsRed under the ubiquitous 
CAG promoter. Panel F is an overlay of Panels D and E showing both GFP 
and DsRed were co-expressed in cells targeted by the co-electroporation 
experiment.. A similar pattern of results as seen in Figure 4.8 Panels D, E 
and F was observed in eleven embryos of 18 which displayed the positive 
control. 
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Panels G, H and I show the control experiment co-electroporating 
the CAG- GAL4-PolyA vector with the CAG-DsRed vector. Panel G shows 
that no GFP is expressed, Panel H shows that the electroporation 
experiment was successful in introducing fluorescent expressing vectors 
into the embryo by the expression of the DsRed under the ubiquitous 
CAG promoter. Panel I shows the overlay of images G and H showing 
only red fluorescence from the CAG-DsRed vector. A similar pattern of 
results as seen in Figure 4.8 Panels G, H and I was observed in seven 
embryos of twelve which displayed the positive control. 
To identify that the UAS/ GAL4 system worked correctly the two 
vectors containing minimal promoters were each electroporated with the 
GAL4 containing vector. The results from this experiment can be seen in 
Figure 4.9 on the next page. 
In total three expression vectors were electroporated into embryos; 
the minimal promoter vector, the GAL4 vector and the ubiquitous 
promoter driving Ds-Red. Panels A. B and C show the results from the co-
electroporation of UAS-TK-eGFP, CAG- GAL4-PolyA and CAG-DsRed. 
Panel A shows the green fluorescence produced from the UAS-TK-eGFP, 
which follows a similar pattern of expression to that shown in Panel B 
which shows the red fluorescence produced by the ubiquitous promoter 
driving DsRed expression. Panel C shows that the UAS-TK-eGFP vector is 
activated and transcribed in the majority of cells which have been targeted 
and express the DsRed vector, this is shown in the overlay image in Panel 
C which shows that some cells express only red fluorescence and some  
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Figure 4.9. Chick embryos at H&H stage 11 were electroporated with 
CAG-DsRed positive control plasmid and either TK or E1b minimal 
promoters driving GFP expression, in conjunction with the GAL4 
plasmid. Embryos were allowed to develop to stage 22 and were fixed in 
4% PFA for 24 hours before visualisation using LSCM. Both the E1b and 
TK promoters expressed GFP when the upstream UAS element bound 
with GAL4 protein to initiate transcription. A majority of cells, in both 
experiments, which expressed the DsRed protein also contained the GFP 
protein (panels C and F), showing the cells transcribed three separate 
exogenous plasmids successfully. The images are in different 
magnifications due to the quality of the embryo flat mounting. The E1B–
UAS–DsRed electroporated embryo flat-mounting was flawed, leaving 
undulations in the surface in the area of fluorescence. The area of 
florescence therefore had to be in a smaller magnification window, 
compared to the results from the TK – Gal4 – DsRed electroporated 
embryo. 
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cells only express green fluorescence but the majority of cells express both 
red and green fluorescence. A similar pattern of results as seen in Figure 
4.9 Panels A, B and C was observed in five embryos of five which 
displayed the positive control. 
Panels D, E and F show the results from the co-electroporation of 
UAS-E1b-eGFP, CAG- GAL4-PolyA and CAG-DsRed. Panel D shows the 
green fluorescence produced from the UAS-TK-eGFP, which follows a 
similar pattern of expression to that shown in Panel E which shows the 
red fluorescence produced by the ubiquitous promoter driving DsRed 
expression. Panel F shows that the UAS-TK-eGFP vector is activated and 
transcribed in the majority of cells which have been targeted and express 
the DsRed vector. This is shown in the overlay image in Panel F which 
shows that some cells express only red fluorescence and some cells only 
express green fluorescence but the majority of cells express both red and 
green fluorescence. GFP expression derived from transcription of the 
GAL4 protein driving expression of the UAS element in conjunction with 
the minimal promoter appears in fewer cells than those expressing the 
DsRed driven by the ubiquitous promoter, but  a majority of cells which 
express DsRed also express GFP. A Similar pattern of results as seen in 
Figure 4.9 Panels D, E and F was observed in four embryos of four which 
displayed the positive control. 
 The plasmid containing the TK minimal promoter showed no GFP 
expression when electroporated on its own (Figure 4.9 panel A,B and C), 
but when electroporated in conjunction with the GAL4-expressing vector 
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showed ubiquitous expression in a majority of cells across the area of the 
embryo  targeted by electroporation (Figure 4.9 panels A and C).  
In comparison the E1b expression vector showed significant GFP 
expression when electroporated singly (Figure 4.9 panels D and F). When 
the E1b vector was co-electroporated with the GAL4 expression vector 
into the embryo there was GFP expression in a majority of cells targeted 
by electroporation (Figure 4.9 panels D and F).  
The GFP present in the embryos electroporated only with the E1b 
expression vector could not be endogenous expression, since the GFP 
protein is not found in vertebrate animals. This means the GFP expression 
was transcribed from the expression vector containing the E1b promoter, 
independently of the GAL4 – UAS system. This would indicate that the 
E1b minimal promoter is “leaky” and drives expression of the down-
stream sequence without the presence of an upstream activator to initiate 
transcription.  
The images shown in Figure 4.9 show that a percentage of cells 
express both red and green fluorescence, indicating that chick embryonic 
cells can successfully transcribe three separate expression vectors. The 
results show that the UAS/ GAL4 system was transcribed as well as the 
ubiquitous promoter construct, meaning that cells which express both 
green and red fluorescence have successfully driven the expression of 
three separate constructs.  
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4.3.2 Testing the Activity of the Nkx1.2.1 Element 
Electroporation experiments aimed to identify the activity of the Nkx1.2.1 
element in ovo in two forms, one short sequence containing the Nkx1.2.1 
sequence and one longer sequence which contained the chick genomic 
sequence from the start of the Nkx1.2.1 element, including the endogenous 
Nkx1.2 promoter.  
Expression vectors were created using the Gateway cloning 
reactions (Chapter 2) and amplified through transfection in E. coli cells. 
Purified plasmids were checked for their content before proceeding with 
the electroporation experiments as shown in Figure 4.14 and 4.15. 
Restriction digest analysis of the vectors was carried out to see if the 
results tallied with the predicted size of the plasmid fragments from 
restriction digest maps. Table 4.7 shows the expected size of fragments 
produced by incubating the Nkx1.2 5’ plasmid with the NcoI restriction 
enzyme was 1791 and 4913 bp in length. The expected size of fragments 
produced by incubating the Nkx1.2.1 plasmid with the EcoRI restriction 
enzyme was 325, 1140 and 4016 bp in length. These fragment sizes were 
calculated from restriction digest maps shown in Figures 4.11 and 4.12 
which were created using the Vector NTI software.  
The 1.5% agarose gel shown in Figure 4.10 was run to visualise the 
size of the restriction digest fragments and the bands shown on the gel 
were of the predicted size. Plasmids were quantitatively analysed using 
spectrophotometry (Figure 4.13), because the concentration and purity of 
the DNA affects the electroporation results (Momose et al. 1999). The two 
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chromatograms in Figure 4.13 show the spectrophotometry traces of the 
DNA samples, showing a smooth peak at 260nm with no other peaks 
which would imply contamination of the samples, the purity of the 
sample is shown by the 260/280 ratio, with both samples scoring higher 
than 1.9. 
 
 
 
 
 
 
 
 
 
 
Lane Vector                 Restriction enzyme   Digested fragment size 
(bp) 
M          Hyper ladder 1 
1          Nkx1.2 5’ eGFP pA  NcoI  1791, 4913 
2          Nkx1.2.1 TK eGFP  EcoRI  325, 1140, 4016 
 
Table 4.7. The restriction enzyme fragment size of 
the two reporter constructs. The two vectors were 
tested to see if the ligation of the entry vectors into 
the expression vector was successful by checking 
the size of the digested fragments after specific 
restriction digest of the expression vector. 
 
Figure 4.10. 1.5% agarose gel, run for 45 minutes at 
80 volts. The contents of the gel lanes are shown 
in Table 45.1 above.  
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Figure 4.11. Restriction digest map of the Nkx1.2 5’-eGFP-pA expression 
construct created using Vector NTI software. The Figure shows the 
vector in circular form, in total the vector is 6704bp in size with the chick 
Nkx1.2 5’ element identified as a black and white arrow on the lower left 
of the vector and the eGFP element is identified as the orange arrow at the 
top left of the vector. The position of the restriction digest sites are 
identified by blue lines across the vector, with the name of the restriction 
digest site attached. Restriction digest names shown in red indicate a 
restriction digest site that only appears once on the vector and so would 
linearise the vector only. 
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Figure 4.12. Restriction digest map of the Nkx1.2.1-TK-eGFP expression 
construct created using Vector NTI software. The Figure shows the 
vector in circular form, in total the vector is 5481bp in size with the chick 
Nkx1.2.1 element identified as a black and white arrow on the lower left of 
the vector, the TK promoter position is identified by the green line to the 
left of the vector and the eGFP element is identified as the orange arrow at 
the top left of the vector. The position of the restriction digest sites are 
identified by blue lines across the vector, with the name of the restriction 
digest site attached 
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Figure 4.13. Spectrophotometry traces showing the purity and 
concentration of the expression vectors. Panel A shows the Nanodrop 
readout for the Nkx1.2 5’-TK-eGFP vector showing the DNA peak at 260 
nm with a high concentration of sample after Maxi prep purification. . 
Panel B shows the Nanodrop readout for the Nkx1.2 1-TK-eGFP vector 
showing the DNA peak at 260 nm with a high concentration of sample 
after Maxi prep purification. 
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 The spectrophotometry traces in Figure 4.13, coupled with the 
results gained from the agarose gel shown in Figure 4.10 show that both 
vectors contain the expected sequences and are of an appropriate 
concentration to carry out the electroporation experiments. 
Both constructs were independently electroporated into the ventral 
midbrain of an H&H stage 11 chick embryo in ovo. A positive control 
plasmid CAG-DsRed was co-electroporated in each experiment to identify 
the area to be targeted. Both proteins were visualised using the confocal 
microscope, the GFP protein has an excitation peak at a wavelength of 488 
nm (Inouye & Tsuji 1994), and DsRed an excitation peak of 543 nm (Baird 
et al. 2000). 
  The expression pattern of the Nkx1.2 5’ reporter construct was not 
as expected; the plasmid was expressed in a majority of cells across the 
area targeted through electroporation, with no obvious discrete expression 
pattern (Figure 4.14, Panels A and C). The plasmid was expressed in fewer 
cells than the positive control, but the cells which expressed the Nkx1.2 5’ 
plasmid did not seem to be ordered in a specific expression pattern within 
the ventral midbrain, a similar pattern of results as seen in Figure 4.14. The 
results shown in Panels A, B and C were observed in eleven embryos of 
eleven which displayed the positive control in the appropriate area 
(ventral midbrain). 
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Figure 4.14. Chick embryos at H&H stage 11 were electroporated with 
CAG-DsRed positive control plasmid and either Nkx1.2 5’ or Nkx1.2.1 
elements with the TK minimal promoter driving GFP expression. Part 1 
is a diagram of the arc patterning within the midbrain and the orientation 
of the fluorescence as shown in Figure 4.1, the black square shows the 
orientation of the images in Figures A to F in the ventral midbrain of the 
developing chick embryo. Part 2 shown the results of embryos develop to 
stage 22 and fixed in 4% PFA for 24 hours before visualisation using 
LSCM. The Nkx1.2 5’ construct expressed GFP (Panels A and C) in a 
majority of cells which expressed the positive control CAG-DsRed vector, 
whilst the reporter construct containing Nkx1.2.1 (Panels D and F) 
expressed in very few (<10). A positive control was utilised to mark all 
cells which were successful targeted with electroporation, these cells 
express the DsRed protein and are shown in red in Panels B, and E. 
 
 
 
 
1. 
2. 
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Figure 4.15. Chick embryos at H&H stage 11 were electroporated with CAG-DsRed 
positive control plasmid and a plasmid containing the Nkx1.2.1 element with the TK 
minimal promoter driving GFP expression. Part 1 is a diagram of the arc patterning 
within the midbrain and the orientation of the fluorescence as shown in Figure 4.1. 
The larger red box in Image 1 shows the orientation of the images in Figure A, B and 
C. The smaller black box shows the orientation of Figures D, E and F, with the smaller 
blue box identifying the orientation of the images in Figure G, H and I. Part 2 shown 
the results of embryos develop to stage 22 and fixed in 4% PFA for 24 hours before 
visualisation using LSCM. The ventral area of the neural tube expressing the reporter 
constructs was visualised at a lower magnification (x5) to show the targeted area 
(Panels A, B and C). The reporter construct containing Nkx1.2.1 expressed in very few 
cells (<10) in the ventral midbrain (Panels D and F). Cells orientated more laterally 
than those pictured in Panels D, E and F expressed the CAG-DsRed positive control 
plasmid but did not express the plasmid containing the Nkx1.2.1 element. A positive 
control was utilised to mark all cells which were successful targeted with 
electroporation, these cells express the DsRed protein and are shown in red in Panels 
B, E and H. 
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The Nkx1.2.1 reporter construct drove expression in few cells within the 
ventral midbrain, these were orientated close to the midline of the embryo, 
and could only be visualised under high magnification due to the limited 
amount of GFP present. A similar pattern of results as seen in Figure 4.14 
Panels D, E and F was observed in eight embryos of 24 which displayed 
the positive control in the appropriate area (ventral midbrain). 
  The ventral midbrain targeted by electroporation was visualised in 
red using the positive control reporter construct in Figure 4.15, Panels B 
and C. These Panels show the area within which the Nkx1.2.1 plasmid 
expression was visualised. Panels D, E and F of Figure 4.15 are of a higher 
magnification and are repeated from Figure 4.14 Panels D, E and F. Figure 
4.15 shows the specificity of the Nkx1.2.1 construct expression, which was 
patterned only in cells orientated next to the midline of the ventral 
midbrain, but not expressed in a more dorsal pattern, as shown in Figure 
4.15, Panels G, H and I.  
 
4.4 Analysis and Discussion 
4.4.1 Using the Chick Embryo for Reporter Construct Analysis 
To carry out functional testing of the Nkx1.2.1 sequence a reporter 
construct was needed that had the potential to drive expression from the 
Nkx1.2.1 sequence during embryo development. Because the expression of 
the reporter construct only needed to be analysed over a limited time 
period during neurogenesis, the reporter construct did not need to be 
integrated into the host DNA through stable transfection, but rather could 
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be expressed transiently in the form of plasmids which were introduced to 
the host’s cells where they were transcribed and translated by endogenous 
proteins. For this reason, chick embryos were utilised for genetic analysis 
of the Nkx1.2.1 sequence, acknowledging that the concentration and purity 
of the DNA affects the electroporation results (Momose et al. 1999), the 
DNA concentration and purity was assessed so successful electroporation 
experiments using chick embryos would be reliable. 
 
4.4.2 The TK Element Acts as a Minimal Promoter But the E1b Element 
Appears “Leaky” 
The minimal promoter should be necessary but not sufficient to start 
transcription of the reporter construct, if the minimal promoter is “leaky” 
and in certain circumstances drives transcription independently, then that 
would produce a false positive result and mask enhancer activity that is 
being analysed. The experiments show that the E1b heterologous 
promoter was ‘leaky’ and drove expression independently of the UAS-
GAL4 system. This means that the promoter would be unsuiTable for 
analysing the activity of enhancers in-ovo, but the TK promoter would be 
suiTable for further use in this project as a heterologous promoter. 
Research utilising the E1b element as a heterologous promoter to 
identify the activity of regulatory elements (Ko et al. 2005) has shown that 
the promoter does drive a reporter construct containing specific cancer 
markers in a tissue specific fashion (Yu et al. 1999). There are a number of 
differences between these experiments and the research carried out in this 
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project. The reason that E1b did not act as a heterologous promoter in 
experiments carried out using the GAL4/UAS system could be attributed 
to the expression vectors used. In the oncology research where E1b was 
successfully used as a heterologous promoter, the backbone of the reporter 
construct was adenoviral, which contained the endogenous E1b promoter.   
The experiments carried out using GAL4/UAS used a Tol2 vector 
backbone for the reporter constructs, which is derived from the vertebrate 
fish species Medaka (Koga et al. 1996). It could be that elements associated 
with the E1b element within the adenoviral vector assisted to create the 
heterologous expression. The E1b gene and associated promoter are 
adenoviral specific, in comparison to this, the TK gene is conserved from 
viruses to vertebrates (Harrison et al. 1991) with the TK promoter 
containing highly conserved binding sites (Arcot et al. 1989), it could be 
this lack of conservation which resulted in the mis-expression of the 
reporter construct under the control of the adenoviral E1b promoter in the 
chick embryo. This is unlikely, as in experiments in human HeLa cells the 
minimal promoter E1b is used within a luciferase vector (Nornes et al. 
1998), derived from the firefly, so the E1b element can work successfully 
as a minimal promoter in a non-viral vector. 
 The difference observed in the expression of E1b and its function as 
a minimal promoter could be attributed to species specific differential 
expression of reporter constructs. It has been noted previously that 
different reporter constructs are suitable for different cell types 
(Makkonen et al. 2011), further research needs to be carried out to identify 
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if there is a difference of the expression patterns of reporter constructs 
within vertebrate species. 
 
4.4.3 Analysis of the Expression Patterns of Candidate Nkx1.2 
Regulatory Elements 
No regulatory elements have yet to be associated or annotated for the 
Nkx1.2 gene. The gene is involved in patterning the midbrain arcs, an area 
from which complex axonal outgrowths occur. Previous experiments have 
shown that by mis-expressing certain genes involved in the arc 
patterning of the midbrain, including Nkx1.2 (Schubert & Lumsden 2005), 
the axon scaffold of the developing embryo brain is negatively affected. So 
the precise expression of the midbrain arc genes is needed for accurate 
axon patterning during neurogenesis.  
Two lengths of sequence were chosen to maximise the possibility of 
accurately identifying the cells within which the Nkx1.2.1 element was 
active. One sequence contained the Nkx1.2.1 element plus the endogenous 
Nkx1.2 promoter (Nkx1.2 5’), and the second sequence was the 400bp 
highly conserved sequence Nkx1.2.1 element. 
The plasmid containing the Nkx1.2 5’ element was electroporated 
into the ventral midbrain of the chick embryo, but did not show the 
predicted expression pattern. Instead of expressing in <100 cells as the 
expression pattern was predicted for a reporter construct driven by 
enhancer activity associated with a gene endogenously expressed in a 
relatively small and specific are of the ventral midbrain, the expression 
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pattern of the vector mimicked that of the ubiquitous promoter chick β-
actin contained in the CAG-DsRed vector. This expression pattern was 
concluded as an inaccurate representation of the activity of an enhancer 
associated with the Nkx1.2 gene, with the possibility that the sequence was 
lacking an associated repressor in the exogenous sequence, which together 
may regulate downstream gene expression synergistically. The Nkx1.2.1 
element plus the Nkx1.2 promoter without the un-identified repressor 
gave massive over-expression and mimicked the expression of the 
ubiquitous promoter.  
By testing the expression pattern of a reporter construct which 
contained the Nkx1.2 promoter without the Nkx1.2.1 element, it can be 
assessed whether the Nkx1.2 promoter needs to be associated with an 
unidentified repressor for accurate gene expression, or if the over-
expression issue is associated with the ~1600 bp sequence which spans the 
length between the Nkx1.2.1 element and the Nkx1.2 gene sequence. 
 
4.4.4 The Nkx1.2.1 Expression Showed Appropriate Spatial and 
Temporal Patterning 
The Nkx1.2.1 element electroporated into the ventral midbrain of the chick 
embryo showed expression more along the lines of those predicted for a 
positive regulatory element. The expression of the vector sequence only 
occurred within cells located in the ventral midbrain, and in <10 cells in 
each embryo tested. This would indicate that the Nkx1.2.1 element was 
transcriptionally active in these cells and not the surrounding cells.  
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 One limitation noted in the transgenic expression of the Nkx1.2.1 
element was the low number of cells which expressed GFP, identifying the 
Nkx1.2.1 element was active in that cell, this could be attributed to the 
mosaic patterning of reporter constructs which occurs from 
electroporation experiments  (Chalfie & Kain 2005), sTable transgenic mice 
could be created to identify the total number of cells within which the 
Nkx1.2.1 element is active during midbrain development in the embryo. 
This experiment would also ascertain if the activity of the element was 
conserved between avians and mammals. 
The activity Nkx1.2.1 element correlated with the expression pattern 
of endogenous Nkx1.2 in the midbrain. From this it was concluded that the 
element further testing for binding affinity with the EMX2 protein, to 
identify if this HCNCS, which is active in the ventral midbrain during 
neural development, is associated with the EMX2 protein, which is 
expressed in the ventral midbrain during neural development. 
Reporter expression activated by conserved enhancers has been 
shown to be spatially restricted (Itasaki et al. 1999), the area of expression 
of the reporter mirrors all, or part, of the expression pattern of the 
associated endogenous gene. The results of the patterning from the 
Nkx1.2.1 element in this study overlaps endogenous Nkx1.2 expression 
within the ventral midbrain (Schubert et al. 1995b) and are comparable to 
those found in other enhancer studies, such as the research on the Emx2 
enhancer elements studied within the forebrain in the mouse embryo 
(Suda et al. 2010). The Emx2 research identified a number of different 
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enhancer elements which activated reporter construct expression in 
discrete areas within the forebrain, within which endogenous Emx2 
expression has been characterised (O’Leary & Nakagawa 2002). Within the 
caudal neural tube Nkx1.2 is expressed within the spinal part of the neural 
plate, posterior to the youngest somite (Spann et al. 1994). The Nkx1.2.1 
element identified in this project has been shown to be active in the caudal 
neural plate (Kate Storey, pers. Comm.) where Nkx1.2 is expressed, but in 
the absence of Emx2. This would indicate that the enhancer is regulated by 
different transcription factors. 
 
4.5 Chapter Conclusions 
The results of this chapter have demonstrated that the Nkx1.2.1 element 
displays enhancer activity in the ventral midbrain consistent with 
regulation by Emx2. To show if there is physical binding, and if the Emx2 
protein binds directly to the Nkx1.2.1 element, further in vitro experiments 
such as electrophoretic mobility shift assay (EMSA) to assess the binding 
affinity needed to be carried out. 
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Chapter 5 – Emx2 Protein Expression and 
binding Affinity Analysis with the Nkx1.2.1 
Element 
 
5.1 Introduction 
As described in Chapters 1 and 4 of this thesis, previous work indicated 
there is a regulatory loop between the genes Nkx1.2 and Emx2. Work 
carried out in Chapter 4 identified the Nkx1.2.1 element activity in vivo; the 
next step was to test the binding affinity between the Nkx1.2.1 element and 
the Emx2 protein. To identify if Emx2 interacts directly with the Nkx1.2 
gene, an electrophoretic mobility shift assay (EMSA) was carried out, 
requiring purified soluble Emx2 protein for the binding assay. This 
chapter is concerned with the production and purification of Emx2, from 
genetic sequence to accurately folded protein, for the use in EMSA 
experiments.  
A relatively large amount of homogenous protein needs to be 
isolated to confidently reveal the biochemical and structural properties of 
a particular protein. To isolate sufficient quantities of protein from the 
model organism (in this case chick) directly would be a challenging, time 
consuming and expensive exercise. To produce a recombinant protein for 
EMSA analysis, the decision first needs to be made as to which cells to use 
to produce the protein. The common options are bacteria; insect or human. 
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5.1.1 Electrophoretic Mobility Shift Assay (EMSA) 
Emx2 has a proposed role as a DNA-binding transcriptional activator of 
Nkx1.2 (M. Ahsan and F. R. Schubert, unpublished data), and this was 
tested using the electrophoretic mobility shift assay (EMSA). EMSA is a 
biochemical technique used to study the affinity of proteins or ligands for 
nucleic acids. It is based on the observation that in a polyacrylamide gel, 
the mobility of a specific DNA-protein complex differs from that of the 
free DNA (Garner & Revzin 1981). The free DNA will usually have a faster 
migration rate since it has a smaller molecular mass and can migrate 
through a gel faster. The protein-DNA complex will have a larger mass 
and will run more slowly through the gel (Fried et al. 1981). Also known 
as bandshift or gel-retardation analysis, it allows the separation and 
quantification of the free and bound forms of a DNA target. The main 
parameter that can be determined from these studies is the equilibrium 
dissociation constant, Kd. 
 To carry out appropriate EMSA studies to identify the binding 
affinity between the Nkx1.2.1 element and the Emx2 protein, the Emx2 
protein was first synthesised and then isolated.  
 
5.1.2 Recombinant Protein Synthesis  
A standard protocol for expression and purification of a protein of interest 
is through heterologous expression in a bacterial host cell.  
The most widely used expression host is the bacterium Escherichia 
coli (E. coli). The pET system (Novagen) is a system for cloning and 
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expression of recombinant proteins in E. coli controlled by the 
bacteriophage T7 polymerase. The pET vectors in the Novagen library 
were designed from an original cloning vector called pBR322 (Studier & 
Moffatt 1986). From this there is now a large selection of cloning vector 
constructs predominantly used to drive expression in E. coli cells.  The 
system, schematically represented in Figure 5.1, works by using BL21DE3 
strains of E. coli cells which have a T7 RNA polymerase sequence under 
the control of the LacUV5 promoter. In the absence of IPTG (Isopropyl β-
D-1-thiogalactopyranoside) the LacR protein binds to the promoter and 
inhibits transcription of the T7 gene (Figure 5.1A). With the addition of 
IPTG (Figure 5.1B), the LacR protein is displaced by the IPTG which 
allows E. coli RNA polymerase to bind and T7 transcription is initiated. T7 
is the polymerase which initiates transcription of the target gene of the 
pET vector, which is present in the cells through bacterial transformation. 
Emx2 protein was produced in a pRSET vector (another family of 
T7 promoter expression vectors) to study the role of Emx2 in scapula 
development in mice (Capellini et al. 2010). The study expressed a His-
tagged Emx2 protein in E. coli cells. E. coli cells were also used to express 
the Emx2 protein using a pGEX vector (T7 promoter expression vector 
with a GST affinity tag, see section 5.1.2), this time to express the Emx2 
protein, which was used to study the interactions with a Sox2 enhancer in 
the telencephalon of the developing mouse brain (Mariani et al. 2012). 
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Figure 5.1 The Transcriptional silence of the T7 polymerase gene which 
is reversed through the addition of IPTG. A) in the absence of IPTG the 
LacR gene (red square) codes for the LacR protein (red circle) which 
represses T7 expression. B) with the addition of IPTG the transcription of 
T7 is switched on by displacement of the LacR protein with the IPTG 
protein at the lacUV5 promoter site. This allows binding of the RNA 
polymerase to transcribe the T7 gene which is natively translated. C) The 
T7 protein then binds to the T7 viral promoter on the pET vector and 
transcribed the target gene which has been cloned into the pET vector.   
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Protein synthesis in prokaryotes has limitations however; roughly 65% of 
eukaryotic intracellular proteins do not express or are formed in inclusion 
bodies in E. coli (Hirose et al. 2011). The temperature at which the cells are 
incubated is a variable which can influence the process of protein build-up 
in inclusion bodies (Groot & Ventura 2006). For proteins to be removed 
from inclusion bodies they have to be processed with high amounts of 
urea and then re-folded through titration, which is time consuming. As 
well as this, Emx2 has an amino acid sequence containing a cysteine, 
which could form a disulphide bond (de Marco 2009). This type of bond 
does not naturally form in prokaryotes such as E. coli, because the 
cytoplasm is in a reduced state, whereas disulphide bridge formation 
occurs in an  oxidisation reaction, mediated at the endoplasmic reticulum 
(ER) in eukaryotic cells (Sevier & Kaiser 2002). Prokaryotic cells like E. coli 
do not possess the ER, although mutant E. coli cell lines have been created 
which are adapted for the formation of disulphide bonds (Lilie et al. 1998). 
Another limitation of E. coli is its lack of ability for post-translational 
modifications (Schein 1989), which leads to un-folded, partially folded or 
inaccurately folded induced eukaryotic protein.  
Baculovirus mediated protein production in insect cell lines can be 
used to produce recombinant eukaryotic proteins with accurate tertiary 
structure (formed through post-translations modifications). The use of 
recombinant viral vectors to express the protein utilises the productivity of 
the viral vector to transcribe the gene, while the protein folding and post 
translational modifications are carried out by the (eukaryotic) insect cell 
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machinery (Altmann et al. 1999). The cell line Sf9 was first isolated from 
the ovaries of a species of moth Spodoptera frugiperda (Vaughn et al. 1977).  
In work published in 1998, mouse Emx2 protein was expressed using 
baculovirus in Sf9 cells (Mallamaci et al. 1998), and the protein was used 
to create polyclonal antiserum against Emx2 for antibody staining of the 
developing mouse brain 
 Non-lytic expression in insect cells involves transiently or stably 
transfecting into the chromosomal DNA of the insect cells (McCarroll & 
King 1997) to produce recombinant protein, this form of protein 
expression produces higher protein yield within a smaller time-frame 
compared to the baculovirus mediated insect cell host production (Olczak 
& Olczak 2006). The limitation of the virus-free systems is that an 
additional screen step is needed to identify viable clones (McCarroll & 
King 1997). 
 Mammalian cell lines can be utilised for protein synthesis on a large 
scale. The human cell line HEK 293 (human embryonic kidney cells, 
experiment number 293) were first created by transforming the cells with 
adenovirus DNA (Graham et al. 1977). This cell line has been used for 
many years as a host for eukaryotic protein expression. The cells are 
derived from epithelial origins, the biochemical machinery is capable of 
accurate post-translational modifications and folding for a wide variety of 
mammalian and non-mammalian proteins (reviewed by Thomas & Smart 
2005). In a study on the proliferation of neural stem cells (Galli et al. 2002), 
human Emx2 was cloned into retroviral vector and transfected into human 
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neural stem cells, to produce Emx2 protein with a haemaglutinin (HA) 
tag. 
When looking at the interactions of Emx2 with eLF4E in the adult 
mouse olfactory neuroepithelium (Nédélec et al. 2004), the Emx2 protein 
sequence was cloned into a pGEX-derived vector, creating a GST fusion 
protein (see section 5.1.2) which was cultured in COS-7 cell lines (derived 
from monkey kidney tissue). The resulting GST-Emx2 was used to raise 
antibodies in rabbit for immunochemistry analysis in mouse.  
Another option for protein synthesis is cell-free wheat germ extract 
(Marcu & Dudock 1974) which contains all the components necessary for 
protein synthesis, while being a ‘cell free’ system (the cells are lysed and 
the internal components purified for use in vitro (Madono et al. 2011)). 
When studying the interactions between the transcription factors SP8 and 
Emx2 in the embryonic mouse brain (Zembrzycki et al. 2007), the Emx2 
sequence was cloned into a mammalian expression vector and the protein 
was expressed using the TNT wheat-germ kit from Promega.  
 
5.1.3 Recombinant Protein Purification  
Affinity tags are used to isolate the protein from crude biological media. A 
fusion protein is produced with the recombinant protein in conjunction 
with a peptide sequence of the affinity tag protein; when the crude 
biological media is run across a surface which attracts the affinity tag the 
fusion protein is isolated. 
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Glutathione S- transferase (GST) is often used as an affinity tag; the 
DNA sequence is inserted in frame with the open reading frame encoding 
the protein of interest in an expression vector which creates a fusion 
protein. The GST structure of the protein has a high affinity for the 
Glutathione (GSH) molecule which can be fixed to a matrix in a column, 
so that the fusion protein is isolated from the crude biological cell 
contents. Drawbacks to this method are that the GST structure is 
comparably large (220 amino acids, approximately 26KDa) and may 
interfere with the native state of the protein.  
Adding a poly-histidine tag (hHis6-tag) to a protein means that the 
protein can be isolated from the crude biological cell contents through 
affinity purification using a nickel column. Poly-histidine tags are 
relatively small compared to other affinity tags and so are much less likely 
to obscure the binding activity which is being analysed in this research. 
Histidine is a positively charged amino acid, and this means it will attach 
to a negatively charged column, but it also means the His-tag will have a 
charge that could non-specifically attract the negatively charged DNA 
during an EMSA experiment. A protein with 6 His-sequence at either the 
N or C-terminus can be purified from the crude protein solution through a 
nickel column (Schmitt et al. 1993) or through the use of Ni+2 NTA (Knecht 
et al. 2009). 
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5.1.4  The Oxford Protein Production Facility (OPPF) 
The Oxford Protein Production Facility (OPPF) is a structural proteomics 
facility at Oxford University, in the division of structural biology of the 
Department of Medicine. The facility is funded by the Medical Research 
Council and the Biotechnology and Biological Sciences Research Council 
as a national resource centre for the production and crystallisation of 
proteins. It is the first stage of national proteomic analysis to use the vast 
amount of data gathered from the Human Genome Project and other 
genome projects. 
The OPPF has a wide range of vectors in the pOPIN library; the 
pOPIN vector suite combines a large variety of expression vectors with the 
In-Fusion™ enzyme, to create a novel high throughput (HTP) cloning 
process which allows expression of the protein from a single vector into a 
variety of host cells, from E. coli to mammalian HEK293 cells. The process 
is a single-step method, where the PCR product is cloned directly into the 
expression vector, all of which are His-tagged to enable easy purification 
through a His-trap column, with the His-tag being cleavable from the 
protein either with 3C protease, SUMO protease or Carboxypeptidase A, 
for improved crystallisation. For this project, 6 vectors were chosen to 
maximise the probability of producing a soluble Emx2 protein, whilst 
minimising redundancy and overlap of vector properties The Table of 
vectors used is shown in Figure 5.2 and also shows the position in which 
the sequence is inserted and the flanking sequence of the vectors.. Two 
types of induction were used in the OPPF research to induce expression 
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Figure 5.2. pOPIN vector information. Panel A identifies the flanking 
sequence of the point of interest, Panel B shows the sequence features of 
the pOPIN F vector and the relative size of the proteins produced, Panel C 
shows an information Table for 10 different vectors of the pOPIN vector 
suite with the molecular weight of the associated affinity tags and the 
sequence length of the affinity tag. Adapted from OPPF information 
Figures. 
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of the target gene; IPTG induction and auto-induction. Both work by 
activating the transcription of the T7 gene, which is under the control of 
the lacUV5 promoter. Auto-induction is carried out by using Auto 
Induction Media (AIM) which contains glucose. This glucose is 
preferentially metabolised during cell growth, which prevents uptake of 
lactose until the glucose is depleted. When this occurs lactose is taken up 
and converted into allolactose by β-galactosidase. Allolactase causes the 
release of the LacR repressor from its site on the lacUV5 promoter, 
inducing expression of the T7 RNA polymerase, which allows expression 
of the target gene by the T7 RNA polymerase. 
The facility’s pOPIN vector suite and extensive knowledge of 
protein production was utilised for this project to help with the 
production of the Emx2 protein. The first stage of application to work with 
the OPPF was the submission of the application form (Appendix 6) stating 
project description and a brief outline of how the OPPF may be able to 
contribute to the project. From there the application was reviewed by 2 
separate reviewers to grade the application on its feasibility (the 
application for this project gained two 4/5 scores) and then a two week 
period to organise for a researcher to attend the OPPF full-time to carry 
out the experiments under the guidance of the OPPF researchers. 
The focus of the research in this chapter, through the use of the 
OPPF, as well as independent protein synthesis research, was to 
synthesise an appropriate concentration of purified Emx2 protein, to test 
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the interaction between the Emx2 protein and the Nkx1.2.1 element, by 
carrying out an EMSA study.   
 
5.2 Methods 
5.2.1 Mariani et al (2012) Purification 
Mariani et al. published a paper in 2012 analysing the binding affinity of 
the Emx2 protein with a candidate enhancer of the SOX2 gene. The protein 
expression assay of Emx2 in E. coli was run as follows: 
 The Emx2 cDNA was cloned in frame into the pGEX2T expression 
vector  
 E. coli BL21 strain cells were transformed with the plasmid and 
cultures were grown at A600 midlogarithmic phase  
 Protein expression was induced with 0.1mM IPTG for 3 h at 37oC.  
 Protein from the soluble fraction was run through a Ni2+ column 
 Protein was eluted by titrating increased amounts of imidazole 
through the column (Mariani et al. 2012) 
This method, although not fully informative, was initially followed to 
produce soluble Emx2 protein.  
 
5.2.2 Anatomy of the Emx2 Protein 
PyMOL software was used to predict the tertiary structure of the Emx2 
protein, shown in Figure 5.3. The resulting image was inconclusive; 
mapping the tertiary structure of the homeodomain, but with uncertain 
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mapping of the rest of the structure. The majority of the tertiary structure 
was estimated through the PyMOL software because it was characterised 
as “unknown residues” which mean the protein sequence was 
incomparable to any known protein structure within the PyMOL library. 
The structure was therefore estimated according to the charges of the 
amino acids. From this it was identified that the C terminus was more 
exposed than the N-terminus of the protein structure so the Emx2 protein 
sequence was ligated into the vector pET28b to create a C-terminus His-
tagged fusion expression plasmid. 
 
 
 
 
Figure 5.3. PyMOL predicted 
structure of the Emx2 
protein. The C-terminus of 
the protein is labelled. The 
homeobox domain is shown 
as green ribbon at the top of 
the protein, with the 
unknown residues predicted 
structure as green sticks. The 
N-terminus of the protein is 
orientated within the protein. 
 
 
 
 
5.2.3 Expression Vector Formation and Verification 
The Emx2 sequence was synthesised using primer sequences (see Chapter 
2.5.2) found through analysing the Emx2 gene sequence. A PCR reaction 
162 
 
was carried out using the primer sequences and the chick cDNA sequence 
as a template.  
 To ligate the Emx2 sequence into the pET28b vector, the fragment 
and the vector were both cut using restriction enzymes XhoI and EcoRI (as 
shown in Table 2.5 of the Materials and Methods Chapter), then a T4 
ligase kit (NEB) was used to ligate the fragment and the expression vector. 
A molar ratio of 3:1 vector to fragment was used. The reagents are listed in 
Table 5.1 below.  
 
Reagent        Amount 
10x T4 Ligase Buffer      2 µL 
Vector DNA        50 ng 
Fragment DNA       37 ng 
T4 DNA Ligase enzyme      1 µL 
Nuclease free water       to 20 µL 
Table 5.1. Reagents used in expression vector ligation reaction.  
 
Transformation and overnight cultures (Chapter 2.5.9) were carried out 
using chemically competent E. coli cells to amplify the plasmid, followed 
by plasmid purification (Chapter 2.5.10) to isolate the plasmid from the 
cell debris. The conformation of the expression vector was checked to 
ensure the fragment was ligated in the right place and in the right 
orientation. This was done by restriction enzyme reaction (Chapter 2.5.2) 
to cut the vector at specific point mapped out. 
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5.2.4 Transformation and Overnight Cultures 
The pET28b Emx2 vector was transformed (Chapter 2.5.9) into BL21 (DE3) 
Gold cells and plated on LB agar plates containing Kanamycin. Following 
overnight incubation of the transformed cells, a single colony was taken 
from the plate and used to inoculate 10 mL LB medium containing 
Kanamycin. This culture was incubated overnight at 37oC in a shaking 
incubator. 
 
5.2.5 Inoculation and Growth of Starter Culture 
100 µL of the overnight culture was added to 10 mL LB culture containing 
Kanamycin (100µg/ml). The cultures were incubated at 37oC in a shaking 
incubator at 250 rpm and a sample removed every 30 minutes to be 
analysed in the spectrophotometer, until the cells reached an optimum cell 
density (OD600) light scattering reading of approximately 0.6 protein 
expression was then induced using IPTG. 
 
5.2.6 IPTG Induction and Cell Harvesting 
Isopropyl-β-D-thiogalactopyranoside (IPTG) was added at a final 1mM 
concentration to the cell cultures to induce expression of the target protein 
during further incubation. Cells were then incubated for a further 5 hours 
before being harvested from the growth media by spinning in a Beckman 
centrifuge at 14000 (20800 x g) for 10 minutes. The pellet was stored at -
80oC overnight.  
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5.2.7 Sonication 
After freezing overnight the cell pellets were resuspended in 50ml of 
Sonication buffer (materials and methods) plus a Tablet of cOmplete 
EDTA-free protease inhibitor (Roche) to stop degradation of the proteins. 
The Sonics Vibra-cell sonicator was set to run a pulse for 3.3 seconds with 
the pulse off for 9.9 seconds and run for a total pulse time of 10 minutes 
(probe temperature 20oC, amplitude 30%) the cell suspension was kept on 
ice during sonication. 
 
5.2.8 Solubility Assay 
The sonicated solution was centrifuged at 18000g for 30 minutes at 4oC in a 
Beckman Coulter Avanti J-20XP centrifuge to separate the soluble and 
insoluble fractions. The total sonication solution, the centrifuged 
supernatant and the resuspended cell pellet were incubated at 95oC for 5 
minutes with SDS PAGE loading dye and then run down an SDS-PAGE 
gel (Chapter 2.5.19) to visualise in which fraction the protein of interest 
resided. 
 
5.2.9 Isolation of His Tagged Proteins 
Soluble fractions from small scale protein assays were run through a His-
spin column. Soluble fractions isolated from large scale protein growth 
assays were filtered (0.22um) and applied at 1ml/minutes to a pre-
equlibrated 1ml His-Trap FF column using the AKTA Prime system. The 
AKTA prime (GE healthcare) is designed to purify soluble protein from 
165 
 
cell lysis solution. The AKTA Prime has an A280 sensor but no A360 
sensor so it will only detect the presence of protein, with no information of 
the corresponding DNA concentration. The system was pre-run with 
buffer A (chapter 2.4), the cell supernatant was then run through the 
column and the unbound protein collected in 4ml fractions., bound 
proteins were eluted with a 0 – 100% gradient of Buffer B (Chapter 2.4) 
with 500nM imidazol and collected in 1ml fraction for analysis with SDS 
Page and western blot assays. 
 
5.2.10 Insoluble Protein Protocol 
Post-sonication the cell lysis was centrifuged at 18000rpm for 30 mins at 
4oC. The pellet was resuspended in 10ml of 8 M urea and 12% Sarkosyl 
was added. The solution was incubated overnight at 4oC with shaking at 
250 rpm. 
To reduce the sarkosyl concentration down to 1% the solution was 
diluted using solubilisation buffer. The insoluble protein solution was 
diluted to 0.2 mg/mL using 8 M urea and subject to serial overnight 
dialysis using Spectra/Por™ molecular porus membrane tubing: 
 
O/N 1: 10 volumes: 
 50 mM Tris-HCl pH 8.0, 4 M urea, 10 mMCaCl2,, 10 mM MgCl, 150 mM NaCl 
O/N 2: 10 volumes : 
50 mM Tris-HCl pH 7.2, 2 M urea, 10 mMCaCl2,, 10 mM MgCl, 150 mM NaCl 
O/N 3: 10 volumes: 
 50 mM Tris-HCl pH 7.2, 10 mMCaCl2,, 10 mM MgCl, 150 mM NaCl 
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5.2.11 OPPF Setting up HTP PCR Reactions 
HTP PCR reactions were set up to synthesise the varying lengths of Emx2 
sequence. The PCR reactions were set up on ice as follows: First 42µl of the 
Master Mix (Chapter 2 Table 2.7) was dispensed into each well of the PCR 
plate. 3µl of diluted (10µM) forward and reverse primer was added to the 
appropriate wells of the PCR plate, followed by 2µl of template plasmid 
(10-20ng/ul) into each PCR well. The plates were sealed with a foil seal 
and loaded into the Veriti PCR machine (ABI). The PCR settings and 
stages are shown in Table 5.2. 
 
5.2.12 OPPF Analysis of PCR Products 
The PCR sequences were analysed to identify if they were accurately 
synthesised. When the thermal cycling was complete 2.0 µl of 5x DNA 
Loading Buffer was added to each well of a fresh PCR plate. 5µl aliquots 
of each PCR product was then added to the dye and loaded onto a 1.25% 
TBE Agarose gel, a column at a time. The gel was run at 100V for 30 
minutes. The gel was imaged using BIORAD Gel Dock Imager. 
 
Step  Temp (°C)  Time (sec) Purpose 
1  94   120  Pre-heat lid 
2  98   10  Denaturing 
3 x30 60   30  Annealing 
4  68   30  Extension 
5  68   120  Final extension 
6  4   Hold  Prevent further cycling 
Table 5.2. HTP PCR steps and temperature profile, run took about 2 hours 
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5.2.13 OPPF Purification of PCR products 
The PCR fragments bind to magnetic beads to purify the PCR products 
before ligation into the pOPIN vectors. This is done by gently shaking the 
AMPure XP bottle to re-suspend any magnetic particles then pipetting 
90µl AMPure into each reaction in the PCR plate from section 5.3.11. The 
AMPure XP and PCR reaction solution was mixed thoroughly by 
pipetting. The samples were incubated for 3-5 minutes at room 
temperature to bind the PCR products of 100bp and larger to the magnetic 
beads. The reaction plate was placed onto a SPRIPlate 96R magnet for 5 
minutes to separate the beads from the solution. This step separates the 
bead-bound PCR products, 100bp and larger, from un-bound PCR 
reagents and primers. With the reaction plate still situated on a magnet the 
cleared solution was aspirated from the reaction pate and discarded 
without disturbing the magnetic beads. 200 µL of 70% ethanol was added 
to each well of the reaction plate and incubated for 30 seconds at room 
temperature. The ethanol was then aspirated  and discarded, this ethanol 
step was repeated twice more and the plate was air-dried for 10-20 
minutes on a bench top to allow complete evaporation of any residual 
ethanol. 30 µL of elution buffer (EB 10mM Tris pH 8.0) was added to each 
well of the reaction plate and mixed by pipetting the mixture up and 
down. With the reaction plate still situated on the magnet, 30µl of the 
supernatant was taken from each well to a fresh PCR Plate. In this fresh 
PCR plate 5 µL of purified PCR product was mixed with 2µL of DNA 
loading buffer and run on a 1.25% TBE Agarose gel. 
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5.2.14 OPPF In-Fusion Reactions and HTP Transformation 
The Purified PCR fragments were then ligated into the pOPIN vectors. To 
add the fragment into the pOPIN vector 1µl (100ng) of the appropriate 
linearised pOPIN was transferred to each well of a fresh PCR plate.  Then 
10-250ng of purified insert was then added to the appropriate wells of the 
PCR plate.  10 µl of water was transferred to each well and 10µl of the 
total solution was transferred to a dry-down In-Fusion™ plate within 
which the contents were mixed briefly by pipetting up and down. The 
reactions were then sealed with a foil seal. The reactions contained in the 
plate were incubates at  42°C for 30 minutes in the Veriti thermocycler.  
When complete the In-Fusion reactions were transferred to ice and diluted 
by the addition of 40µl of TE.  This solution was then transformed into 
OmniMaxII cells by transferring 5ul of the diluted In-Fusion reaction into 
each aliquot of competent cells. The cells were then incubated on ice for 30 
minutes followed by a heat-shock of the cells for 30 seconds at 42°C in a 
water bath. The cells were then returned to the ice for 2 minutes. 300µl of 
Power Broth (PB)/SOC (with no antibiotic) was added to each tube of cells 
which were then transferred to a 37°C incubator for 1 hour. After 
incubation, 30µl of the cells was transferred onto LB Agar plates 
supplemented with Antibiotic. The plates were shaken vigorously by 
hand, and given 10-15 minutes for the plates to dry off before inverting 
them and incubating overnight at 37°C. 
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5.2.15 OPPF Colony Picking and HTP Culture 
Individual colonies were picked and added into each well containing 
300µl of Power Broth (PB)/SOC with appropriate antibiotic. The plate was 
sealed with a gas-permeable adhesive seal and shaken at 200-225 rpm at 
37°C over-night in a shaker. 
 
5.2.16 OPPF HTP Harvesting and Glycerol Stock Preparation 
Permanent glycerol stocks were made by transferring 100µl from each 
well containing cells from section 5.3.14 to an MTP which contained 
100µl/well of filtered LB/30%v/v glycerol, this was sealed and stored at -
80°C. The gas-permeable seal on each 96-well culture plate was replaced 
with a solid seal and the cells were harvested by centrifugation at 5000g 
for 15 minutes. Following the centrifugation step the supernatant media 
was discarded. 
 
5.2.17 HTP Mini Plasmid Preparation Using Wizard SV96 Purification 
Plates  
The plasmid mini-preps were performed on the Bio-Robot 8000.   
 
5.2.18 OPPF PCR Screening for Construct Verification  
The validity of the vector constructs were ascertained through PCR 
screening with the reverse primer initially used in section 5.3.11. The 
reactions were set up on ice in the skirted PCR plates. 22µl of the OPPF 
HTP PCR master mix (Chapter 2 Table 2.8) was dispensed into each well 
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of the PCR plate followed by 1.5µls of diluted (10µM) reverse primer 
which was added to the appropriate wells of the PCR plate. Finally 1.5µls 
of construct plasmid was added to the appropriate wells of the PCR plate 
which was then sealed with a foil seal and loaded into the Veriti thermal 
cycler. The PCR settings are shown in Table 5.3 below 
 
Step  Temp (°C)  Time (sec) Purpose 
1  94   120  Pre-heat lid 
2  94   30  Denaturing 
3 x30 60   30  Annealing 
4  68   120  Extension 
5  68   240  Final extension 
6  4   Hold  Prevent further cycling 
Table 5.3. Verification PCR steps and temperature profile, run took 
about 2 hours. A 6.5µl aliquot of PCR product was analysed on a 1.5% 
Agarose gel, and the colonies were scored (Appendix 3). 
 
5.2.19 OPPF E. coli Expression Strain Transformations  
The pOPIn vectors containing the Emx2 fragments were expressed in E. 
coli. 3µl of each mini-prepped expression plasmid was added to the 
competent cell aliquots which were incubated on ice for 30 minutes. This 
was followed by heat-shocking of the cells for 30 seconds at 42°C before 
the cells were returned to ice for 2 minutes. 300 µl of Power Broth (no 
antibiotic selection) was added to each cell tube. The tubes were then 
transferred to a 37°C static incubator and incubated for 1 hour. 30µl of the 
cells per well were transferred from the transformation reactions onto LB 
Agar plates supplemented with antibiotic which were tipped by hand to 
spread the cells, the plates were then left for 10-15 minutes for the plates to 
dry off before inverting the plate and incubating overnight at 37°C. 
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5.2.20 OPPF Small Scale Expression Screen  
5.2.20.1 Standard IPTG Induced Expression Screen 
To prepare the growth media for IPTG expression, 0.7ml of Power Broth 
was supplemented with 1µl/ml of the appropriate antibiotic per well of a 
deep-well block plate. Individual colonies were picked and transferred 
into each well. The deep well plates were sealed with gas-permeable 
adhesive seals and shaken at 240 rpm at 37°C overnight.   
The overnight cultures were then diluted transferring 150µl 
(Lemo21) or 250µl (Rosetta2 placI) of overnight culture into 500 µl of fresh 
power broth (with appropriate antibiotic). The diluted cultures were 
shaken at 240 rpm at 37°C for 3-5 hours. After shaking the cultures were 
cooled by further shaking at 240 rpm at 20°C for 20 minutes. Once cooled 
the cells were induced with IPTG, which was added to a final 
concentration of 1mM. The cultures were grown overnight (~18 hours) by 
shaking at 200-225 rpm at 20°C. 
 
5.2.20.2 Expression Screen with Auto-Induction Media 
To prepare the growth media for auto-induced expression, 0.7ml of Power 
Broth was added to a deep-well block plate and supplemented with 
1µl/ml of the appropriate antibiotic per well. Individual colonies were 
picked and transferred into each well. The deep well plates were sealed 
with gas-permeable adhesive seals and shaken at 200-225 rpm or 600 rpm 
at 37°C overnight. The overnight cultures were then diluted transferring 
150µl (Lemo21) or 250µl (Rosetta2 plac I) of overnight culture into 500 µl 
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of fresh power broth (with appropriate antibiotic). The diluted cultures 
were shaken at 200-225 rpm at 37°C for 4-6 hours. The temperature was 
then reduced to 25°C and shaking continued at 200-225 for a further 20-24 
hours. 
 
5.2.21 OPPF HTP Expression Screen Plate Re-formatting and Harvesting 
The cells need to be isolated from the growth media so that their content 
can be analysed. To do this 1.0 ml of culture was transferred from each 
well into a fresh 96-well deep-well plate. The cells were harvested by 
centrifugation at 6000g for 10 minutes, thereafter the media was decanted 
and discarded from the cell pellets by inverting the plates. The plates 
containing the pellets were then sealed and stored at -80°C.  
 
5.2.22 OPPF Ni2+-NTA Miniature Expression Screen Protocol 
This manual protocol was adapted from that used on the QIAGEN 
BioRobot 8000 with QIAGEN Magnetic Ni-NTA. The frozen cell pellets 
were re-suspended completely in 210µl of Lysis Buffer (NPI-10-Tween) 
supplemented with 1mg/ml Lysozyme and 400 units/ml of DNAse Type I.  
The solution was left for 30 minutes for the Lysozyme and DNAse to take 
action before the lysate was cleared, then centrifugation of the deep-well 
block plates at 6000g for 30 minutes at 4°C. 20µl of the Ni-NTA magnetic 
bead suspension was added into each well of a fresh flat-bottomed MTP 
and the supernatant of the spun solution was transferred into the plate 
containing the magnetic bead solution without disturbing the ‘Insoluble’ 
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pellet. The plate was mixed at room temperature using a MTP shaker. 
After shaking the plate was placed on the 96-Well Magnet for 1 min and 
the supernatant was removed from the beads with a pipette. 200 μl of 
Wash Buffer was added to each well, the plate then removed from the 
magnet and shaken on the microplate shaker for 5 minutes. The plate was 
placed back on the 96-Well Magnet for 1 minute, and the buffer removed. 
Finally 50 μl of Elution Buffer was added to each well, mixed on the MTP 
shaker for 1 minute, placed on the 96-Well Magnet for 1 minute, and the 
supernatant transferred to a fresh MTP for analysis on SDS-PAGE. 
 
5.2.23 OPPF SDS PAGE Analysis of Ni2+-NTA Purified Proteins 
The results of the expression screen were analysed on an SDS PAGE gel. 
10µl of each fraction was mixed with 10µl of SDS-PAGE loading in a fresh 
96-well PCR plate. The plate was re-sealed and boiled for 3 minutes. 
The gel tanks were set up in accordance with the instructions from 
Invitrogen. 10µl/ was loaded into each well of the gels. 5µl of Low M.W. 
marker (NEB) was placed in well 1 of each gel and 5µl in well 26 of each 
gel. The Voltage was set to 200V and the gel run until the blue dye reached 
the bottom. 
To stain the gel, it was removed from the plastic casing and placed 
in a plastic box.  The gel was covered with Instant Blue and left for 30-60 
min. The gel was de-stained by removing the stain and covering the gel 
with water until de-stained (this de-stain step was repeated if necessary). 
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The gels were photographed and scores given for the expression (the 
Table of scoring can be seen in the Appendix 3). 
 
5.2.24 DNA substrates For EMSA 
This chapter investigated 7 PCR amplicon lengths as probes, ranging from 
400 bp to 200 bp in length. The vector used for six of the seven PCR 
reactions was plasmid pDEST_tol 2, containing the Nkx1.2 HCNCS 
(Chapter 3 Figure 3.2). The six PCR primers used are shown below in 
Table 5.4 (Oligos 1-6). Oligos 1&6 formed the full length 400 bp sequence. 
The 200bp Left-Short, Middle-Short and Right-Short PCRs were made 
using oligos 1&3, 2&4 and 3&6 respectively. The 300bp Left-Long and 
Right-Long were made using oligos 1&5 and 2&6. Oligos 7 and 8 were 
PCR primers that generated a non-specific 200 bp DNA sequence (based 
on the pUC 19 vector, kindly donated by Dr. Darren Gowers). This PCR 
was used as a control DNA fragment to test for non-specific binding of 
Emx2 proteins to DNA. 
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Oligo No.        Name            Length  Sequence (5'-3') 
1 0 bp forward  20 TGGAACCACAGTCCACTTTG 
2 100 bp forward  23 GGCTTCTCCTTAAAGATAATATC  
3 200 bp forward  20 CAATATCTCAGCTGTCTACG  
4 200 bp reverse  21 CGTAGACAGCTGAGATATTGC 
5 300 bp reverse  20 AGTGATGGCTGTAACAAGCT 
6 400 bp reverse  20 TGAAGTTGGTTTGCTTTCCA 
7 200 bp non-specific F 30 GCGAAAGGGGGATGTGCTGCAAGGCGATTA 
8 200 bp non-specific R 30 CACACAGGAAACAGCTATGACCATGATTAC 
Table 5.4. PCR primers used in this work, with name and 5'-3' sequence.  
 
PCR reactions (50µl) were prepared according to the method in Table 5.5. 
Master Mix was from Roche, at 2x concentration, and contained PWO super 
yield DNA polymerase (25U) with MgCl2 (4mM) and PCR-grade dNTPs 
(12mM) plus reaction buffer. The template plasmid was at a stock 
concentration of 100nM. The PCR primers used were as in Table 8.1 above. 
Finally MgCl2 was made fresh at 50mM. 
 
Component          Stock concentration         Final concentration     Volume added (µl)  
Distilled Water -   -   -   18 µl  
Master Mix     2x   1x   25 µl 
Template plasmid (pDEST_tol2) 100 µM   5 µM   3 µl  
Forward primer   10 µM   0.2 µM   1 µl 
Reverse Primer   10 µM   0.2 µM   1 µl 
MgCl2    50nM   2 mM   2 µL  
Total reaction volume        50 µl  
Table 5.5. Components for PCR reactions. 
 
PCR cycling conditions were as stated in Table 5.6 below. In brief, these 
comprised 25 cycles of denaturation (95oC) annealing (54oC) and extension 
(72oC). 
All PCR products were purified using a Machery-Nagel PCR purification 
kit. In brief this was a spin column format using a standard bind-wash-
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elute protocol. PCR products were eluted into 30 µl of elution buffer 
(10mM Tris-HCl, pH 7.5).  
 
Step  Temp (°C)  Time (sec)  Purpose 
1  95   60   preheat lid 
2  95   15   initial denaturation 
3     5 cycles 65   15   initial annealing 
4  72   120   initial extension 
5  95   15   denaturation 
6     25 cycles 65   15   annealing 
7  72   120   extension 
8  72   480 (8 mins)  final extension 
9  4   hold   prevent further cycling 
Table 5.6 PCR steps and temperature profile; runs took about 2.5 hr. 
The concentration of PCR products was determined by spectrophotometry  
of 2 µL aliquots on a Nano Drop-1000 spectrophotometer. Each trace had a 
clear absorbance at 260 nm. The concentration (in nM) and the 260:280 nm 
ratio was automatically calculated for each trace. Samples (5 µl) of each 
PCR were run on a 1.5% (w/v) agarose gel in 1x TAE buffer with ethidium 
bromide.  
 
Component     Stock concentration Final concentration     Vol. added to 20 ul reaction 
Left-Short DNA  100 nM   25 nM   5 uL 
Middle-Short DNA 100 nM   25 nM   5 uL 
Right-Short DNA  100 nM   25 nM   5 uL 
Left-Long DNA  100 nM   25 nM   5 uL 
Right-Long DNA  100 nM   25 nM   5 uL 
Full Length DNA  100 nM   25 nM   5 uL 
Non-specific DNA 100 nM   25 nM   5 uL 
Table 5.7. PCR fragments concentration of stock and working solutions 
 
  
5.2.25 Proteins used for EMSA studies 
Experiments were conducted using two forms of the Emx2 protein. These 
proteins were partial lengths of the full-length protein, and were 
177 
 
synthesised during the period of research at OPPF. The proteins used 
were ‘CORE’ and ‘INTER’, as stated in Table 5.8. These proteins were 
diluted in 1x Reaction Buffer from 16 µM stocks (see below, Table 5.9) and 
gave a range of dilutions from a maximum of 4000 nM down to 15 nM as 
required for EMSA experiments. A third protein; MMP Pro-cat1, was a 
His-tagged matrix metalloproteinase enzyme, used to test for non-specific 
His-tag mediated DNA binding; the purified protein was a kind gift from 
Dr Andy Pickford.  
 
Component     Stock concentration Final concentration   Vol. added to 20 ul EMSA 
Emx2 CORE protein 16 µM     4000 nM   5 ul 
Emx2 INTER protein  16 µM    4000 nM   5 ul  
MMP Pro-Cat1  16 µM  4000 nM   5 µl 
Table 5.8. Summary of proteins and DNA used. 
 
 
5.2.26 Reagents used for EMSA studies 
The EMSA experiments were carried out using TA buffer at a 50x stock 
solution (Table 5.9), the buffer was EDTA-free as the EMSA gel is a native 
gel and to avoid chelating divalent cations. The binding reaction was 
carried out in Reaction Buffer (RB).  
Reagent / components    Storage 
TA buffer (50x)    Stored at RT as 1 l solution (used at 1×) 
Tris-acetate (2 M) 
RB buffer    Stored at RT as 1 l solution (used at 1×) 
20 mM Tris-HCl (pH 7.3, 100 mM NaCl, H2O  
Loading Buffer    Stored at RT as 1 l solution (used at 1×) 
40% (w/v) sucrose, 1x RB, H2O, bromophenol blue 
SyBr gold (1x)     Stored at -20oc (use 
1 ul of 10,000x stock per 10 ml water. Usually 100 ml made 
Table 5.9. Reagents used during the EMSA experiments 
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5.2.27 Binding reaction Method  
This section shows how the PCR products and Emx2 protein constructs 
were analysed by EMSA to assess their binding affinity.  A typical EMSA 
contained the following;  
Component Stock concentration Final concentration         Volume added (µl) 
RB buffer  2x  1x        10 µl 
DNA            100 nM  25 nM         5 µl 
Protein 16 µM     Variable                      5 µl 
(3 to 13 dilutions)  
Reactions incubated at RT for 30 mins 
Loading buffer  5x  1.7x         10 µl 
Binding reactions (30µl) were loaded onto a 5% (w/v) native polyacrylamide gel 
Table 5.10. Typical EMSA components for a binding reaction between 
protein and DNA.  
 
5.2.28 Native polyacrylamide gels 
For each EMSA experiment, a 5% (w/v) native polyacrylamide (PA) gel 
was prepared. The gel dimensions within the glass plates were 16 cm2 and 
2 mm thick. Gels were run in pairs on an ATTO Midikit gel 
electrophoresis tank. For two gels, 100 ml gel mix was prepared as follows: 
 
5% (w/v) PA  12.5 ml of 19:1, 40%(w/v) concentrate (stored at 4oc) 
1x TA buffer  2 ml of 50x TA stock (stored at RT) 
Water   85 ml 
AMPS   500 µl of fresh 10%(w/v) stock (0.1 g in 1 ml water)  
TEMED  100 µl of stock (98% v/v)  (store at 4oC) 
 
 
Reagents were mixed and poured between clean plates, and a 14 well 
comb added. Gels were left to set for 40 minutes, before removing the 
comb, adding 1x TA running buffer, cleaning the wells and pre-running at 
80 V for 5 min. Samples were loaded with increasing concentrations of 
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Emx2 constructs from left to right and the gel run at gel at 80 V for 4 
hours. The gels plates were separated and the gel submerged in 1x SYBR 
Gold staining solution at room temperature for 30 minutes on a rocking 
platform. Gels were imaged using a Fuji-Film FLA3000 with a blue laser 
(at 473 nm) and blue filter.  
 
5.2.29 Data analysis of the EMSA gels  
The digital image of each gel was analysed using the freeware program 
ImageJ (http://imagej.nih.gov/ij/). This involved drawing horizontal boxes 
around the free DNA and the bound DNA complexes on each gel. A 
sample screen shot is shown below in Figure 5.4 Panel A of the next page. 
This allows the background counts to be clearly identified and the gel 
bands to be quantified by their peak area, as shown in Figure 5.4 Panel B, 
corrected values were then obtained by decreasing each value by the 
amount of the smallest peak, thereby creating a range of numbers which 
may or may not incrementally increase from 0 (depending if there is 
binding affinity to create a ‘shift’ or not). For each gel the counts for free 
DNA should decrease and bound DNA increase, as shown in Figure 5.4 
Panel C. The increase in bound DNA was fitted to a one-site ligand 
binding model in the program Grafit5 (Erithacus software). This gave a 
value for the Kd in nM and also for maximum binding (capacity). The unit 
for Kd is molar (usually µM, nM etc.), since it is defined as the 
concentration of protein or ligand that gives half-maximal binding. This is 
similar to the Km value found in Michaelis-Menten enzyme kinetics, where 
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Figure 5.4 An example of using the ImageJ software to quantify the Free 
DNA in an EMSA gel. Panel A shows the EMSA gel with the area of the 
gel to be quantified highlighted in red. This area is chosen to cover the 
base of the un-shifted DNA (which has spread slightly up the sides of the 
well) but also including below the base of the well, as a control. This area 
is then processed through the imageJ software which produces an image 
of the dark and light areas of the gel as peaks and troughs. These are 
quantified as shown in panel C, which highlights the decrease in the 
amount of free DNA along the gel lanes in the red box. 
 
  
A 
B 
C 
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Km is the concentration of substrate that gives half-maximal rate. The value 
for Kd is therefore normally found by titrating increasing concentrations of 
protein (or binding ligand) onto a fixed DNA concentration. After gel 
electrophoresis, the percentage of separated free and bound DNA species 
at each protein concentration are determined, either by staining the gel 
with a fluorescent dye, or by autoradiography of radiolabelled DNA. The 
data for the bound species are fitted to a one-site ligand-binding equation, 
where the percentage of bound DNA is plotted as a function of the free 
protein concentration. The following equation was used for fitting data in 
this chapter, and is shown below in Fig 5.3:  
][
].[
][
FreeK
FreeCapacity
Bound
d 

 
Figure 5.5. One-site ligand binding equation. 
 ‘Bound’ corresponds to the percentage of bound DNA (determined by 
experiment); ‘Capacity’ is the theoretical maximum binding percentage 
(100%); ‘Free’ represents the free protein concentration (Emx2 constructs 
in this chapter), and Kd is the dissociation constant, measured in the same 
units as ‘Free’. 
 
 
5.3 Protein Optimisation Results 
The focus of this section of research was to synthesise purified chick Emx2 
protein for subsequent binding experiments. To do this the chick Emx2 
protein coding sequence (Mariani et al. 2012)  was amplified (from the 
chick Emx2 plasmid (Bell et al. 2001)) using PCR with the Emx2 primers 
(Chapter 2.5.2). The Emx2 sequence was then ligated into the pET28b 
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vector. After the ligation experiment the expression vector was analysed to 
check the DNA concentration and purity of the DNA. To test if the ligation 
of the Emx2 sequence into the pET28b vector was successful, restriction 
digest of the expression vector was carried out to identify if the vector was 
‘cut’ at the correct point predicted using the Vector NTI software. The 
Vector NTI map of the pET28b Emx2 expression vector in Figure 5.7 
identified 4 sites where the restriction enzyme PvuII would cut the vector 
(Table 5.11). Fragment sizes obtained after the PvuII digest were consistent 
with the prediction (Figure 5.6). The readout of the spectrophotometry is 
shown in Figure 5.8, showing a smooth trace with a peak of light 
absorption at 260 nm, with no peak at 280 nm or 270 nm.  
The spectrophotometry tests showed the vector was of a high 
enough concentration and purity to use for protein induction in E. coli 
cells, and the restriction digest showed that the Emx2 fragment was 
accurately ligated into the vector in the right position and orientation. 
 
Lane  Vector      Restriction enzyme   Digested fragment size (bp) 
M   Hyper ladder 1 
1    pET28b + Emx2    PVU II  93, 1000, 2076, 2932 
  
Table 5.11. Restriction enzyme digest fragment 
size of pET28b vector containing the Emx2 
protein sequence.  
 
 
Figure 5.6. 1.5% agarose gel, run for 45 minutes at 
80 volts. The contents of the gel lanes are shown 
in Table 5.11 above. The expression vector was 
incubated with the restriction enzyme for 1 hour 
and the resulting fragments separated. 
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Figure 5.7. Restriction digest map of the PET28b-Emx2 construct created 
using Vector NTI software. The Figure shows the vector in circular form, 
in total the vector is 6101bp in size with chick Emx2 element at the top 
right of the vector, identified by the green arrow. The position of the 
restriction digest sites are identified by blue lines across the vector, with 
the name of the restriction digest site attached. Restriction digest names 
shown in red indicate a restriction digest site that only appears once on 
the vector and so would linearise the vector only. 
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Figure 5.8. Spectrophotometry traces showing the purity and 
concentration of the vectors. Panel A shows the Nanodrop readout for the 
pET28b vector showing the DNA peak at 260 nm with a high 
concentration of sample after mini prep purification. Panel B shows the 
Nanodrop readout for the pET28b+Emx2 expression vector showing the 
DNA peak at 260 nm with a high concentration of sample after Maxi prep 
purification 
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5.3.1 Induction of Emx2 Protein Expression 
Using the online software Protparam the chick Emx2 protein is 28.3 kDa in 
size. The total size of the Emx2 protein with a His-tag attached to it makes 
it approximately 33Kd in size, adding only 5Kd to the total weight of the 
protein. 
Figure 5.9 Panel A is an SDS PAGE gel showing the protein content 
of the cell aliquots removed from the incubating cell culture every hour. 
Samples for analysis were taken every 30 minutes before IPTG induction 
(time point indicated by the blue arrow). From the time the aliquot of the 
overnight culture was added to the starter culture. After IPTG induction 
samples were taken every hour. The content of each lane is an aliquot of 
pelleted cells, resuspended in SDS PAGE buffer and boiled. The gel shows 
the increase in concentration of all the proteins, shown by an increase in 
band intensity between the cells harvested at 5, 6 and 7 hours. This 
indicated that the cell density within the media increased, this is 
confirmed by the graph in Figure 5.8 Panel B (next page) which shows an 
increase in OD600 over the time-course of the experiment. The gel shows a 
strong increase of amount of induced protein (yellow arrow) after the 
addition of IPTG (blue arrow), this concentration of induced protein does 
not appear to decrease. Over time, although the intensity of the bands 
from endogenous E. coli proteins does not seem to increase further over 
time after IPTG induction. The yellow arrow marks the increased density 
of a band at ~33KD in size; the same size of protein as the Emx2 protein. 
This protein is induced by the addition of IPTG to the  
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Figure 5.9. Protein concentration of cells, from aliquots taken every hour 
from the point of inoculation of the media to 5 hours after induction 
with IPTG, total time of incubation was 9 hours. Panel A shows the SDS 
PAGE gel of the IPTG induction analysis. The gel shows the Seeblue® plus 
2 pre-stained protein marker in lane M. The number above the wells 
indicates the time (in minutes) which the cells were incubated for post 
inoculation of the culture. An aliquot of the culture was taken every hour 
and the whole sample was boiled with SDS buffer and run to form this 
image. The blue arrow highlights the point at which IPTG was added. The 
yellow arrow highlights the induced protein approximately 33KD in size. 
Panel B is a graph showing the increase in OD600 reading of absorbance, 
showing the density of the cell culture increased over time. 
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Figure 5.10. Clarifying the accuracy of the His-tagged antibody for 
western blot analysis. An SDS PAGE gel and a western blot of pre and 
post IPTG induction with a positive control. Panel A is an SDS PAGE gel, 
lane 1 (M) contains Seeblue® plus 2 pre-stained protein marker, lane 2 
contains an aliquot of the cell culture 210 minutes after initial culture 
inoculation but pre-IPTG induction. Lane 3 contains an aliquot of the cell 
culture 240 minutes after initial culture inoculation but pre-IPTG 
induction. Lane 4 contains an aliquot of the cell culture 300 minutes after 
initial culture inoculation and 60 minutes after IPTG induction. Lane 5 
contains an aliquot of the cell culture 480 minutes after initial culture 
inoculation and 240 minutes post IPTG induction. Lane 6 contains the his-
tagged protein Pro-Cat1 as a positive control for the western blot in Panel 
B. Panel B is an identical gel which has been processed through a western 
blot experiment to show the presence of a specific protein using an 
antibody. The yellow arrow indicates the presence of the His-tagged Emx2 
protein. 
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growth media and can therefore be estimated to be the His-tagged Emx2 
protein. 
Figure 5.10 (previous page) is an SDS PAGE gel and a western blot 
of the pre and post IPTG cell content. This experiment was carried out to 
analyse if the induced protein, initially identified in Figure 5.9, was the 
His-tagged Emx2 protein. To test this, an SDS PAGE gel (Figure 5.10 Panel 
A) was run containing two cell samples from pre-IPTG induction time 
points and two cell samples from post-IPTG induction time points. These 
samples were run with a positive control – Pro-Cat1 protein with a His-tag 
29.5 kDa in size to confirm the antibody was binding to the His-tag of the 
fusion protein.  The gel shows the increase intensity of the band of 
induced protein after IPTG induction (yellow arrow) of the cell culture. 
When run on a western blot (Figure 5.10 Panel B) to visualise the His-tag 
with anti-His antibody staining, the band of protein which appears after 
IPTG induction is shown to containing proteins with a high His-content. 
Figures 5.9 and 5.10 indicate that the protein induced by IPTG induction is 
approximately 33 kDa in size and contains a number of histidine residues. 
 
5.3.2 Solubility Evaluation 
The experiment, which repeated the protocol of Mariani et al. from 2012, 
was carried out with the chick Emx2 protein. In the protocol from the 
Mariani et al. paper a GST-tag was used to create a large GST-fusion 
protein with the Emx2 protein. Figure 5.11 shows the majority of the 
induced protein (yellow arrow) from the cell lysis existed in the pellet, as 
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opposed to the supernatant, meaning the protein is insoluble. This could 
be due to inadequate sonication of the cells, or that the IPTG induced 
Emx2 protein exists predominantly in inclusion bodies. The majority of 
the endogenous proteins also appeared to be in the insoluble fraction, 
which could point towards incomplete sonication of the cells, although 
even with only partial sonication of the cells, a proportion of the induced 
protein should appear in the soluble fraction (supernatant) if it exists in a 
soluble form within the cells.  
With the view of increasing the amount of protein in the soluble 
fraction, optimisation of the protocol was carried out, altering a variety of 
variables including temperature and growth medium with the aim of 
enhancing the amount of soluble protein within the overall fraction.  
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Figure 5.11 A repeat of the Mariani et all 
(2012) method. An SDS PAGE gel 
showing the solubility assay of the Emx2 
protein. After IPTG induction the cells were 
incubated for a further hour and then 
harvested. The cells were lysed and then 
spun in a centrifuge to separate the soluble 
and insoluble fractions. The gel shows the 
Seeblue® plus 2 pre-stained protein marker 
in lane M. The total cell lysis content (pre 
centrifuge)  is in lane T. The protein 
contained in the pellet, resuspended in SDS 
buffer is in lane P. The supernatant from 
the cell lysis was run in lane S.  
Figure 5.12. Analysis of the effect of time on cell growth. An SDS PAGE 
gel showing the protein concentration of cells grown at 25oC, from 0 – 4 
hours post IPTG induction. The gel shows the Seeblue® plus 2 pre-
stained protein marker in lane M. Lanes 2 and 3 are aliquots taken at 0 
hours after IPTG induction, with the insoluble proteins contained in the 
pellet of the spun cells in lane 2, and the soluble proteins contained in the 
supernatant of the spun cells in lane 3. Lanes 4 and 5 are aliquots taken at 
1 hour after IPTG induction, the blue arrow indicates the presence of the 
IPTG induced Emx2 protein,. Lanes 6 and 7 are aliquots taken at 2 hours 
after IPTG induction. Lanes 8 and 9 are aliquots taken at 3 hours after 
IPTG induction. Lanes 10 and 11 are aliquots taken at 4 hours after IPTG 
induction. 
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5.3.2.1  Temperature Reduction to Reduce the Prevalence of 
Inclusion Bodies 
The issue of inclusion bodies was first addressed by reducing the 
incubation temperature of the cells from 37oC to 25oC, as shown in Figure 
5.12. The induced protein can be seen in the pellet fraction from 1 hour 
post-IPTG induction, as indicated by the yellow arrow in the Figure. The 
induced protein resided in the insoluble fraction 1 hour post-IPTG 
induction onwards, and was not present in the soluble fraction at any time 
point of the experiment. The majority of the endogenous proteins exist in 
the insoluble fraction of the cells, which could again indicate incomplete 
cell lysis, highlighting a problem with either the sonication or the 
lysozyme Tablets. When comparing the results of the induced protein 
incubated at 25oC with the results from the incubation at 37oC the strength 
of the induced band appears weaker, this may indicate optimal IPTG 
induction of the protein occurs at a temperature closer to 37oC than 25oC. 
 This data suggests that the Emx2 protein is produced 
predominantly in an insoluble form in E. coli cells regardless of 
temperature, but it may be possible to purify the small amount of protein 
which exists in the soluble fraction. 
 
5.3.3 His-Tag Purification of the Protein 
The supernatant shown in Figure 5.10 was analysed through the AKTA 
prime using a His-trap column, for analysis of the His-containing proteins 
(Figure 5.13). The SDS PAGE gel shows the results from the AKTA prime 
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experiment. In lanes titled 6-14, are fractions containing bound protein 
displaced from the His-trap column, these fractions were identified as 
containing protein due to the AKTA prime’s A280 sensor which showed a 
peak when proteins (aromatics) pass across the sensor. The readout from 
the AKTA prime is shown as a graph in Panel B of Figure 5.13. The gel in 
Panel A show proteins were present in the fractions, but none of the size 
of the induced Emx2 protein. As indicated by the yellow arrows in Panel 
A, the total cell lysis and pellet fraction did contain the induced protein, 
but it was not present in the soluble fraction at a high enough 
concentration to be picked up on the column. 
Panel B shows the readout of the A280 sensor in dark grey, with the 
percentage of imidazol in light grey. The A280 readout shows a large 
amount of unbound protein is passed across the sensor as the soluble 
fraction is run through the column, then as the percentage of Imidazol 
increases a peak can be seen as bound protein on the column is displaced 
by the imidazol. The samples which caused this peak are contained within 
the fractions 6-14, which although they contain protein, are not the right 
size to be the Emx2 protein 
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Figure 5.13. AKTA Prime containing a His-trap column. An SDS PAGE 
gel of fractions from an AKTA prime his-tagged protein isolation 
experiment.  Lane 1 contains Seeblue® plus 2 pre-stained protein marker. 
Lane 2 contains total cell lysis post-sonication, lane 3 contains the pelleted 
sonication solution, lane 4 contains the flow through from the column. 
Lane 6 -13 are aliquots of fractions which gave out a reading of 280 nM 
from the AKTA prime, which identifies if protein is present in the fraction. 
 
A 
 
 
 
 
 
 B 
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5.3.4 Clarification of Induced Insoluble Protein 
To solubilise the insoluble Emx2 protein present in the pellet fraction of 
the cell lysis, the insoluble portion was processed through the ‘insoluble 
protein protocol’ which involved resuspending the pellet in 8 M urea. The 
sample was then put through serial dialysis to reduce the urea molarity 
from 8 M to 3.5 M. the samples from the repeated centrifugation steps and 
a sample of the final pellet contents were run on an SDS PAGE gel, shown 
in Figure 5.14 on the next page. 
 The gel shows a large amount of endogenous E. coli protein is 
solubilised from the insoluble fraction after the first of the centrifugation 
steps (lane S1). The level of protein solubilised in each subsequent 
centrifugation step is less, as shown by the intensity of the band on the 
SDS PAGE gel. The band of induced Emx2 protein, which runs at just 
below the 36KD band of the maker, is not present in any of the solubilised 
samples (S1-S5) and the Emx2 protein is only present in the sample of the 
pellet, as indicated by the yellow arrow in lane P on the gel. This gel 
indicates that 8 M urea does not solubilise the insoluble induced Emx2 
protein expressed in E. coli cells. Further attempts were made to solubilise 
the Emx2 protein from the insoluble fraction of the cell lysis. 
 Sodium lauroyl sarcosinate (sarkosyl) is an ionic surfactant used to 
unfold proteins by disrupting their tertiary structure (Frankel et al. 1991). 
Sarkosyl was added to the lysis buffer at increasing percentage increments 
to identify if a percentage of sarkosyl was necessary for the solubilisation 
of the insoluble Emx2 protein. 
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Figure 5.14. Use of urea to solubilise the Emx2, an SDS PAGE gel of the 
solubility assay of the protein after treatment with 8M urea and DTT.  
Lane M contains Seeblue® plus 2 pre-stained protein marker, lane S1 
contains  a sample of the supernatant after the first centrifuge stage, lane 
S2 contains a sample of the supernant after the second centrifuged; the 
pellet from the first centrifuge step was re-solubilised, sonicated and spun 
in the centrifuge. Lane S3 contains a sample of the supernant after the 
third centrifuged; the pellet from the second centrifuge step was re-
solubilised, sonicated and spun in the centrifuge. Lane S4 contains a 
sample of the supernant after the fourth centrifuged; the pellet from the 
third centrifuge step was re-solubilised, sonicated and spun in the 
centrifuge. Lane S5 contains a sample of the supernant after the fifth 
centrifuged; the pellet from the fourth centrifuge step was re-solubilised, 
sonicated and spun in the centrifuge. Lane P contains a sample of the final 
pellet dissolved in SDS buffer.  
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Figure 5.15 (next page) shows the gel montage of the addition of sarkosyl 
to the lysis buffer. This gel shows that, over a percentage range of 0% to 
20% of sarkosyl, no Emx2 protein appeared in the soluble fraction of the 
experiment, but stayed in the insoluble pellet.  
 With the addition of urea in conjunction with the sarkosyl in the 
lysis buffer, the Emx2 became partially soluble (Figure 5.16). Below 8% 
sarkosyl the majority of the induced protein still resided in the insoluble 
fraction (lanes titled P for pellet), but above 10% sarkosyl the majority of 
the Emx2 band exists in the soluble fraction of the experiment (lanes titled 
S for supernatant), indicating that with urea and a concentration of >10% 
sarkosyl the Emx2 protein can be solubilised. Two bands are present in 
the position of the induced Emx2 protein. 
 
5.3.5 Purification and Solubilisation of the Induced Insoluble Protein 
To purify the solubilised Emx2 protein, the resulting solution from the 
urea and sarkosyl experiments needed to be run through an affinity 
column to isolate the His-tagged proteins. For this to be carried out the 
urea molarity and sarkosyl concentration needed to be reduced, otherwise 
the solution would strip the column and void the results. To reduce the 
urea molarity, serial dilution of the soluble fraction was carried out, which 
resulted in a large amount of the protein precipitating and returning to an 
insoluble form.   
  
 
 
 
 
 
 
 
 
 
Figure 5.15. An SDS PAGE gel montage showing the effect of increasing amounts of Sarkosyl in the lysis buffer on the target protein 
solubility. Lane 1 contains Seeblue® plus 2 pre-stained protein marker. Lane 2 and 3 represent samples from the pellet and the 
supernatant (P and S) of the cell lysis treated with no sarkosyl. Lanes 4 and 5 represent samples from the pellet and the supernatant (P 
and S) of the cell lysis treated with 2% sarkosyl. Lanes 6 and 7 represent samples from the pellet and the supernatant (P and S) of the cell 
lysis treated with 4% sarkosyl. Lanes 8 and 9 represent samples from the pellet and the supernatant (P and S) of the cell lysis treated with 
6% sarkosyl. Lanes 10 and 11 represent samples from the pellet and the supernatant (P and S) of the cell lysis treated with 8% sarkosyl.  
Lanes 12 and 13 represent samples from the pellet and the supernatant (P and S) of the cell lysis treated with 10% sarkosyl. Lanes 14 and 
15 represent samples from the pellet and the supernatant (P and S) of the cell lysis treated with 12% sarkosyl. . Lanes 16 and 17 represent 
samples from the pellet and the supernatant (P and S) of the cell lysis treated with 14% sarkosyl. . Lanes 18 and 19 represent samples 
from the pellet and the supernatant (P and S) of the cell lysis treated with 16% sarkosyl. Lanes 20 and 21 represent samples from the 
pellet and the supernatant (P and S) of the cell lysis treated with 18% sarkosyl. Lanes 22 and 23 represent samples from the pellet and the 
supernatant (P and S) of the cell lysis treated with 20% sarkosyl. 
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Figure 5.16.  The effect of increasing amounts of Sarkosyl in conjunction with 4M urea in the lysis buffer on the target protein 
solubility.  Lane 1 contains Seeblue® plus 2 pre-stained protein marker. Lane 2 and 3 show the samples from the pellet and the 
supernatant (P and S) of the cell lysis treated with no sarkosyl and 4M urea, with the percentage of sarkosyl increasing by 2% in each 
sample, while the concentration of urea is kept at 4M for all the experiments. Lanes 4 and 5 represent treatment with 2% sarkosyl and 4M 
urea.  Lanes 6 and 7 contain treatment with 4% sarkosyl and 4M urea. Lanes 8 and 9 contain treatment with 6% sarkosyl and 4M urea. 
Lanes 10 and 11 contain treatment with 8% sarkosyl and 4M urea. Lanes 12 and 13 contain treatment with 10% sarkosyl and 4M urea. 
Lanes 14 and 15 contain treatment with 12% sarkosyl and 4M urea. Lanes 16 and 17 contain treatment with 14% sarkosyl and 4M urea. 
Lanes 18 and 19 contain treatment with 16% sarkosyl and 4M urea. Lanes 20 and 21 contain treatment with 18% sarkosyl and 4M urea. 
Lanes 22 and 23 contain treatment with 20% sarkosyl. 
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The remaining solution was titrated to reduce the concentration of 
sarkosyl, which resulted in further precipitation of the protein. The 
resulting solution was run through an AKTA prime containing a His-trap 
column, this produced only minimal positive results (shown in Lane 1 and 
2 of Figure 5.16), the fractions collected contained no protein, indicating all 
the Emx2 protein had precipitated. 
 The bands which are visualised in Figures 5.15 and 5.16 have been 
purified through the serial treatment of urea and DTT, so by treating the 
solubilised protein solution containing 4 M urea and 10% sarkosyl with 
Strataclean™ resin the diluted protein could be concentrated to a level 
which can be used for EMSA studies using the Emx2 protein. 
 Figure 5.17 on the next page shows the results from the fractions of 
the AKTA which gave minimal peaks indicating protein. As shown in 
lanes 1 and 2 there was no protein present in the fractions from the AKTA 
prime of the solution after reducing the amount of urea and sarkosyl. The 
band visible in lane P is the Emx2 protein from the precipitate which 
‘crashed out’ during the dilution of the solution to reduce the 
concentration of urea. This pellet was re-suspended in the 4 M urea and 
10% sarkosyl lysis buffer and this solution was then treated with 
Strataclean™ resin to increase the concentration of the dilute protein. The 
resulting band in Figure 5.16, named 1+strataclean does not appear to be 
more intense than the band in lane P, which would indicate that the 
concentration of the protein solution had not increased with the 
Strataclean™ treatment.  
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Figure 5.17 An SDS PAGE gel showing the protein containing fractions 
from the AKTA prime, with the results from the pellet treated with 4M 
Urea and sarkosyl, and a concentrated sample of the supernatant. Lane 
M contains Seeblue® plus 2 pre-stained protein marker. Lane 1 contains as 
sample from fraction 1 that gave a minimal positive reading on the AKTA 
prime that it contained protein. Lane 2 contains as sample from fraction 2 
that gave a minimal positive reading on the AKTA prime that it contained 
protein. Lane P contains a sample of the Sarkosyl and 4M urea treated 
pellet, from the centrifugation step after the dilution of urea, which caused 
the majority of the protein to precipitate. Lane 1+ Strataclean contains a 
sample of fraction 1 which was treated with StrataClean. The yellow 
arrows in lanes P and 1+Strataclean indicate the presence of the Emx2 
protein. 
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5.4 OPPF Protein Optimisation Results 
The results from the OPPF protein production experiments are shown as 6 
separate composite gel Figures on the following pages. These were created 
from the four different variables of expression; two different types of 
competent cell and two different types of induction. With the 8 different 
protein sub-forms expressed, shown in Table 5.12 (Full length; HD-C 
terminus longest Homology; HD longest N and C terminus; Core domain; 
Intermediate extensions to domain; Longest extension N short C; Longest 
N terminal to C terminus; Shortest N terminal to C terminus) in 6 different 
expression vectors (E; F; S3c; TRX; M; E3CHALO) means that each 
expression variable contained 48 experiments. The original gels from the 
OPPF experiment can be found in the Appendix (Appendix 4). Bands 
visualised on the OPPF gels are soluble proteins which contain a 6 His 
sequence at either the N or C-terminus. As shown in the gel composites, 
there are a number of native E. coli proteins which are present in the gel, 
indicating that E. coli contains proteins with a His sequence. It is possible 
to differentiate between the expressed protein and the native E. coli 
proteins by identifying the size of the Emx2 proteins compared to the size 
markers. Another way to differentiate between E. coli proteins and the 
Emx2 protein is that the native proteins are expressed across a wide 
variety of the experiments, with the Emx2 proteins only being expressed 
sporadically across the composite images. 
 Figure 5.18 shows the experiments which were carried out using 
the E pOPIN vector. The yellow arrows on the gel identify the presence of  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.12 OPPF lengths of EMX2 protein sequence sub-forms. A comparison of the lengths of the 8 different protein sub-forms 
expressed: Full length; HD-C terminus longest Homology; HD longest N and C terminus; Core domain; Intermediate extensions to 
domain; Longest extension N short C; Longest N terminal to C terminus; Shortest N terminal to C terminus. 
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Figure 5.18. A composite gel image of the protein produced using the pOPIN vector E with a His-tag at the 
C-terminus of the protein. The 8 different Emx2 protein sub-structures are labelled at the top of the image. 
The coloured squares at the top of the image relate to the conditions under which the protein was produced; 
the red square indicates the vector was transformed into Lemo cells with IPTG induction of the exogenous 
protein. The green square indicates the vector was transformed into Lemo cells with protein being expressed 
through the method of auto-induction. The blue square indicates the vector was transformed into Rosetta cells 
with IPTG induction of the exogenous protein. The purple square indicates the vector was transformed into 
Rosetta cells with protein being expressed through the method of auto-induction. The yellow arrow indicates 
the presence of protein which is the right size to be the Emx2 protein. 
 
Figure 5.19. A composite gel image of the protein produced using the pOPIN vector F with a His-tag at the 
N-terminus of the protein. The 8 different Emx2 protein sub-structures are labelled at the top of the image. 
The coloured squares at the top of the image relate to the conditions under which the protein was produced; 
the red square indicates the vector was transformed into Lemo cells with IPTG induction of the exogenous 
protein. The green square indicates the vector was transformed into Lemo cells with protein being expressed 
through the method of auto-induction. The blue square indicates the vector was transformed into Rosetta cells 
with IPTG induction of the exogenous protein. The purple square indicates the vector was transformed into 
Rosetta cells with protein being expressed through the method of auto-induction. 
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the Emx2 protein. The CORE domain protein sequence produced two 
proteins of the right size to be Emx2, both were expressed in the Rosetta 
cells using both the ITPG induction method and the auto induction 
method. The Emx2 protein sequence titled ‘Intermediate extension to 
domain’ produced two proteins of the right size. These were in Lemo cells 
using both different induction types. The two CORE domain proteins are 
~8kDa on the gel, with their accurate size predicted as being 7899 Da 
(protein sub-form = 6930 Da, E His-tag = 969 Da). The two INTER proteins 
are ~9-11 kDa on the gel, with their accurate size predicted as being 9659 
Da (protein sub-form = 8690 Da, E His-tag = 969 Da). 
The two ‘Intermediate extension to domain’ sub-forms of the 
protein ran a shorter distance down the gel compared to the two CORE 
domain sub-forms of the protein. This is because the Intermediate protein 
is larger than the CORE protein and therefore had lower mobility when 
travelling through the gel. The E pOPIN vector produced the 4 proteins 
predicted to be Emx2 sub-forms. The four protein bands containing Emx2 
protein appear stronger than any of the native proteins containing 6-His 
residues.  
 Figure 5.19 shown on the previous page shows a lack of any 
proteins containing the 6-His residue of the size of the Emx2 protein.  The 
proteins that were present in the CORE domain lanes are too large to be 
Emx2 CORE domain proteins; the same is true for the proteins in the 
intermediate extension to domain lanes. The proteins in these lanes all lie 
at a level which identifies them to be ~18 kDa in molecular mass or higher.  
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Figure 5.20 A composite gel image of the protein produced using the pOPIN vector S3C with a His-tag and 
a SUMO3C tag at the N-terminus of the protein. The 8 different Emx2 protein sub-structures are labelled at 
the top of the image. The coloured squares at the top of the image relate to the conditions under which the 
protein was produced; the red square indicates the vector was transformed into Lemo cells with IPTG 
induction of the exogenous protein. The green square indicates the vector was transformed into Lemo cells 
with protein being expressed through the method of auto-induction. The blue square indicates the vector was 
transformed into Rosetta cells with IPTG induction of the exogenous protein. The purple square indicates the 
vector was transformed into Rosetta cells with protein being expressed through the method of auto-induction. 
Figure 5.21. A composite gel image of the protein produced using the pOPIN vector TRX with a His-tag and 
a TRX tag at the N-terminus of the protein. The 8 different Emx2 protein sub-structures are labelled at the top 
of the image. The coloured squares at the top of the image relate to the conditions under which the protein was 
produced; the red square indicates the vector was transformed into Lemo cells with IPTG induction of the 
exogenous protein. The green square indicates the vector was transformed into Lemo cells with protein being 
expressed through the method of auto-induction. The blue square indicates the vector was transformed into 
Rosetta cells with IPTG induction of the exogenous protein. The purple square indicates the vector was 
transformed into Rosetta cells with protein being expressed through the method of auto-induction.  
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These proteins could not be the accurate Emx2 sub-forms of the protein as 
they are larger than predicted size. The results from Figure 5.18 suggest 
that the F-His tag has not worked in any of the experiments, regardless of 
the variables of competent cell type of induction method.  
Figure 5.20 is the composite gel image of the Emx2 sub-forms 
contained in the S3C expression vector. The Figure shows a number of 
proteins containing 6-His residues were extracted through the Ni2+ NTA 
method. The gel shows that a number of proteins from different growth 
variables and Emx2 sequence lengths are ~10-13 kDa in size. The S3C His-
tag is 13213 Da in size, and even the smallest Emx2 sequence is 6930 Da in 
size, so the proteins of sizes ~10-13 kDa in size are hypothesised to be the 
S3c vector without the Emx2 sub-form sequence. This rearrangement of 
the genetic material within the expression vector can occur during the 
amplification process in E. coli; alternatively there may have been a 
problem with the ligation of the Emx2 sequences into the S3C vector. 
 The same problem of the expression vector being expressed 
without containing the Emx2 sequences was seen in the results from the 
TRX expression vector shown in Figure 5.21.  The band of proteins which 
is shown in the majority of lanes for the HD longest N and C terminus, 
Core domain, Intermediate extensions to domain, Longest extension N 
short C, Longest N terminal to C terminus and Shortest N terminal to C 
terminus. Because the Emx2 sequences contained in the TRX vector 
different in kDa mass the proteins should be of marginally different 
lengths on the gel, but this is not the case; the bands appear to be of a   
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Figure 5.22. A composite gel image of the protein produced using the pOPIN vector M with a His-tag and a 
maltose binding protein (MBP) tag at the N-terminus of the protein. The 8 different Emx2 protein sub-
structures are labelled at the top of the image. The coloured squares at the top of the image relate to the 
conditions under which the protein was produced; the red square indicates the vector was transformed into 
Lemo cells with IPTG induction of the exogenous protein. The green square indicates the vector was 
transformed into Lemo cells with protein being expressed through the method of auto-induction. The blue 
square indicates the vector was transformed into Rosetta cells with IPTG induction of the exogenous protein. 
The purple square indicates the vector was transformed into Rosetta cells with protein being expressed 
through the method of auto-induction.  
 
Figure 5.23 A composite gel image of the protein produced using the pOPIN vector E3CHALO with a His-
tag and a E3CHALO tag at the N-terminus of the protein. The 8 different Emx2 protein sub-structures are 
labelled at the top of the image. The coloured squares at the top of the image relate to the conditions under 
which the protein was produced; the red square indicates the vector was transformed into Lemo cells with 
IPTG induction of the exogenous protein. The green square indicates the vector was transformed into Lemo 
cells with protein being expressed through the method of auto-induction. The blue square indicates the vector 
was transformed into Rosetta cells with IPTG induction of the exogenous protein. The purple square indicates 
the vector was transformed into Rosetta cells with protein being expressed through the method of auto-
induction. 
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standard mobility across the gel, indicating they are the TRX His-tagged 
protein without the Emx2 protein sub-form.  
 This phenomenon was repeated in the experiments carried out 
using the M expression vector shown in Figure 5.22, and in experiments 
using the S3CHALO expression vector shown in Figure 5.23.  
 Figure 5.22 shows the His-tagged Maltose Binding Protein (MBP) 
which has a 42711 Da mass. This is the lower of the two bands which are 
exhibited in all but 4 of the experiments (excluding the CORE domain 
produced in Lemo cells induced with IPTG, and the Shortest N terminal to 
C terminus expressed in Lemo cells induced with IPTG and Rosetta cells 
in both induction types). The upper band sits at ~48 kDa. Both of these 
double bands seem to be of a standard size across the gel and so neither 
band is predicted to contain Emx2 proteins. The upper band in the 
experiments containing the Full length Emx2 sequence is ~46 kDa, which 
could be the Full length Emx2 protein expressed in the M expression 
vector. 
 Figure 5.23 shows a similar situation of the expression vector being 
expressed without the Emx2 sequence. The band which appears in the 
majority of the lanes in the composite image of Figure 5.23 are ~50 kDa in 
size but this does correlate with the size of the expected protein product 
using the E3CHALO expression vector. This could either be a problem 
with the E3CHALO vector, ligation into the E3CHALO vector or 
rearrangement of the ligated vector in the competent cells.  
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5.5 EMSA Protein Binding Results 
Having obtained appropriate amounts of purified protein containing the 
Emx2 DNA-binding domain, EMSA was used to test if these protein sub-
forms (synthesised at OPPF) could specifically bind to the Nkx1.2.1  
sequence. For this purpose, 7 lengths of DNA were synthesised (through 
PCR, Section 5.3.23), a schematic representation of these DNA sequences is 
shown below in Figure 5.24. 
A 
 
B 
Figure 5.24. Lengths of DNA used for EMSA studies. Panel A is a 
representation of the double-stranded DNA sequences used. These were 
generated by PCR using the primers from Table 2.1 in Chapter 2, The full-
length sequence is 400 bp of the Nkx1.2.1 HCNCS candidate enhancer 
sequence. The forward primers are shown as blue arrows and reverse 
primers are shown in red arrows. PCR primer number is given above each 
arrow. Panel B is a representation of the position of the 5’-ATTA 
sequences, highlighted by green circles on the Nkx1.2.1 sequence. 
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5.5.1 Pathfinder Bandshift Experiments with CORE and INTER 
If the Emx2 protein binds specifically with the Nkx1.2.1 sequence, the 
affinity between the two is measured as the dissociation constant (Kd) 
(Section 5.3.28). To investigate whether a Kd value was obtainable between 
the Emx2 proteins and the HCNCS candidate enhancer, a preliminary 
experiment was carried out. These trial experiments were started by 
individually incubating the ‘Left Short’, ‘Middle Short’ and ‘Right Short’ 
200bp sequences of DNA (Figure 5.24) at increasing concentration of 
CORE or INTER proteins, at 10, 100 and 1000 nM concentration. This gave 
24 individual binding reactions, including six no-protein control reactions 
(containing only the DNA sequence plus 1x Reaction buffer (RB)). The 
resulting gels and graphical analysis are shown below in Figures 5.25 and 
5.26. The preliminary experiments were carried out to assess if there was 
any binding occurring which could then be more extensively analysed in 
further analysis using EMSA. 
The binding experiment was quantitatively analysed using the 
ImageJ software and the bound DNA was plot on bar graphs to show the 
increase of bound DNA as the protein concentration increased (Figure 
5.4). Both gels A and B in Figure 5.25 were run at 80 volts for 2 hours. 
 
5.5.2 Pathfinder Bandshift Results 
Figure 5.25 shows binding reactions using the CORE Emx2 protein with 
each of the three 200bp oligonucleotides representing a section of the 
HCNCS candidate enhancer of the Nkx1.2 gene. Hyperladder 1 was used 
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as a marker in lanes 1 and 14 of images A and B, and has also overlapped 
in the gel in image A, from lane 1 into lanes 2, 3 and 4, where identical 
banding can be seen in these lanes and the strength of the bands decreases 
from the left well (well 2) to the right (well 4). Figure 5.25 lanes 4 to 5 
shows that the left-short sequence of DNA shifts in its horizontal 
orientation between the CORE Emx2 protein concentrations of 100 and 
1000nM. Not all the DNA shifts but there is an increase of DNA from 
being un-bound, which is running parallel with the 200bp band of the 
Hyperladder 1 marker ladder, in wells 2, 3 and 4, to bound DNA which 
runs more slowly through the gel; as its association with the protein 
hinders its progress through the native polyacrylamide. This is shown in 
Figure 5.26 Graph A which shows the increase of bound as the 
concentration of CORE Emx2 protein increases. The 200bp Middle short 
DNA sequence in Figure 5.25 Panel A, lanes 6-9 does not appear to shift 
up the gel therefore meaning there is a negligible amount of protein 
binding to the DNA and most of the DNA of the middle short sequence 
stays unbound, as is shown in graph B. The Emx2 CORE protein plus the 
200 bp sequence of the right short sequence does show a binding reaction 
occurs as can be seen in image A between wells 12 and 13 which is a 
protein concentration of 100 and 1000nM respectively. The DNA can be 
seen to fully shift upwards in its horizontal orientation with the DNA in 
well 13 running slower (and therefore higher) in the gel and not aligning 
at the 200bp height of the Hyperladder 1 marker in lane 14. This increase 
in bound DNA can be seen quantitatively in graph C. 
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Figure 5.25. EMSA experiments were carried out in preliminary research 
to identify if any of the three 200bp DNA sequences derived from the 
400bp HCNCS candidate enhancer would bind with either of the Emx2 
protein structures. Panel A shows the EMSA experiments using the CORE 
protein against the left short sequence (lanes 2-5), middle short sequence 
(lanes 6-9) and right short sequence (lanes 10-13). Panel B shows the 
EMSA experiments using the INTER protein against the left short 
sequence (lanes 2-5), middle short sequence (lanes 6-9) and right short 
sequence (lanes 10-13). The red arrow in Panel B indicates a good example 
of unshifted DNA at a concentration of 100 nM of INTER Emx2 protein, 
while the blue arrow indicates a good example of shifted DNA in a 
concentration of 1000 nM of the INTER Emx2 protein. 
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Figure 5.25 Image B is an acrylamide gel showing the association between 
the ‘inter’ Emx2 protein and the three 200bp sequences of the Nkx1.2.1 
sequence. Wells 2, 3 and 4 show no shift in the running height of the DNA, 
but well 5 shows a defined jump in the height of the DNA band, showing 
the DNA has formed an interaction with the ‘inter’ Emx2 protein which 
causes the DNA to run through the gel slower. This result is shown 
quantitatively in graph A. The same shift of DNA with the ‘inter’ Emx2 
protein can be seen with all three 200bp sequences of the Nkx1.2.1 HCNCS 
candidate enhancer. Each shift of DNA occurs between the concentrations 
of 100 to 1000nM of the ‘inter’ Emx2 protein. As seen in the three graphs 
the inter protein shifts a larger percentage of DNA of each of the three 
different DNA sequences compared to the CORE protein structure. 
Neither of the protein constructs shift the total amount of DNA at the 
maximum protein concentration of 1000nM, as seen on all three graphs, 
the amount of bound DNA does not reach 100% at any data point.  
 
5.5.3 Summary of Pathfinder Bandshift Experiments 
The preliminary data was shown in a bar graph format, as opposed to a 
line graph, because of the limited number of concentrations used. This 
preliminary EMSA study was carried out to assess if there was any 
binding affinity occurring between any of the three 200bp Nkx1.2.1 
sequences and the two Emx2 constructs, which can be easily interpreted 
from the bar graph as the readings increase and move away from the x-
axis. This preliminary study showed that there was a direct interaction  
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Figure 5.26. Panels A, B and C show the logarithmic change of the 
EMSA experiments in Figure 5.25. Panel A compares the percentage of 
bound left-short DNA at increasing levels on Protein concentration, of the 
two Emx2 protein constructs. Panel B compares the percentage of bound 
middle-short DNA at increasing levels on Protein concentration, of the 
two Emx2 protein constructs. Panel C compares the percentage of bound 
right-short DNA at increasing levels on Protein concentration, of the two 
Emx2 protein constructs. (Due to the low amount of data points (protein 
concentrations) the data is expressed in a bar graph rather than a line 
graph) 
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between the Emx2 protein constructs and sub-sequences of the Nkx1.2.1 
HCNCS candidate enhancer. Although shifting occurred, the total amount 
of DNA was not fully shifted at the maximum protein concentration of 
1000nM. 
 
5.6 Principal EMSA Results 
From this preliminary study it was decided to synthesise alternative 
lengths of Nkx1.2.1 DNA to see if by lengthening the sequences of the left 
and right oligonucleotides to include half of the middle sequence each, 
whether this would increase or decrease the association of the DNA to the 
protein, as the binding affinity of the short middle sequence seems to be 
the weakest of the three tested in the preliminary experiments. A 400bp 
sequence was also synthesised of the full HCNCS candidate enhancer 
KNX1.2.1 to see if the full sequence caused a gel shift when bound to the 
Emx2 protein isoforms synthesised at OPPF. The full catalogue of DNA 
sequences used in all EMSA experiments in this study is schematically 
represented in Figure 5.24 of the introduction of this Chapter. 
It was also decided to run the gels for a longer period of time, 
leaving the voltage at the same level of 80 volts to show any gel shifts with 
more clarity, without compromising the gel through over-heating. 
From the positive Kds obtained in these preliminary experiments, a 
second set of EMSAs were carried out to further analyse the interaction 
between the Emx2 protein and the Nkx1.2 HCNCS candidate enhancer.  
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The results are shown as a series of 12 Figures which are organised and 
colour coded as shown below: 
 
 
Figure 5.27 - Emx2 CORE binding to Left Long           
Figure 5.28 – Emx2 CORE binding to Right Long  
Figure 5.29 – Emx2 CORE binding to Left Short 
Figure 5.30 – Emx2 INTER binding with Left Short 
Figure 5.31 – Emx2 CORE binding with Middle Short 
Figure 5.32 – Emx2 INTER binding with Middle Short 
Figure 5.33 – Emx2 CORE binding with Right Short 
Figure 5.34 – Emx2 INTER binding with Right Short 
Figure 5.35 – Emx2 CORE binding with Full length sequence 
Figure 5.36 - Emx2 INTER binding with 200 bp non-specific DNA 
Figure 5.37 - Pro-Cat1 binding with Left Short and Middle short 
Figure 5.38 - Pro-Cat1 Binding with Right Short and 200 bp  
non-specific DNA 
Dilution 
series 
between 
526 & 
4000 nM 
Dilution series between 
15 & 2000 nM 
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Free DNA (raw 
counts)
Bound DNA 
(raw counts)
total raw 
counts
Conc of 
protein 
(nM)
Free DNA 
(corrected)
Bound DNA 
(corrected)
19205.652 106.497 19312.15 0 99.45 0.55
16477.861 117.376 16595.24 15 99.29 0.71
18752.669 126.669 18879.34 23 99.33 0.67
17841.619 146.083 17987.70 35 99.19 0.81
17361.548 152.205 17513.75 52 99.13 0.87
15598.962 10042.669 25641.63 78 60.83 39.17
14530.962 13163.548 27694.51 117 52.47 47.53
13898.548 14399.962 28298.51 176 49.11 50.89
13361.962 15525.376 28887.34 263 46.26 53.74
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Figure 5.27. An EMSA experiment assessing the binding affinity of the 
300bp DNA Left-long DNA sequence with the Emx2 CORE protein 
structure. Panel A is the EMSA gel with increasing concentration of 
protein from lane 1 (0 nM of protein) to lane 14 (2000 nM of protein). Panel 
B is a Table of results quantitativly showing bound and unbound protein 
from the gel. Panel C is a graph comparing the amounts of bound and 
unbound DNA as the amount of protein increases. Panel D is the 
quantitative analysis of the EMSA gel from Panel A, from which a Kd   
value was calculated (Table below the graph). 
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Free DNA (raw 
counts)
Bound DNA 
(raw counts)
total raw 
counts
Conc of 
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(nM)
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Figure 5.28. An EMSA experiment assessing the binding affinity of the 
300bp DNA Right-long DNA sequence with the Emx2 CORE protein 
structure. Panel A is the EMSA gel with increasing concentration of 
protein from lane 1 (0 nM of protein) to lane 14 (2000 nM of protein). Panel 
B is a Table of results quantitativly showing bound and unbound protein 
from the gel. Panel C is a graph comparing the amounts of bound and 
unbound DNA as the amount of protein increases. Panel D is the 
quantitative analysis of the EMSA gel from Panel A, from which a Kd   
value was calculated (Table below the graph). 
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The voltage through the gel was decreased between the pathfinder 
experiments and the main EMSA experiments from 80 volts to 70 volts, to 
facilitate the gel running for a longer period of time without the 
temperature of the apparatus become a factor which could negatively 
impact the clarity of the resulting gel. Running the gel for a longer period 
of time at a lower temperature also increased the accuracy of the Kd  value 
calculations. 
Figure 5.27A  is a native polyacrylamide gel showing the binding 
reaction of the left-long DNA sequence to the CORE Emx2 protien. As 
shown quantivatively on the graph in Figure 5.27 C and 5.27 D there is a 
shift to the DNA but due to the poor quality of the gel it is difficult to 
distinguish the specific protein concentration at which the shift takes 
place. The comb used in the gel of image C was loose and therefore a 
defined set of wells were not created. Once this problem was identified the 
combs were checked to fit tightly into the glass plates and no further 
problems arose. 
 Figure 5.28 shows the EMSA of the CORE Emx2 protein construct 
with the right-long Nkx1.2.1 DNA sequence, with the graph in Figure 5.28 
C and D showing a quatatative analysis of the shift of DNA in Figure 
5.28A.  
The results from Figures 5.27 and 5.28 show that there is a shift in 
the DNA across the concentration  from 0 – 2000 nM of protein, indicating 
that the inclusion of the central section of the Nkx1.2.1 sequence does not 
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Free DNA (raw 
counts)
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Figure 5.29. An EMSA experiment assessing the binding affinity of the 
200bp DNA Left-short DNA sequence with the Emx2 CORE protein 
structure. Panel A is the EMSA gel with increasing concentration of 
protein from lane 1 (0 nM of protein) to lane 7 (4000 nM of protein). Panel 
B is a Table of results quantitativly showing bound and unbound protein 
from the gel. Panel C is a graph comparing the amounts of bound and 
unbound DNA as the amount of protein increases. Panel D is the 
quantitative analysis of the EMSA gel from Panel A, from which a Kd   
value was calculated (Table below the graph). 
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Free DNA (raw 
counts)
Bound DNA 
(raw counts)
total raw 
counts
Conc of 
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Figure 5.30. An EMSA experiment assessing the binding affinity of the 
200bp DNA Left-short DNA sequence with the Emx2 INTER protein 
structure. Panel A is the EMSA gel with increasing concentration of 
protein from lane 1 (0 nM of protein) to lane 7 (4000 nM of protein). Panel 
B is a Table of results quantitativly showing bound and unbound protein 
from the gel. Panel C is a graph comparing the amounts of bound and 
unbound DNA as the amount of protein increases. Panel D is the 
quantitative analysis of the EMSA gel from Panel A, from which a Kd   
value was calculated (Table below the graph). 
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reduce or stop the binding of the CORE Emx2 construct, and that the 
central part Nkx1.2.1 sequence can be ‘shifted’ in conjunction with either 
the left or right part of the HCNCS. 
 Although a shift was seen across the concentrations between 
0 to 2000nM of protein construct in Figures 5.27 and 5.28, it was decided to 
increase the maximum concentration to 4000nM with the hopes that this 
would better clarify the shift and more accurately calculate the Kd value 
between the specific protein constructs and the oligonucleotides in the 
binding assay. 
The three short 200bp DNA sequences; short-left, short-middle and 
short-right (Figure 5.25) were then re-tested to the higher protein 
concentration with the CORE Emx2 protein construct. Figures 5.29, 5.31 
and 5.33 represent the binding assays of the three sequences with the 
CORE sequence. This shows that by taking the protein concentration to a 
higher maximum concentration the middle-short sequence can be ‘shifted’ 
(Figure 5.31) which shows that binding interactions do occur between the 
CORE Emx2 protein construct and the short-middle DNA sequence, but 
only above a protein concentration of 2000nM, this explains why there 
was no shift in the short-middle sequence in the preliminary experiment.   
Figures 5.30A, 5.32A and 5.34A are gels of the INTER protein run with the 
three 200bp short DNA sequences. These experiments were carried out to 
identify if the different sub-structures of the Emx2 protein, synthesised at 
OPPF, would have different binding affinities. From the results this does 
appear to be the case, the red graph boxes in Figure 5.29 and 5.30 are   
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Figure 5.31. An EMSA experiment assessing the binding affinity of the 
200bp DNA middle-short DNA sequence with the Emx2 CORE protein 
structure. Panel A is the EMSA gel with increasing concentration of 
protein from lane 1 (0 nM of protein) to lane 7 (4000 nM of protein). Panel 
B is a Table of results quantitativly showing bound and unbound protein 
from the gel. Panel C is a graph comparing the amounts of bound and 
unbound DNA as the amount of protein increases. Panel D is the 
quantitative analysis of the EMSA gel from Panel A, from which a Kd   
value was calculated (Table below the graph). 
D C 
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Free DNA (raw 
counts)
Bound DNA 
(raw counts)
total raw 
counts
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Figure 5.32. An EMSA experiment assessing the binding affinity of the 
200bp DNA Middle-short DNA sequence with the Emx2 INTER protein 
structure. Panel A is the EMSA gel with increasing concentration of 
protein from lane 1 (0 nM of protein) to lane 7 (4000 nM of protein). Panel 
B is a Table of results quantitativly showing bound and unbound protein 
from the gel. Panel C is a graph comparing the amounts of bound and 
unbound DNA as the amount of protein increases. Panel D is the 
quantitative analysis of the EMSA gel from Panel A, from which a Kd  
value was calculated (Table below the graph). 
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experiments carried out on the left-short DNA sequence with the two 
different protein structures, the graphs in Figures 5.31 C and 5.31 D and 
5.32 C and 5.32 D which have orange borders are experiments carried out 
on the middle-short DNA sequence and graphs in Figures 5.33 C and 5.33 
D and 5.34 C and 5.34 D with a green border are experiments carried out 
with the right-short DNA sequence. When comparing the different 
sections of DNA there is a difference in binding affinity for each protein 
structure. The CORE Emx2 protein structure has the tightest binding 
affinity to the left-short sequence, of the three sequences, where as this is 
the sequence which has the largest Kd number for the inter Emx2 protein 
structure. When comparing all 6 DNA sequences the left-long and right-
long have the lowest Kd values, with the left-short DNA sequence having 
the tightest binding affinity. 
Figure 5.35 shows the gel of the binding assay between the CORE 
Emx2 protein construct and the full HCNCS which in total is 
approximately 400bp long. The gel shows that the full 400bp sequence 
does shift in the presence of relatively high concentration of the protein. 
This gel is shorter in length than the gels with 200bp DNA sequences; 
although they were all run for the same time in the same gel conditions. 
This is because the 400bp sequence will run more slowly through the gel 
due to its larger relative size compared to the 200bp sequences. So in lanes 
1, 2, 3 and 4 there is no shift occurring upon the DNA but the DNA has 
run less distance through the gel compared to the DNA visualised in the   
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Figure 5.33. An EMSA experiment assessing the binding affinity of the 
200bp DNA Right-short DNA sequence with the Emx2 CORE protein 
structure. Panel A is the EMSA gel with increasing concentration of 
protein from lane 1 (0 nM of protein) to lane 7 (4000 nM of protein). Panel 
B is a Table of results quantitativly showing bound and unbound protein 
from the gel. Panel C is a graph comparing the amounts of bound and 
unbound DNA as the amount of protein increases. Panel D is the 
quantitative analysis of the EMSA gel from Panel A, from which a Kd  
value was calculated (Table below the graph). 
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Free DNA (raw 
counts)
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(raw counts)
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Figure 5.34. An EMSA experiment assessing the binding affinity of the 
200bp DNA Right-short DNA sequence with the Emx2 INTER protein 
structure. Panel A is the EMSA gel with increasing concentration of 
protein from lane 1 (0 nM of protein) to lane 7 (4000 nM of protein). Panel 
B is a Table of results quantitativly showing bound and unbound protein 
from the gel. Panel C is a graph comparing the amounts of bound and 
unbound DNA as the amount of protein increases. Panel D is the 
quantitative analysis of the EMSA gel from Panel A, from which a Kd  
value was calculated (Table below the graph). 
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gel images of the shorter DNA sequences because there is more resistance 
from the polyacrylamide matrix. 
To clarify the impact of the binding assays of the Emx2 protein 
constructs and the Nkx1.2.1 DNA sequences, control experiments needed 
to be carried out. 
Because the Emx2 protein construct is a highly conserved  
homeodomain  it has DNA binding activity. The results shown in the 
preliminary study could be false positives due to the general binding 
affinity of the transcription factor Emx2. It could be that the Nkx1.2.1 
elements showing to bind to the Emx2 construct do so because the 
construct has non-specific DNA binding affinity. This would mean that it 
binds to almost any piece of DNA, regardless of whether it is a HCNCS or 
not. To test this, a 200bp sequence of the pUC-19 vector was synthesised 
and run against the INTER Emx2 protein construct (Figure 5.36) and 
against a non-homeobox protein Pro-cat1 as a double-negative test (Figure 
5.38). This shows that there is some binding occurring at the maximum 
concentration of protein but at a relatively high concentration, and the Kd 
value of the binding affinity between the Emx2 inter protein and the 200bp 
pUC-19 sequence is larger than any of the Kd values between the Nkx1.2.1 
HCNCS and the Emx2 constructs. So although there is some non-specific 
binding occurring between the inter Emx2 protein and DNA, the values of 
Kd for the specific binding reactions are higher and show a tighter binding 
between the Nkx1.2.1 sequence and the Emx2 protein. 
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Free DNA (raw 
counts)
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(raw counts)
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Figure 5.35. An EMSA experiment assessing the binding affinity of the 
400bp full HCNCS candidate enhancer sequence with the Emx2 CORE 
protein structure. Panel A is the EMSA gel with increasing concentration 
of protein from lane 1 (0 nM of protein) to lane 7 (4000 nM of protein). 
Panel B is a Table of results quantitativly showing bound and unbound 
protein from the gel. Panel C is a graph comparing the amounts of bound 
and unbound DNA as the amount of protein increases. Panel D is the 
quantitative analysis of the EMSA gel from Panel A, from which a Kd  
value was calculated (Table below the graph). 
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Free DNA (raw 
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Figure 5.36. An EMSA experiment assessing the binding affinity of the 
200bp non-specific pUC19 DNA sequence with the Emx2 INTER protein 
structure. Panel A is the EMSA gel with increasing concentration of 
protein from lane 1 (0 nM of protein) to lane 7 (4000 nM of protein). Panel 
B is a Table of results quantitativly showing bound and unbound protein 
from the gel. Panel C is a graph comparing the amounts of bound and 
unbound DNA as the amount of protein increases. Panel D is the 
quantitative analysis of the EMSA gel from Panel A, from which a Kd  
value was calculated (Table below the graph). 
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The Emx2 constructs used in this project have His-tags attached to 
the C-terminus of the protein sequence. As stated in section 5.1.4 the His-
tag attached to a protein emits its own charge. His-tags are positively 
charged elements which will attract a negatively charged element such as 
a DNA molecule. The His-tag of the Emx2 protein constructs could 
interfere with the binding assay EMSA and give a false positive result, 
with the DNA binding to the his-tag element only, without any specific 
binding to the Emx2 protein.  
To address this, a His-tagged protein named Pro-cat1 was 
evaluated for its binding affinity with the Nkx1.2.1 element to identify the 
level of binding which occurs between the his-tag and the DNA, separate 
from any binding occurring between the DNA and the Emx2 protein 
construct, as there should be no direct interaction between the Nkx1.2.1 
HCNCS and the Pro-cat1 protein. This would establish a base-level of 
binding affinity. These negative control experiments are shown in Figures 
5.37 and 5.38. These are the gels showing the binding affinity of the 
protein Pro-cat1 with the 200bp sub-elements of the Nkx1.2.1 element. 
These gels show no obvious binding affinity and this was quantitatively 
supported by the graphs 5.37B, 5.37C, 5.38B and 5.38C showing no 
significant increase in the amount of bound-DNA between 0nm of protein 
and 4000nM of Pro-cat1 protein. 
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Pro-Cat1+Left Short & Middle Short DNA 
 
 
 
 
 
 
 
 
 
              
 
 
Figure 5.37. An EMSA experiment assessing the binding affinity of the 
200bp left-short and middle-short DNA sequences with the Pro-Cat1 
His-tagged protein. Panel A is the EMSA gel with with the left-short DNA 
experiment in lanes 1-7, and the middle-short DNA experiment in lanes 8-
14. Pro-Cat1 protein concentration increases from lane 1 (0 nM of protein) 
to lane 7 (4000 nM of protein) and lane 8 (0 nM of protein) to lane 14 (400 
nM of protein). Panel B is the quantitative analysis of the EMSA gel from 
Panel A of the Left-short binding affinity to the Pro Cat1 prtoein 
comparing the amount of bound and unbound DNA at each 
concentration. Panel C is the quantitative analysis of the EMSA gel from 
Panel A of the Middle-short binding affinity to the Pro Cat1 prtoein, 
comparing the amount of bound and unbound DNA at each 
concentration. 
C B 
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Pro-Cat1+Right Short & Non-Specific DNA 
 
 
 
 
 
 
 
               
 
 
 
Figure 5.38. An EMSA experiment assessing the binding affinity of the 
200bp right-short and non-specific pUC19 DNA sequences with the Pro-
Cat1 His-tagged protein. Panel A is the EMSA gel with with the right-
short DNA experiment in lanes 1-7, and the non-specific pUC19 DNA 
experiment in lanes 8-14. Pro-Cat1 protein  concentration Increasses from 
lane 1 (0 nM of protein) to lane 7 (4000 nM of protein) and lane 8 (0 nM of 
protein) to lane 14 (400 nM of protein). Panel B is the quantitative analysis 
of the EMSA gel from Panel A of the Right-short binding affinity to the 
Pro Cat1 protein comparing the amount of bound and unbound DNA at 
each concentration. Panel C is the quantitative analysis of the EMSA gel 
from Panel A of the non-specific pUC19DNA binding affinity to the Pro 
Cat1 protein, comparing the amount of bound and unbound DNA at each 
concentration. 
C B 
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5.7 Discussion 
Proteins containing the homeodomain have been shown to bind to specific 
DNA sequences (Laughon et al. 1988). The research carried out in this 
chapter aimed to identify specific binding between the homeobox protein 
Emx2, and the Nkx1.2.1 element identified through bioinformatic analysis 
in chapter 3. Attempts to express the Emx2 protein were made, so that 
further experiments could be carried out to identify the possibility of 
direct binding occurring with the Nkx1.2.1 candidate enhancer. Problems 
with the synthesis of the protein meant that two artificial subunits of the 
Emx2 protein, both containing the homeodomain, were synthesised at the 
OPPF, and found to directly bind to the Nkx1.2.1 element.  
 
5.7.1 In-House Attempts to Express a Soluble form of the Emx2 Protein 
The initial approach to purify the chick Emx2 protein was based on 
previous reports of successful expression of tagged mouse Emx2 protein 
in E. coli (Capellini et al. 2010, Mariani et al. 2012). Capellini et al. have 
used a his-tag while Mariani et al. used a GST-tag, the Mairiani paper did 
not specify if the GST tag was specifically used as a solubilising agent, and 
given that a GST-tag is considerably larger than the his-tag (the total size 
of the Emx2 protein with a GST-tag makes it approximately 53Kd, almost 
doubling the weight of the protein), it may interfere with the functional 
analysis of Emx2, it was decided to use the pET28B vector which 
introduces a his-tag into the protein.  
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Although a variety of different experiments were carried out to 
optimise the expression of a soluble form of the Emx2 protein, the majority 
of Emx2 protein existed in an insoluble form, which, although solubilised 
through the use of urea in conjunction with sarkosyl, only a very small 
amount of protein maintained solubility during the process of serial 
dialysis to reduce the concentration of urea and sarkosyl, which would, if 
left in solution, strip the His-trap column and so could not be purified.  
Through addition of glucose to the growth media, varying the 
temperature of cell incubation and limiting the time of IPTG induction to 
reduce toxicity to the cells, every effort was made to optimise the soluble 
fraction of the Emx2 protein produced in the cells.  
Protein concentration during the period of IPTG incubation was 
analysed to identify if it was feasible to reduce the time of incubation with 
IPTG. The protein could be toxic to the cells in high concentrations. When 
this proved ineffective, it was decided to treat the Emx2 as an insoluble 
protein, contrary to Mariani et al. 2012 and as such, unfold and then refold 
the protein after the protein was initially expressed in the E. coli cells. 
Previous work using sarkosyl at a 10% concentration resulted in 
95% of the target proteins being solubilised, but, in a percentage range 
from 0% to 20% no Emx2 appeared in the soluble fraction of the 
experiment after treatment with sarkosyl. Through the use of varying 
concentrations of urea, plus the use of the surfactant sarkosyl, the protein 
was solubilised. However, this progress was undone by the protein 
‘crashing out’ of solution once the urea concentration was reduced, 
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indicating that the protein only exists in a soluble form at high urea 
concentrations. When attempting to re-fold the protein, it precipitated 
back into an insoluble form within the solution. 
The AKTA prime was used to purify the soluble protein fraction 
through a his-trap column. This had an A280 sensor which identifies only 
the presence of protein. The Emx2 protein is a transcription factor, 
meaning it binds directly with DNA, so the use of an AKTA Purifier 
which has an A280 and an A260 sensor (which detects the presence of DNA 
as well as protein) would identify if the DNA degradation steps were 
successful. If the protein is bound with DNA during purification of cell 
lysis, this could affect the purification of the protein.  
A second approach to protein expression was tried through 
transient transfection of mammalian HEK cells was tried, with the aim of 
producing a soluble form of the Emx2 protein. These experiments are still 
ongoing at the time of submitting this thesis.   
After the poor results for protein production in the lab, it was 
decided to work in conjunction with the OPPF to utilise their pOPIN 
vector suite to express soluble Emx2 protein. 
 
5.7.2 Attempts to Express a Soluble form of the Emx2 Protein at the 
OPPF Facility  
The protein production from the OPPF service yielded less soluble protein 
than was expected. With 48 different constructs being expressed in two 
cell lines with two methods of induction, totalling 192 separate 
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experiments; only 5 experiments yielded soluble protein that could be 
taken on for further analysis, with only 2 constructs being expressed. All 
the experiments using the full length Emx2 sequence in the M expression 
vector constructs showed possible presence of the full Emx2 protein with 
the M expression tag. But with the presence of the M expression vector 
without the Emx2 sequence in each experiment it was decided not to 
investigate the Emx2 full length expression with the M expression vector 
further, and no other experiments yielded positive results for the Full 
Length Emx2 sequence. 
Of the three constructs expressed none were the full sequence 
spanning the 246 amino acids. One construct was 91 amino acids in length, 
with the other two measuring 63 and 79 amino acids in length. Although 
all the three protein structures cover the highly conserved homeodomain 
towards the 3’ end of the sequence, they cover only roughly 30% of the full 
sequence of the protein. This means that the tertiary structures of the three 
constructs will be markedly different from that of the full Emx2 protein.  
It may not diminish the binding capabilities of the constructs, as the 
homeodomain within the Emx2 is a known binding domain in 
orthologous proteins (Mariani et al. 2012). For the purpose of EMSA 
analysis, all three of the constructs would be suiTable to carry out 
experiments to identify if there is direct binding occurring to the HCNCS 1 
identified in Chapter 3. The His-tag attached to each protein is of a 
relatively small size and so would likely not interfere with the binding 
ability of the protein by blocking any possibly binding sites, and, although 
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the His-tag does carry a small positive charge, it is again unlikely to 
interfere with the binding of the protein constructs with the DNA, 
although this was addressed with control experiments using non-specific 
His-tagged proteins to identify if the His-tag alone can bind DNA. 
The solubility of the protein fragments did seem to depend on the 
sequence of the protein. There was more soluble protein produced from 
smaller protein fragments, although the majority of the protein 
experiments of all Emx2 protein sequence lengths were insoluble. 
Particular insoluble protein production was seen in the sequences which 
included the very end of the full sequence, towards the C terminus. The 
protein sequence entitled ‘intermediate extensions to domain (173-251 bp 
along the ~300 bp sequence of the full protein) had higher  solubility 
across all the variables of vector, induction type and cell type, but no 
conclusive results could be drawn because the overall soluble protein 
yield was so low. 
The method of induction did not seem to alter the solubility of the 
protein constructs; the same result of solubility was seen whether the 
protein was induced by IPTG or through the use of AIM.  There was 
however, a noticeable difference in the soluble protein production 
between the two different cell lines used. Overall, of the 5 experiments 
which yielded adequate amounts of Emx2 protein, 4 of them were 
produced from Lemo21 competent cells. This difference in BL21 strains of 
cells could be further examined to see if an alternative strain produced 
more positive results. 
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With the protein expression options in E. coli at OPPF exhausted, a 
small scale expression screen was carried out to identify if the full length 
Emx2 sequence could be successfully expressed in a soluble form in insect 
cells infected with baculovirus containing the recombinant Emx2 
sequence.  The results from this produced no soluble full length Emx2 
protein that could be immediately used without cleavage of the large 
affinity tag, but an alternative Emx2 substructure was produced as a 
soluble protein. This result had not been obtained during the expression 
work with E. coli, but it gives a third construct option for further analysis. 
The results from the baculovirus expression can be found in the Appendix 
(Appendix 7). 
The pOPIN suite and OPPF site itself are a very useful tools for a 
huge variety of research fields, with the intensive lab work carrying out 
full expression and analysis of proteins in a relatively short time frame. 
The variety of DNA vectors used in the pOPIN suite enabled this project 
to use multiple expression vectors to identify if the affinity tag was 
affecting the solubility of the Emx2 protein. It can be concluded from the 
initial work and the work carried out at OPPF that the full 246 aa length 
Emx2 protein is not a highly soluble protein when expressed in E. coli 
cells, regardless of the affinity tag. 
 
5.7.3 EMSA Experiments with the Two Sub-Forms of the Emx2 Protein 
Utilising the two Emx2 constructs, which are artificial, truncated forms of 
the whole Emx2 protein, EMSA studies were carried out to identify the 
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binding affinity of the Emx2 sub-forms with the Nkx1.2.1 sequence. A 
number of EMSA gels were run in this project to assess the occurrence and 
strength of the interaction between the Emx2 protein and the Nkx1.2.1 
HCNCS. A preliminary experiment was carried out (Section 5.5.1) which 
identified there was direct binding occurring between the sub-sequences 
of the Nkx1.2.1 sequence and the substructures of the Emx2 protein.   
To further analyse the interaction, a variety of DNA sequence 
lengths spanning the HCNCS were incubated with two different 
substructures of the Emx2 protein and run to identify the Kd binding 
affinity to quantitatlvely analyse the interaction between the DNA and the 
protein.  
The initial Pathfinder EMSA experiments showed that the middle 
200bp section of Nkx1.2.1 DNA sequence did not ‘shift’ compared to the 
left and right sequences. But through the inclusion of the central section of 
the Nkx1.2.1 sequence to both the left and right sequences, creating a left 
long and right long 300bp sequence the central part Nkx1.2.1 sequence can 
be ‘shifted’ inconjunction with either the left or right part of the HCNCS.  
Although a shift was seen across the concentrations between 0 to 2000nM 
of protein construct, the protein concentration was increased to a 
maximum concentration 4000nM with the hopes that this would better 
clarify the shift and more accurately calculate the Kd value between the 
specific protein constructs and the oligonucleotides in the binding assay. 
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The three short 200bp DNA sequences; short-left, short-middle and 
short-right were then re-tested to the higher protein concentration with 
the CORE Emx2 protein construct. This showed that by taking the protein 
concentration to a higher maximum concentration the middle-short 
sequence can be ‘shifted’ which shows that binding interactions do occur 
between the CORE Emx2 protein construct and the short-middle DNA 
sequence, but only above a protein concentration of 2000nM. This explains 
why there was no shift in the short-middle sequence in the preliminary 
experiment.   
Experiments were also carried out to identify if the different sub-
structures of the Emx2 protein, synthesised at OPPF, would have different 
binding affinities. The smaller the disassociation constant (Kd) the tighter 
the protein is bound to the DNA. From the results data shown in Figure 
5.39 where the Kd data of all the different sequences and protein structures 
is compared, there is a difference in binding affinity for both protein 
structures. When comparing all 6 DNA sequences the left-long and right-
long have the lowest Kd values. This could be attributed to the left-long 
sequence containing all three of the ATTA binding sites (Figure 5.23). The 
400bp sequence also contained all 3 ATTA binding sites but had a larger 
Kd value. This could be due to the increased size of the sequence, which 
meant that the shift was comparably smaller than the 200bp EMSA 
experiments. One option to overcome this could be to repeat the 400bp full 
sequence experiment and run it for a longer period, to make the gels  
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length (bp) 
No. Of 
ATTA Sites 
EMX2 CORE 
protein Kd µM 
EMX2 INTER 
protein Kd µM 
Left short 200 2 2.59 1.24 
Middle short 200 2 1.12 1.26 
Right short 200 1 0.88 1.97 
Left long 300 3 0.2 n/a 
Right long 300 2 0.47 n/a 
Full length 400 3 1.45 n/a 
 
B 
 
 
 
 
 
 
 
 
Figure 5.39 A Table and graph to represent the findings from the EMSA 
experiments which show the Kd values of the multiple experiments 
carried out. Panel A is a Table showing all of the Kd values gathered from 
the EMSA experiments. Panel B is a graph comparing all of the Kd values 
from each EMSA experiment that was carried out. The fractions stated 
above the bars of of the graph in Panel B indicate the number of ATTA 
sites within the DNA fragment in the EMSA experiment.  
2/3 
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comparable to the 200bp gel lengths. This may make the Kd value more 
accurate and produce a tighter binding affinity calculation. 
The control experiments indicate that the binding of the homeobox 
protein Emx2 is specific to the binding of the Nkx1.2.1 DNA sequences 
when compared to the non-specific DNA sequence and the non-homeobox 
protein used in the control experiments. This indicated that the binding 
affinity found in all the Emx2 and Nkx1.2.1 DNA sequence experiments is 
specific and indicates that both sub-forms of the protein have a specific 
affinty to the Nkx1.2.1 DNA sequence. 
Kd values for proteins vary widely (Figure 5.40), this could be 
attributed to their evolutionary function; some evolved to have a tight 
controlling effect on a gene, or a weaker, modulated effect. As well as this, 
the Kd values for a protein-ligand interaction can be altered, sometimes by 
several orders of magnitude, by changes in the solution’s salt 
concentration, pH or other variables (Nelson & Cox 2008). 
The ‘shift’ produced from the EMSA experiments in this project 
were not as pronounced as those observed in published data researching 
transcription factor binding (Mariani et al. 2012), this published research 
produced clear bands of ‘shifted’ material with defined bands of free and 
bound DNA. One difference between the Mariani et al. EMSA and those in 
this research, which could account for the difference in definition of the 
free and bound material is the ratio of the acrylamide / bis acrylamide in 
the polyacrylamide gel. 
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Figure 5.40. the range of dissociation constants for interactions in 
different biological systems. Certain interactions, such as that between 
the protein avidin and the enzyme cofactor biotin, fall outside the normal 
ranges. Sequence –specific protein-DNA interactions reflect proteins that 
bind to a particular sequence of nucleotides in DNA, as opposed to 
general binding to any DNA site. *a reported dissociation constant is valid 
only for the particular solution conditions under which it was measured. 
(taken from Nelson & Cox, 2008) 
 
The higher the ratio of bis acrylamide to acrylamide, the more cross links 
created. In the Mariani research the gel was of a ratio of 29:1, this gives a 
relatively open polyacrylamide meshwork, which would more readily 
produce clearly defined bands of bound and free DNA across the gel. In 
the research for this project a tighter polyacrylamide meshwork was 
utilised (at a ration of 19:1) which means there was a higher ration of 
cross-links formed from the bis acrylamide. This increase in cross links 
creates a tighter network of polyacrylamide, and can be used to observe 
binding affinity of smaller complexes, whereas a higher ration of 
acrylamide to bis acrylamide creates a gel with fewer cross links and gives 
better resolution for larger complexes (Hellman & Fried 2007).  
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Although the binding Kd values taken from EMSA experiments 
between the Emx2 protein and the Nkx1.2.1  element, when compared to 
the data produced from the EMSA using the 200 bp non-specific DNA, 
highlight the relative affinity between the Emx2 protein and the  Nkx1.2.1  
element, there is marked variation of the Kd values between the two Emx2 
forms. This could be attributed to the difference in the sequence of the two 
proteins. For instance; it has been identified that modification or deletion 
of the sequence-independent C-terminal domain (CTD) of the 
(transcription factor) P53 gene ‘drastically alters’ the ability of the protein 
to bind to the target DNA (Laptenko et al. 2015). This could also be the 
case for the Emx2 protein in this research; the deletion of the majority of 
the N terminus, and the C terminal end past the homeodomain of the 
protein also being absent, could misrepresent the binding affinity of the 
wild-type Emx2 potein to the Nkx1.2.1 element. As previously mentioned 
the binding affinity data, gained from the EMSA gels, from this project is 
minimal compared to published ‘shifts’ looking at transcription factors. By 
successfully synthesising the truncated Emx2 proteins designed at OPPF, 
more accurate characterisation of the binding activity of the Emx2 protein 
could be ascertained. A repeat of the EMSA experiments using the OPPF 
designed, truncated Emx2 proteins, as well as the full chick Emx2 protein 
would be more conclusive in identifying the binding affinity associated 
with the Nkx1.2.1 element. Carrying out these further experiments would 
increase the reliability of the data produced here.  
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There are limitations to the EMSA experiments in this study; the 
binding site cannot be identified so there is still a margin of error that the 
results could be associated with the His-tag as opposed to specific protein 
binding of the Emx2 protein. Although the negative control experiments 
using Pro-cat1 make this unlikely. Optimisation of the EMSA protocol for 
the Emx2-Nkx1.2.1 binding affinity could produce further insight into the 
accurate dissociation constant. By shortening the probes through deletion 
analysis the minimal binding sequence could be identified. Alternatively 
utilising DNAse1 footprinting to identify the specific binding site/sites 
within the conserved element would define the area of binding which 
occurs within the EMSA experiment and outline the specific sequences of 
binding.  
One of the main difficulties encountered with the EMSA gels was 
the ‘smile’ or edge effect on the sides of the gel, created by the uneven 
distribution of current across the gel, an example of the ‘smile effect’ can 
be seen in Figure 5.25 with the runs to the edge of the gels being distorted 
slightly in an upwards angle on the outer-most side of the run. A high salt 
concentration in the protein or DNA samples would also contribute to the 
‘smile effect’.  The ‘smile effect’ would not account for the shift that can be 
seen in Figure 5.4 and multiple bands within each well can be visualise at 
the higher concentrations of protein. This is not to deny that the edge 
effect has not slightly warped the well to the right of the figure, but it is 
possible to see the increase in the upper position of the band within the 
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well, at the expense of the lower portion of the band, indicating a small 
shift up the gel.  
 By altering the reagents within the EMSA experiment, such as salt 
concentration or pH, a more precise Kd value could be obtained, this 
coupled with altering the ration of acrylamide -bis acrylamide of the 
EMSA gel could elucidate more accurate binding affinity data. 
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Chapter 6 – Conclusions 
 
6.1 Findings 
The purpose of this research was to identify and characterise a regulatory 
element associated with the Nkx1.2 gene, which was involved in the 
theoretical regulatory loop between Nkx1.2 and Emx2. The results from 
this research have identified a conserved DNA non-coding element 
associated with the Nkx1.2 gene that activates transcription in the ventral 
midbrain in vivo, and is bound directly by two artificially truncated forms 
of the Emx2 protein. Further work using EMSA is needed to identify if the 
whole Emx2 protein directly binds to the Nkx1.2.1 element but it can be 
hypothesised this HCNCS known as the Nkx1.2.1 element acts as an 
enhancer which controls the regulation of the Nkx1.2gene by the Emx2 
protein. 
 
6.2 The Relevance of this Research 
The gene regulatory network (GRN) which exists in the ventral midbrain 
of the developing chick embryo governs the patterning of the midbrain 
arcs, which in turn directs the appropriate formation of at least two 
midbrain nuclei involved in the motor system of the organism. Figure 6.1 
shows a hypothetical GRN which identifies some of the main genes 
expressed in the developing midbrain and the associated physical 
structures; the diencephalon-midbrain boundary (Pax6), the midbrain-
hindbrain boundary (Otx2 with Gbx2), dorsal midbrain (BMP),  
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Figure 6.1. A GRN map of the major signalling events within the midbrain during 
embryo development. Pax6 patterns the boundary between the diencephalon and 
midbrain (DMB) (Walther & Gruss 1991), Pax6 suppresses En1 expression at the DMB, 
Pax6 also suppresses Wnt signalling in the rostral midbrain from the DMB (Walther & 
Gruss 1991). Pax6 and Emx2 down regulate each other in the telencephalon and 
developing cortex (Muzio et al. 2002) and are both expressed in the patterning of the 
midbrain arcs in co-localised, but no overlapping, expression patterns (Schubert & 
Lumsden 2005). BMP is expressed along the dorsal midline of the developing midbrain 
(Furuta et al. 1997), with BMP expression promoting En1 expression (identified in the 
caudal neural tube by Timmer et al. 2002). BMP also inhibits FGF8 expression (in the 
developing hippocampus (Shimogori et al. 2004)). En1 is expressed in the 
mesodiencephalon (Alves dos Santos & Smidt 2011). Wnt signalling is expressed in the 
midbrain (Wilkinson et al. 1987) and targets En1 (Danielian & McMahon 1996). FGF8 
represses Wnt expression in patterning of the midbrain (Crossley et al. 1995). Emx2 is 
expressed in the Mesencephalon (Simeone, Gulisano, et al. 1992) and targets Wnt 
expression (in the cerebral cortext, Shimogori et al. 2004) and Nkx1.2 expression (in the 
midbrain, M. Ahsan and F. R. Schubert, unpublished data) as well as inhibiting FGF8  
expression (in the cerebral cortex, Shimogori et al. 2004). Nkx1.2 is expressed in the 
ventral midbrain (Spann et al. 1994) and inhibits Emx2 expression (Schubert & Lumsden 
2005). Shh is expressed along the ventral floorplate of the neural tube of the 
Mesencephalon (Ericson et al. 1995) and induces the expression of midbrain arc genes, 
including Emx2, in a concentration dependent manner (Agarwala & Ragsdale 2002), as 
well as forming an expression loop with FoxA2 (Bayly et al. 2012) which is expressed in 
the midbrain (Ferri et al. 2007). FGF8 which is expressed in the midbrain towards the 
MHB (Heikinheimo et al. 1994) and inhibits Emx2 and Otx2 expression (in the rostral 
Prosencephalon (Crossley et al. 2001)). FGF8 expression forms the IsO (Martinez et al. 
1999), FGF8 diffuses into the mesencephalon (Crossley et al. 1996), where it induces En1 
(Shamim et al. 1999). The midbrain-hindbrain boundary (MHB) is patterned by the co-
repression of Otx2 and Gbx2 (reviewed by Hidalgo-Sánchez et al. 2005) and this co-
repression promotes FGF8 expression adjacent to the MHB (Martinez et al. 2013). 
Transcription factors are shown in Black text with signalling molecules in grey text. Green 
arrows indicate downstream expression in the midbrain, with red lines indicating 
downstream repression occurring in the midbrain. Blue arrows and lines indicate 
downstream actions which have been shown to occur in areas other than the midbrain. 
Dotted lines indicate speculative actions. The yellow dotted line between Nkx1.2 and 
Emx2 indicated the research focus of this project. 
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the ventral midbrain (Shh) and the significant interactions and regulatory 
outcomes between these areas. 
.  The importance of appropriate expression of the Nkx1.2 and Emx2 
genes for arc patterning has been identified through gain of function 
experiments in the chick embryo (M. Ahsan and F. R. Schubert, 
unpublished data). The negative correlation in expression patterns led to 
the hypothesis tested in this project.  
The effect of the Emx2 protein on the expression of the Nkx1.2 gene 
is likely to be controlled by an intermediary, regulatory element; 
specifically an enhancer sequence, but no enhancer sequences have been 
characterised or annotated for the Nkx1.2 gene. By identifying the 
sequence which regulates the expression of Nkx1.2 by Emx2, a more 
thorough understanding of the developing brain can be obtained. 
The aim of this research was to identify areas of highly conserved 
non-coding sequence (HCNCS) and assess, through in-vivo investigation, 
whether the HCNCS identified acted as an enhancer involved in the 
regulatory loop between Emx2 and Nkx1.2. This required both 
computational and biological analysis. 
The initial findings proposed by this study indicate a direct binding 
interaction between the Emx2 protein and the candidate enhancer Nkx1.2.1 
to target the activation of the Nkx1.2 gene in the ventral midbrain during 
arc patterning. This gives further insight into the GRN of the midbrain arc 
patterning, with the possibility that a direct feedback loop between other 
arc patterning homeobox genes; such as Pax6 (Agarwala et al. 2001) and 
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Emx2 (Agarwala & Ragsdale 2002) which have co-localised but not 
overlapping expression patterns, with Emx2 patterning arcs 2 and 3, and 
Pax6 patterning the intervening region between arcs 2 and 3. The opposite 
appears true between Emx2 and Six3 (Schubert & Lumsden 2005) which 
overlap in patterning arcs 2 and 3 respectively. This indicates that the 
homeobox genes form both positive and negative feedback loops creating 
the discrete patterns of expression seen in the midbrain arc formation. By 
researching further into the GRN of the midbrain arcs, a better 
understanding of the control mechanisms which govern formation of the 
oculomotor complex (OMC) and the red nucleus (RN) could be obtained 
in the future.  
 
6.2.1 Identification of the Nkx1.2.1 Element  
Sequence comparison research identified a number of HCNCS around the 
Nkx1.2 gene; one in particular had a high level of conservation comparable 
to that of the Nkx1.2 gene sequence.  
One of the most extensive sequence comparisons have been 
performed using the β-globin gene cluster (Hardison et al. 1997). 
Comparisons between Mouse/human revealed large amounts of 
homology across regions of known regulatory elements. In contrast, 
comparisons between mammalian and bird β-globin clusters did not 
demonstrate any significant homology of the regulatory elements, even 
those which are known to be functionally analogous. The gene 
duplications which give rise to the clusters seem to have occurred 
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independently in mammalian and avian lineages (Hardison et al. 1997), 
because of this, the individual genes within the β-globin gene cluster 
appear to have developed distinct regulatory elements independently, an 
example of evolutionary convergence of gene function. This may not be 
the case for genes that have not undergone genetic duplication, since 
homologous regulatory elements present in different species represent 
evolutionary conservation from a common ancestral regulatory element 
(Göttgens et al. 2000). Both Emx2 and Nkx1.2 have homologues (Emx1 and 
Nkx1.1 respectively) within the vertebrate genome, and the Nkx1.2.1 
element has been shown to be conserved between the Nkx1.1 and Nkx1.2 
gene in mice and Chick (Appendix 5), this indicates that the Nkx1.2.1 
regulatory element has been associated with the Nkx1 gene prior to any 
gene duplication which occurred during evolution. 
The ENCODE consortium data (Birney et al. 2007)  analysed in this 
project highlighted areas of DNA in an open chromatin conformation 
which could be accessible for transcription factor binding, which gave an 
insight into possible regulatory sequences. But, although the ENCODE 
data was useful in reinforcing the position of candidate regulatory 
sequences, the data does not supply any more information into how the 
regulatory elements acts, and is acted upon, only that the specific 
sequence is occupied by a DNA binding factor present in a particular 
cellular context (Alonso et al. 2009). By carrying out DNAseI footprinting 
analysis of the sequence, a more accurate binding sequence would be 
identified than that associated with multiple sequence alignment (MSA), 
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which could then be used to carry out EMSA analysis with the Emx2 
protein to gain more accurate dissociation constant data. DNAseI 
hypersensitivity has been previously used to identify enhancer sequences 
active during embryo development. Enhancers associated with the MyoD 
gene were showed to interact in vitro with nuclear factors from human and 
mouse embryonic cells through DNAse1 hypersensitivity assays 
(Goldhamer et al. 1995). For analysis of the other candidate regulatory 
elements identified near the Nkx1.2 gene, DNAse1 footprinting may be a 
more informative assay than extensive bioinformatic analysis, although 
the type of cells within which the footprinting was carried out on would 
need thorough consideration. 
 
6.2.2 Analysis of the Activity of the Nkx1.2.1 Element In Ovo Showed 
Expression in the Ventral Midbrain 
The Nkx1.2.1 sequence was expressed in accordance with the predicted 
pattern; its expression was limited only to the area of the ventral midbrain 
and in <50 cells. This 400bp HCNCS was a candidate regulatory element 
that could be further analysed to identify if it exhibited the characteristics 
of an enhancer which would bind the Emx2 protein. 
It was hypothesised that a more accurate pattern of the HCNCS 
could be obtained by placing it in conjunction with the endogenous Nkx1.2 
promoter in an expression vector.  Both the short 400bp HCNCS and the 
longer 5’ region containing the endogenous Nkx1.2 promoter were 
inserted into expression constructs containing the TK minimal promoter 
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and the eGFP sequence to visualise expression of the vector, so creating 
the expression vectors Nkx1.2 5’ and Nkx1.2.1 respectively.  The expression 
pattern of the Nkx1.2.1 was as expected with a small number of cells 
expressing the eGFP, but the expression pattern of the Nkx1.2 5’vector 
showed no tissue or region specificity. The non-specific expression pattern 
of this reporter construct Nkx1.2 5, containing the longer 5’ region of the 
candidate regulatory element, could most likely be attributed to the 
inclusion of the non-conserved sequence between the conserved Nkx1.2.1 
element and the endogenous Nkx1.2 promoter. DNAse1 footprinting of 
the region would identify binding sites which could be further analysed to 
identify if the sequence contains a strong enhancer sequence which would 
justify the ubiquitous expression. By including the conserved element 
within a larger section of non-conserved DNA when looking at an 
enhancer associated with the SCL gene, a more general SCL enhancer was 
identified (Ogilvy et al. 2007); the conserved 3.7kb element was active in 
primitive, but not definitive, erythroblast cells, but a larger 5kb fragment, 
containing the 3.7kb region within it, was active in both fetal and adult 
definitive hematopoietic cells. This was not the case for the Nkx1.2.1 
element, as the larger non-coding sequence failed to show signs of any 
tissue specific patterning. 
Although the analysis of transient expression patterns by using 
reporter constructs containing DNA sequences of interest was limited by 
the high degree of mosaic expression in the transient expression patterns 
(Picker et al. 2002), spatially restricted activity was initiated by the 
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Nkx1.2.1 sequence, inferring the function of the sequence as a tissue 
specific enhancer (Haeussler & Joly 2011). 
 
 
6.2.4  Quantitative Binding Affinity using EMSA Showed Specific 
Binding Between the Nkx1.2.1 Element and the Emx2 Protein 
Electrophoretic mobility shift assays (EMSA) were utilised to identify if 
there was any direct binding occurring between the Emx2 protein and the 
Nkx1.2.1 sequence. From the preliminary experiment data the EMSAs 
showed a positive binding affinity between the two elements, the 
experiments were repeated with higher maximum protein concentrations 
and a larger quantity of concentrations which aided in the more accurate 
plotting of the Kd value. Research into gene expression in endothelial cells 
combined MSA, EMSA and ChIP studied in conjunction with In vivo 
reporter assays to determine the identity and activity of a cis-acting 
enhancer element (De Val et al. 2008). This research produced robust 
results due to the diverse assays carried out on the regulatory element, 
this paper identifies other experiments, like ChIP, which could be carried 
out on the Nkx1.2.1 element as possible future work. 
A number of potential transcription factor binding sites (TFBS) 
conserved between  Human, Mouse and Chick were identified within the 
HCNCS during the bioinformatic stage of this research, and some of these 
TFBS (of Nkx6.1 and GATA protein) corresponded to homeodomain 
binding sites expressed in the patterning of the ventral brain during 
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development  (Briscoe et al. 2000, Collignon et al. 1996). They may also be 
involved in the regulation of Nkx1.2 expression within the GRN in that 
area. The ‘ATTA’ sequence has been shown as an Emx2 binding site in the 
Wnt1 enhancer sequence  (Ilera et al. 1995b). Multiple ‘ATTA’ Emx2 
protein binding sites were identified across the HCNCS and a positive 
correlation was drawn between the strength of binding affinity between 
the Emx2 protein and the number of ATTA sequence sites in the DNA 
sequence. The data from this project suggests that the ATTA sequence is a 
factor in the binding between the two elements, although other factors 
may play a part too. 
Only sub-forms of the Emx2 structure were used in the EMSAs in 
this project, so no conclusions can be drawn as to the binding affinity with 
the Nkx1.2.1 sequence and the full Emx2 protein. The research produced 
from this project supports the idea that there is a specific and direct 
interaction between the Nkx1.2.1 element and the protein, further 
supporting the theory of a regulatory loop between Nkx1.2 and Emx2 
during the patterning in the ventral midbrain. 
 
6.3 Future Work 
The chicken genome has been fully sequenced but the sequence contains 
gaps, and some of these are orientated around the Nkx1.2 gene. From the 
published sequence a number of highly conserved non-coding sequences 
were identified through multiple species alignment of the genome 
sequence around the Nkx1.2 gene. A repeat of the experiments carried out 
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in this study utilising the sequences of the other identified HCNCS 
surrounding the Nkx1.2 would identify if they too played a role in gene 
patterning in the midbrain arcs.  Further to this, as additional  updates to 
the chicken genome are published, a repeat of the initial bioinformatic 
analysis can be carried out to discover if other HCNCS can be identified 
from areas not currently sequenced. From the previous research 
surrounding the expression and regulation of Emx2 in the midbrain 
(highlighted in Figure 6.1) it would be useful to identify candidate 
regulatory elements for the Emx2 gene, to establish if the Nkx1.2 protein 
binds directly, thereby confirming the hypothetical Emx2-Nkx1.2 
regulatory loop.  
The ENCODE data provides a useful tool to identify candidate 
regulatory elements for further study, but there is no neural cell line ChIP-
seq data in the Human ENCODE data to identify if HCNCS and Nkx1.2 
gene are active. The activity of an element can only be analysed in stem 
cells but not in differentiated neural cell lines, although this data is 
available in broader mouse data from the Mouse ENCODE information. 
The analysis of the chromatin formation around the Nkx1.2 gene in neural 
cells would help to identify other, neural specific regulatory elements that 
may only become active after differentiation of the stem cells into neural 
cells. 
Enhancers often work in conjunction with multiple elements to 
regulate transcription and, in all likelihood the Nkx1.2.1 element combines 
multiple different enhancers. In research looking at enhancer activity 
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associated with the SCL gene a regulatory element 3.7kb in size was 
identified which acted as an enhancer (Ogilvy et al. 2007), within this 
enhancer were multiple conserved transcription factor recognition 
sequences across the sequence, and with a 400bp core sequence (the same 
length as the Nkx1.2.1 element) essential for hematopoietic and midbrain 
patterning, so further in-depth analysis of the Nkx1.2.1 element is needed 
to identify the specific sites which govern the activity of the sequence, and 
if the enhancer is active specifically in association with Nkx1.2 expression 
in the midbrain, as opposed to the spinal cord (Spann et al. 1994). 
Mutation analysis of the ATTA sites within the Nkx1.2.1 sequence would 
be useful both for electroporation experiments and EMSA experiments. 
This would show whether the ATTA sequences (identified as possible 
binding sites by Catena et al. 2004) are the sites to which Emx2 binds to 
during midbrain arc patterning.   
This project identifies one regulatory element in the regulatory loop 
which occurs between Nkx1.2 and Emx2, but there is still more to 
investigate; the effect of the Nkx1.2 protein on the Emx2 gene would be an 
interesting line of enquiry, with the possibility that, just like in the case of 
Nkx1.2 and Emx2 there is one HCNCS associated with the gene and which 
also binds to the protein. Wnt and BMP have been shown to cooperatively 
regulate the expression of Emx2 in the dorsal telencephalon (Theil et al. 
2002), this research also identified an Emx2 enhancer immediately 
upstream of the Emx2 translational start site, which was bound by 
TCF/Lef cofactors and Smad1 and Smad5, further research into homeobox 
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binding sites within this, and possibly other Emx2 enhancers, would 
broaden the knowledge of the GRN within the developing brain.  
 
6.4 Contribution to Knowledge 
This project has identified a non-coding DNA sequence associated with 
the Nkx1.2 gene, with which sub-forms of the Emx2 protein can bind 
directly. From the experiments in this project this element is hypothesised 
to act as an enhancer involved in the regulation of the Nkx1.2gene by the 
Emx2 protein, which was observed in the patterning of the ventral 
midbrain arches of the chick embryo during development. 
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Appendix 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 1. Black and white photographs of embryonic stages of chick development.  
24 hours post incubation to 74 hours post incubation which refers to H&H stages ranging 
from 10 to 25 respectively. 
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Appendix 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2. 1.5% Agarose gels showing the results from the PRC screening of the 
construct verification at OPPF.  Panel A represents the first batch of colonies picked from 
the transformation of the plasmids, and panel B represents the second batch of colonies 
picked from the transformation of the plasmids. Lane 9 in both panel A and B contain 
Hyperladder 2 DNA marker.  
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Appendix 3 
 
Appendix 3. Analysis of the E. coli expression work carried out at OPPF.  The columns 
entitled “PCR verification” are analysis of the SDS gels. From there a clone was chosen 
(column “composite”) to be transformed for protein production. The analysis of the SDS 
PAGE gels are in the last 4 columns. L_IPTG relates to the results from the Lemo cells 
induced with IPTG. L_ONEX relates to the results from the auto-induced Lemo cells.  
R_IPTG relates the results from the Rosetta cells induced with IPTG. R_ONEX relates to 
the results from the auto-induced Rosetta cells. The cells are colour coded with positive 
results that can be used directly for further protein analysis in green, possible results that 
need further processing before use in further protein analysis in blue. + means that the 
protein has been produced but not in high quantities or with impurities in the gel, ++ 
means the protein has been produced in a relatively high concentration, and +++ means 
the protein has been produced in a high concentration. ? means the gel is not conclusive 
or the protein is not the right size. MBP indicates the presence of the maltose binding 
protein (MBP), SUMO indicates the presence of the SUMO protein, TOO BIG indicates 
the purified protein is too large to be the correct structure. 
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Appendix 4 
 
 
 
 
Appendix 4.1. SDS PAGE gels showing the results from Lemo cells induced 
with IPTG. Panel A shows the results from the wells A01 to H03 (see Figure 7.3) 
and panel B shows the results from wells A04 to H06. Gels show proteins 
purified using the Ni-NTA magnetic beads, with 5µl of low molecular weight 
protein marker (Bio-Rad) in lane 1 and 5µl of high molecular weight protein 
marker (Bio-Rad) in lane 26 of both gels.  
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Appendix 4.2. SDS PAGE gels showing the results from Rosetta cells induced 
with IPTG. Panel A shows the results from the wells A01 to H03 (see Figure 7.3) 
and panel B shows the results from wells A04 to H06. Gels show proteins 
purified using the Ni-NTA magnetic beads, with 5µl of low molecular weight 
protein marker (Bio-Rad) in lane 1 and 5µl of high molecular weight protein 
marker (Bio-Rad) in lane 26 of both gels.  
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Appendix 4.3. SDS PAGE gels showing the results from auto-induced Lemo 
cells. Panel A shows the results from the wells A01 to H03 and panel B shows the 
results from wells A04 to H06. Gels show proteins purified using the Ni-NTA 
magnetic beads, with 5µl of low molecular weight protein marker (Bio-Rad) in 
lane 1 and 5µl of high molecular weight protein marker (Bio-Rad) in lane 26 of 
both gels. The green arrow indicated protein that was of a high enough purity to 
warrant further analysis. 
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Appendix 4.4.  SDS PAGE gels showing the results from auto-induced Rosetta 
cells. Panel A shows the results from the wells A01 to H03 and panel B shows the 
results from wells A04 to H06. Gels show proteins purified using the Ni-NTA 
magnetic beads, with 5µl of low molecular weight protein marker (Bio-Rad) in 
lane 1 and 5µl of high molecular weight protein marker (Bio-Rad) in lane 26 of 
both gels.  
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Appendix 5 
 
 
 
Appendix 5. Conserved transcription factor binding sites within the Nkx1.2 
element comparing the mouse and chick sequence using Vista software. A total 
of 32 transcription factors were found to bind at 33 transcription factor binding 
sites on the sequence. The alignments show varying levels of conservation across 
the sequence (shown in red at the base of each panel). Putative conserved TFBS 
positions are shown as coloured boxes and identified down the left of the Panels. 
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Appendix 6 
 
 
 
  
Appendix 6. OPPF application conformation. 
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Appendix 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 7.1 An SDS PAGE gel showing the results from the protein 
expression study in insect cells using the baculovirus system, 72 hours after 
incubation of the virus with 3ul of vector.  The gel shows the results of soluble 
proteins from infected insect cells with each of the different vectors. Lanes 2 and 
11 contain a positive control sample of the eGFP protein. Lane 3 contains the full 
EMX2 sequence contained in the E vector, lane 4 contains the full EMX2 sequence 
contained in the F vector, lane 5 contains the full EMX2 sequence in the S3C 
vector, lane 6 contains the full EMX2 sequence contained in the TRX vector, lane 
7 contains the full EMX2 sequence contained in the M vector, lane 8 contains the 
full EMX2 sequence in the E3CHALO  vector, lane 9 contains the HD-C terminus 
longest homology sequence contained in the E vector, lane 10 contains the HD-C 
terminus longest homology sequence contained in the F vector. 5µl of low 
molecular weight protein marker (Bio-Rad) was added to lane 1 and 5µl of high 
molecular weight protein marker (Bio-Rad) in lane 12. 
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Appendix 7.2. An SDS PAGE gel showing the results from the protein 
expression study in insect cells using the baculovirus system, 72 hours after 
incubation of the virus wit 300ul of the vector. The gel shows the results of 
soluble proteins from infected insect cells with each of the different vectors. 
Lanes 2 and 11 contain a positive control sample of the eGFP protein. Lane 3 
contains the full EMX2 sequence contained in the E vector, lane 4 contains the full 
EMX2 sequence contained in the F vector, lane 5 contains the full EMX2 sequence 
in the S3C vector, lane 6 contains the full EMX2 sequence contained in the TRX 
vector, lane 7 contains the full EMX2 sequence contained in the M vector, lane 8 
contains the full EMX2 sequence in the E3CHALO vector, lane 9 contains the 
HD-C terminus longest homology sequence contained in the E vector, lane 10 
contains the HD-C terminus longest homology sequence contained in the F 
vector. 5µl of low molecular weight protein marker (Bio-Rad) was added to lane 
1 and 5µl of high molecular weight protein marker (Bio-Rad) in lane 12.  
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Appendix 8 
 
 
 
 
Appendix 8. MSA surrounding the Emx2 gene.  The level of base-pair sequence conservation of 
Emx2 orthologues; comparing the Human sequence against the mouse, Chicken, Pufferfish, 
Zebrafish and Xenopus sequences using Vista online programme 
(http://genome.lbl.gov/vista/index.shtml). The dark blue peaks represent exons and the light blue 
areas represent UTR’s. There are a number of HCNCS conserved across the majority of the 6 
species, as shown within the blue, yellow, red and green boxes. 
 
 
 
 
 
 
 
 
 
